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ABSTRACT 
Diagnostic delays and misdiagnoses are significant problems in modem healthcare, 
particularly in acute care and general practice. While computerised decision support 
systems have been used successfully to reduce errors in preventive care and drug 
prescription, a similar effect has not been achieved for diagnostic error. A newer 
generation diagnostic aid (Isabel), capable of rapid advice provision using a simplified 
user interface, was developed at St Mary's Hospital in 2000. This thesis describes a 
series of evaluations conducted to explore Isabel's effects on diagnostic decision- 
making in acute paediatric practice. Preliminary assessment of system performance by 
the developers using a wide variety of hypothetical and real cases indicated that Isabel 
demonstrated significant accuracy with minimal usage time. In the next stage of 
evaluation, clinicians used the system to make decisions on a balanced set of cases in a 
simulated field study. Changes in the quality of diagnostic assessment by various grades 
of subjects were measured before and after Isabel consultation. Since no suitable metric 
was available to perform this measurement, a new reliable and valid score was 
developed as part of this investigation. All grades of subjects benefited from the use of 
the diagnostic aid in easy and difficult cases. Despite variability in the clinical features 
input into the Isabel system, diagnostic suggestions did not vary significantly across 
subjects. In the next step of evaluation, an assessment of Isabel's impact on junior 
doctors' decision making was performed in a multi-centre clinical trial at four paediatric 
sites. Subjects improved their diagnostic performance by including a number of 
important diagnoses in their workup after system consultation. Numerous technical, 
cultural and systematic barriers prevented the routine use of decision support. Findings 
from this project provide valuable insights into how newer generation diagnostic aids 
can be designed and used to achieve a reduction in diagnostic error. 
3 
DECLARATION 
The work presented in this thesis is the work of the candidate. 
4 
ACKNOWLEDGEMENTS 
A number of people contributed to the work presented in this thesis with great 
enthusiasm. I could not have started on this wonderful journey in the world of 
informatics without the support of Joseph Britto, my clinical supervisor, whose 
boundless enthusiasm provided the constant motivation that I sorely needed to carry on 
each time I faltered. Paul Taylor, my informatics supervisor and pillar of support, was 
always there to offer valuable advice and suggestions throughout, always available for 
reassurance, prompting me to complete my thesis, never turning me away when I 
needed his opinion. Jeremy Wyatt's incisive analysis; Graham Roberts' obsessive 
attention to detail; Mandy Tomlinson's and Helen Fisher's hours of hard work; and 
Jason Maude's non-medical perspectives have all made this work not just possible but 
eminently enjoyable. Thanks are due to Vasanta Nanduri, Mike Coren, Roger Buchdahl, 
Andrew Winrow, Benjamin Jacobs and Nandu Thalange for supporting me through the 
various clinical studies. Thanks are also due to Henry Potts, who offered statistical 
advice. 
Without my wife Anupama's constant support and encouragement through the long 
hours of thesis writing stretching into the night and weekends, I cannot believe that I 
would have ever completed this work. 
I have also learnt enormously from the comments from hundreds of Isabel users and 
subjects in the clinical studies. It is to these anonymous people that I offer my final 
thanks - without their involvement, enthusiasm and effort, I could not have achieved 
any of the results in this thesis. 
5 
GLOSSARY 
ADE Adverse drug event 
AMA American Medical Association 
AME Adverse medical event 
CDSS Clinical decision support system 
CPOE Computerised prescriber order entry 
DDSS Diagnostic decision support system 
DOE Diagnostic error of omission 
DQS Diagnostic quality score 
EMR Electronic Medical Record 
HIV Human Immunodeficiency Virus 
HMPS Harvard Medical Practice Study 
MQS Management quality score 
NLPS Natural language processing software 
QAHCS Quality in Australian Healthcare Study 
QMR Quick Medical Reference 
SSL Secure Sockets Layer 
us United States 
UK United Kingdom 
6 
CONTENTS 
ABSTRACT ..................................................................................................................... 3 
DECLARATION ............................................................................................................. 4 
ACKNOWLEDGEMENTS ............................................................................................ 5 
GLOSSARY ..................................................................................................................... 6 
CONTENTS ..................................................................................................................... 7 
FIGURES ....................................................................................................................... 10 
Chapter 1: INTRODUCTION ...................................................................................... 11 
1.1 Scope of the thesis ............................................................................................................. 12 1.2 Medical adverse events and diagnostic error .................................................................... 14 1.2.1 Definition and epidemiology of error ....................................................................................... 14 12.2 Diagnostic errors ..................................................................................................................... 16 12.3 Summary ................................................................................................................................... 27 1.3 Clinical decision-support systems ..................................................................................... 28 1.3.1 Definition .................................................................................................................................. 28 13.2 Types of CDSS .......................................................................................................................... 29 1.3.3 Role of CDSS in the reduction oftnedical error ....................................................................... 30 1.3.4 Diagnostic decision support systems ........................................................................................ 32 1.3.5 Summary ................................................................................................................................... 40 1.4 The Isabel diagnostic decision support system ................................................................. 41 1.4.1 Origins ...................................................................................................................................... 41 1.4.2 Development process ................................................................................................................ 41 1.4.3 Novelfeatures ........................................................................................................................... 46 14.4 Summary ................................................................................................................................... 47 
Chapter 11: EVALUATION OF CLINICAL DECISION SUPPORT SYSTEMS. 48 
11.1 General principles of evaluation ...................................................................................... 49 H. 1.1 Early stages ofsystem evaluation ........................................................................................... 50 H. 1.2 Evaluation ofsystem impact ................................................................................................... 51 H. 1.3 Challenges in the evaluation ofDDSS .................................................................................... 52 11.2 Plans for evaluation of the Isabel system ......................................................................... 55 11.3 Summary .......................................................................................................................... 57 
Chapter III: EVALUATION OF ISABEL SYSTEM PERFORMANCE ............... 58 
111.1 Background ..................................................................................................................... 59 Iff. 1.1 Previous system performance evaluations ............................................................................. 59 Iff 1.2 Aims and study considerations .............................................................................................. 61 111.2 Materials and Methods ................................................................................................... 63 H1.2.1 Diagnostic reminder toolprototype ....................................................................................... 63 Iff 2.2 Study design and conduct ...................................................................................................... 66 111.3 Results ............................................................................................................................ 
69 
Iff. 3.1 Case material ......................................................................................................................... 69 Iff. 3.2 Clinical data .......................................................................................................................... 69 X. 3.3 Diagnostic accuracy .............................................................................................................. 69 111.3.4 Comprehensiveness and safety .............................................................................................. 72 1113.5 Relevance ............................................................................................................................... 73 111.3.6 Usage time ............................................................................................................................. 73 
111.4 Discussion ....................................................................................................................... 74 111.4.1 Proof of concept ..................................................................................................................... 74 Iff. 4.2 Diagnostic accuracy .............................................................................................................. 75 Iff. 4.3 Comprehensiveness and relevance ........................................................................................ 76 
7 
111.4.4 Usage time ......................................................................................................... 
77 
111.4.5 Limitations 
............................................................................................................................. 
78 
111.4.6 Summary andfuture work ...................................................................................................... 79 
Chapter IV: RESEARCH QUESTIONS .................................................................... 80 
IV. I Research context ............................................................................................................. 81 IV. 2 Research questions ......................................................................................................... 82 IV. 2.1 What is the effect on clinicians' decision making when they use the system during acute 
assessment in a simulated environment? .......................................................................................... 82 IV 2.2 What is the effect on junior doctors' decision making when they use the system during acute 
assessment in a clinical environment? .............................................................................................. 82 
Chapter V: DEVELOPMENT AND VALIDATION OF A SCORE TO MEASURE 
THE QUALITY OF CLINICAL DECISION-MAKING DURING ACU TE 
ASSESSMENT ............................................................................................................. . 83 
V. I Background ..................................................................................................................... . 84 V. 1.1 Outcome measures used to evaluate the impact ofDDSS ...................................................... . 85 V 1.2 The needfor a modified quality score .................................................................................... . 88 V. 2 Concepts used in development of a new quality score ................................................... . 91 V 2.1 Quality of entire plan vs. individual component items ............................................................ 91 V. 2.2 Accuracy versus appropriateness ........................................................................................... . 93 V. 2.3 Summary .................................................................................................................................. 94 V. 3 Scoring process ............................................................................................................... . 95 V 3.1 Pilot study ................................................................................................................................ 95 V 3.2 Construction of a clinical expert panel ................................................................................... 96 V. 3.3 Scoring process: step I Oudging the quality of individual items) ........................................... 97 V 3.4 Scoring process: step 2 (weighting the contribution of individual suggestions to overall plan 
quality) ............................................................................................................................................ 101 V 3.5 Scoring process: step 3 (ensuring relevance) ........................................................................ 102 V 3.6 Scoring process: step 4 (comprehensiveness) ....................................................................... 102 VA Validation of score ......................................................................................................... 104 V4.1 Reliability .............................................................................................................................. 104 V 4.2 Validity .................................................................................................................................. 105 V. 5 Discussion and summary ............................................................................................... 110 V 5.1 Main features of the new scoring system ............................................................................... 110 V. 5.2 Use of the expert panel .......................................................................................................... 113 V 5.3 Diagnostic and management quality scores .......................................................................... 114 V 5.4 Limitations ............................................................................................................................. 115 V 5.5 Summary andfuture work ..................................................................................................... 116 
Chapter VI: EVALUATION OF IMPACT ON CLINICAL DECISION MAKING 
IN A SIMULATED FIELD STUDY ......................................................................... 117 
V1. I Background .................................................................................................................. 
118 
VI. 1.1 Limitations ofsystem performance testing ........................................................................... 118 VI. 1.2 Needfor an Isabel impact evaluation .................................................................................. 119 V1.1.3 Aims and study design considerations ................................................................................. 121 V1.2 Materials and Methods ................................................................................................. 124 V1.2.1 Study design ......................................................................................................................... 124 VI. 2.2 Subjects ................................................................................................................................ 124 VI. 2.3 Case material ....................................................................................................................... 125 VI. 2.4 Study webs ite ........................................................................................................................ 127 VI. 2.5 Training ............................................................................................................................... 127 VI. 2.6 Study procedure ................................................................................................................... 128 V1.2.7 Intervention .......................................................................................................................... 130 VI. 2.8 outcome measures ............................................................................................................... 130 VI. 29Analysis, including statistical analysis ................................................................................ 132 
8 
VI. 2.10 Ethical and Regulatory considerations .............................................................................. 133 VI. 3 Results 
.......................................................................................................................... 
135 
VI. 3.1 Subjects 
................................................................................................................................ 135 VI. 3.2 Cases 
.................................................................................................................................... 136 VI. 3.3 Primary outcome measure ................................................................................................... 13, VI. 3.4 Secondary outcome measures .............................................................................................. 138 VIA Discussion .................................................................................................................... 142 
Chapter VII: EVALUATION OF SYSTEM IMPACT IN A MULTI-CENTRE 
CLINICAL TRIAL ..................................................................................................... 150 
V11. I Background ................................................................................ ................................. 151 VII. 1.1 Factors that influence the success of CDSS in the clinical setting ..................................... 151 VII. 1.2 Current status ofDDSS in clinical practice .................................. ..................................... 152 VII. 1.3 Aims and study design considerations ........................................... ..................................... 154 V11.2 Materials and methods ............................................................... ................................. 156 V11.2.1 Study centres .................................................................................. ..................................... 156 VI1.2.2 Participants ................................................................................... ..................................... 157 V112.3 Patients .......................................................................................... ..................................... 157 VII. 2.4 Study design ................................................................................... ..................................... 158 V11.2.5 Intervention .................................................................................... ..................................... 158 V11.2.6 Outcome measures ......................................................................... ..................................... 161 V71.2.7 Study procedure ............................................................................. ..................................... 161 VJI. 2.8 Analysis, including statistical analysis .......................................... ..................................... 164 VII. 2.9 Sample size estimation ................................................................... ..................................... 167 VII. 2.10 Ethical and Regulatory considerations ........................................ ..................................... 168 V11.3 Results ........................................................................................ ................................. 169 VII. 3.1 Study patients ................................................................................. ..................................... 170 VII. 3.2 Subjects .......................................................................................... ..................................... 173 VII. 3.3 'Unsafe'diagnostic workups ......................................................... ..................................... 174 VII. 3.4 Secondary outcomes ...................................................................... ..................................... 174 W. 3.5 Qualitative analysis ....................................................................... ..................................... 177 V11.4 Discussion .................................................................................. ................................. 178 VII. 4.1 Study design ................................................................................... ..................................... 178 VII. 4.2 Diagnostic uncertainty and DDSS use ........................................... ..................................... 179 VII. 4.3 Diagnostic reasoning ..................................................................... ..................................... 180 V11.4.4 Implications of the study results .................................................... ..................................... 181 V71.4.5 Limitations ..................................................................................... ..................................... 182 
Chapter VIII: CONCLUSIONS AND FUTURE WORK ....................................... 184 
V111.1 General discussion ..................................................................................................... 
185 
V111.2 Future work ................................................................................................................ 
188 
V111.2.1 Research into patient outcomes ......................................................................................... 
188 
V1112.2 Integration into an EMR .................................................................................................... 
188 
VIII. 2.3 Seýf-learning systems ......................................................................................................... 
189 
V111.2.4 Research in other care settings ......................................................................................... 
190 
REFERENCES ............................................................................................................ 
191 
9 
FIGURES 
Figure 1.1: Relationship between diagnostic process errors, misdiagnoses and adverse events ................. 22 
Figure 1.2: Stages of the diagnostic process ............................................................................................. .. 
23 
Figure 1.3: Typical components of a clinical decision support system ..................................................... .. 29 
Figure 1.4: Screenshot ftom DXplain ....................................................................................................... .. 39 
Figure 1.5: Screenshot of diagnostic tree within the Isabel knowledge base ............................................ .. 42 
Figure 1.6: Screenshot of the Isabel system clinical data entry page ........................................................ .. 44 
Figure 1.7: Screenshot of results displayed by the Isabel system ............................................................. .. 45 
Figure 11.1: Stages in the cycle of development and evaluation of DDSS ............................................... .. 49 
Figure 11.2: Step-wise evaluation program planned for the Isabel system ............................................... .. 55 
Figure IV. 1: User interface during system performance testing: clinical data entry ................................ .. 65 
Figure IV. 2: User interface during system performance testing: diagnostic reminders ............................. 66 
Figure IV. 3: Outcome of all cases collected for both stages of system performance evaluation ............... 73 
Figure V. 1: Diagnostic accuracy rates for individual hospitals using the De Dombal system ................... 85 
Figure V. 2: Creation of a fictitious aggregate list from panel members' and subjects' suggestions .......... 98 
Figure V. 3: Scale for diagnostic suggestion ratings and proposed weighting scheme ............................... 98 
Figure V. 4: Scale for management suggestion ratings and proposed weighting scheme ........................... 98 
Figure V. 5: Graphical depiction of entire scoring scheme ....................................................................... 100 
Figure V. 6: Weighting scheme applied to diagnostic items ..................................................................... 101 
Figure V. 7: Weighting scheme applied to clinical actions ....................................................................... 101 
Figure V. 8: Example of a TWSas and scoring procedure for one subject's post-DDSS diagnostic and 
management plan ..................................................................................................................................... 
103 
Figure V. 9: Correlation between DQS and MQS with median subjective score for quality .................... 107 
Figure V. 10: Correlation between median subjective score and DQS and MQS when weighting of 
individual item scores was not applied ..................................................................................................... 
108 
Figure V. 11: Correlation between median subjective score and raw DQS and MQS without subtrac ting 
irrelevant items ......................................................................................................................................... 
109 
Figure VI. 1: Traditional components of a clinical decision- support system ............................................ 120 
Figure VI. 2: Screenshot of simulated study procedure - step I ................................................................ 128 
Figure VI. 3: Screenshot of simulated study procedure - step 2 ................................................................ 129 
Figure V1.4: Flowchart of participants in simulated study ....................................................................... 
135 
Figure VIL 1: Screen I of the trial website used during the clinical trial .................................................. 159 
Figure VII. 2: Screen 2 of the trial website used during the clinical trial .................................................. 160 
Figure VII. 3: Allocation scheme for medical notes in the clinical trial ................................................... 164 
Figure VII. 4: Summary of patients enrolled in study ............................................................................... 169 
Figure V11.5: Number of subjects completing steps I and 2 during clinical trial ..................................... 173 
Figure VII. 6: Correlation between perceived benefit for clinical use and actual improvement in diagnostic 
quality ...................................................................................................................................................... 
176 
10 
Chapter 1: INTRODUCTION 
II 
Introduction 
Ll Scope of the thesis 
Medical error is a major problem in modem healthcare, resulting in significant patient 
harm in the form of death or disability. Despite the recognition that failures in the 
diagnostic process are common, and may account for a large proportion of preventable 
patient adverse events, computerised decision support systems (CDSS), used 
successfully to reduce other forms of error, have shown little impact on diagnostic error. 
In Chapter I of this thesis, the incidence and impact of medical error are described with 
a specific focus on diagnostic error; research related to the use of decision support 
systems, including diagnostic aids, is reviewed with a special emphasis on why 
diagnostic systems have so far failed in the reduction of error; and a description of the 
Isabel diagnostic reminder system is provided, including the candidate's role in the 
development of the system. Chapter II explores how CDSS can be evaluated from a 
clinical perspective; summarises the unique challenges associated with evaluation of 
CDSS; and describes the proposal for a step-wise evaluation of the clinical impact of 
the Isabel system, which constitutes the main body of this research project. Before 
undertaking an evaluation of Isabel's impact on users' decisions, it was important to 
ensure that the system provided accurate advice across a range of cases. In chapter 111, a 
validation exercise using hypothetical and real cases to test the system's performance in 
the hands of the developers, outside the setting of patient care, is described. 
The main research questions are summarised in chapter IV. Subsequent chapters detail 
the steps involved in the development of a new, reliable and valid score to objectively 
measure the quality of users' clinical diagnostic assessment (chapter V); a simulated 
field study in which clinicians of different grades use the Isabel system to process a set 
of balanced cases of varying degrees of difficulty to generate a diagnostic and clinical 
management plan with and without the assistance of Isabel advice (chapter VI); and 
finally, a multi-centre study in which junior doctors use the Isabel system in real life for 
cases in which the need for diagnostic assistance is felt (chapter VII). A number of 
insights gained as part of the research project are summarised in the concluding part of 
this thesis (chapter VIII). The main technical barriers to widespread use of decision 
support systems, and how these can be surmounted, are described; and various cultural 
and human barriers to the routine use of technology are explored. Lessons learrit from 
12 
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this work provide valuable pointers into how newer generation diagnostic aids that 
harness the power of Intemet-based search techniques can be designed and widely 
implemented in the future to reduce diagnostic error. 
13 
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L2 Medical adverse events and diagnostic error 
Medical error and adverse events have come under intense scrutiny following the 
publication of landmark reports in both the United Kingdom and United States 
(Department of Health 2000; Kohn, Corrigan et al. 2000). These reports estimated that 
between 50 and 100 000 humans died each year as a result of medical error, far greater 
than deaths caused by motor vehicle accidents, breast cancer or HIV/AIDS. 
1.2.1 Definition and epidemiology of error 
A recent review showed that as many as 25 different definitions of medical error have 
been used in the literature (Elder, Pallerla et al. 2006). One of the commonest 
definitions was adapted from James Reason's work and used in the Institute of 
Medicine (IOM) report: "the failure to complete a planned action as intended, or the 
use of a wrong plan to achieve an aim " (Kohn, Corrigan et al. 2000; Reason 2000). 
The term 'adverse medical events' (AME) is defined as "unintended injury or 
complication that results in disability at the time of discharge, death or prolonged 
hospital stay, and that is caused by health care management rather than by the patient's 
underlying disease process" (Baker, Norton et al. 2004). AME may or may not be 
caused by medical error. 
L2.1.1 Incidence 
Epidemiological work performed in the hospital inpatient setting over the past two 
decades reveals that the incidence of AME varies between 3.7 and 16% depending on 
location. Studies have now been reported from USA, UK, Dem-nark, Canada, New 
Zealand, and Australia (Brennan, Leape et al. 1991; Wilson, Runciman et al. 1995; 
Thomas, Studdert et al. 2000; Vincent, Neale et al. 2001; Davis, Lay-Yee et al. 2002; 
Baker, Norton et al. 2004). Variation in the incidence of AME may be primarily 
attributable to methodological differences, although the true risk of medical error may 
differ across continents (Thomas, Studdert et al. 2000). 
14 
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One of the landmark studies of medical error among hospital inpatients was the Harvard 
Medical Practice study (HMPS), in which medical charts of patients admitted to 51 
New York state hospitals were reviewed (Brennan, Leape et al. 1991). Subsequent 
studies, such as the Quality in Australian Healthcare Study (QAHCS) and the Canadian 
Adverse Events Study, adapted the study methodology first used in the HMPS (Wilson, 
Runciman et al. 1995; Baker, Norton et al. 2004). 
Table 1.1 summarises key findings from studies of medical error. 
Table 1.1: Summary of findings from key epidemiological studies of medical error among hospital 
inpatients 
HMPS QAHCS Colorado UK N. Zealand Canada 
Period studied 1984 1992 1992 1999 1998 2000 
No. of records screened 30,121 14,179 15,000 500 6579 3745 
Incidence of AME 3.7% 16.6% 2.9% 11.7% 11.2% 7.5% 
Preventable (%) 27.6t 50 30t 48 37 36.9 
Permanent disability (%) 2.6 13.7 7.5 6 10.2 5.2 
Death (%) 13.6 4.9 6.6 8 4.5 15.9 
t In the American studies, the focus was on medical negligence, rather than preventability 
There is scant evidence of medical error in the ambulatory care setting (Hammons, 
Piland et al. 2000). A recent systematic review reported that the incidence of AME 
ranged from 5-80 per 100 000 consultations. Errors in diagnosis were common (26- 
78%) and 60-80% of errors were considered preventable (Sandars and Esmail 2003). 
Preventable adverse drug events (ADE) were also frequent in this setting, occurring at a 
rate of 5.6 per 1000 person-months (Thomsen, Winterstein et al. 2007), and the 
frequency of drug errors was shown to be directly proportional to the number of 
medications prescribed (Gandhi, Weingart et al. 2003). 
L2.1.2 Types of error 
AME are usually classified on the basis of the healthcare process during which the error 
occurred. Roughly half the errors in the HMPS and the QAHCS were related to 
operative factors, although that this may simply reflect the ease with which these errors 
were picked up and identified from chart review (Weingart, Wilson et al. 2000). Among 
non-operative factors, considerable attention has been focused on medication errors, 
since they are common and easily amenable to prevention by the use of computerised 
15 
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drug prescription and dispensing systems (Bates, Leape et al. 1998; Neale, 
Woloshynowych et al. 2001). It has been shown that preventable ADE occurred most 
often during the ordering (56%) and administration stages (24%) (Bates, Cullen et al. 
1995). Drug errors are also common in outpatient care (Bhasale, Miller et al. 1998). In 
the QAHCS, human cognitive errors of omission (such as missed diagnoses) 
outnumbered errors of commission by two to one (Wilson, Harrison et al. 1999). Table 
1.2 shows different types of medical error (diagnostic errors highlighted), with estimates 
of their incidence based on three large epidemiological studies. 
Table 1.2: Contribution of different types of medical error to overall incidence 
HMPS Utah & Colorado New Zealand 
Operative 47.7% 44.9% 24.3% 
Drug errors 19.4% 19.3% 12.3% 
Procedure-related 7.0% 13.5% 7.7% 
Diagnostic 8.1% 6.9% 8.0% 
Treatment 7.5% 4.3% 8.4% 
System-related 3.3% 1.5% 24% 
L2.1.3 Consequences and cost 
Preventable adverse events have been estimated to cause as many as 50 000 deaths in 
the US, and 18 000 unnecessary deaths in Australia (Kohn, Corrigan et al. 2000). While 
errors result in significant patient morbidity and mortality, their implications on 
healthcare costs are also enormous. For England & Wales, the fiscal cost of AME was 
estimated to be an additional 3 million bed-days and fl billion per year (Alberti 2001). 
Each preventable ADE is estimated to cost between $2262 and $4685, and contribute to 
an extra 1.9 to 4.6 days of hospital stay (Bates, Spell et al. 1997; Classen, Pestotnik et 
al. 1997). In the outpatient setting alone, ADE were shown to account annually for 116 
million extra visits to the doctor, 76 million additional prescriptions, 8 million 
admissions to hospital and 199,000 additional deaths (Johnson and Bootman 1997). 
1.2.2 Diagnostic errors 
Although there has been considerable research into the main types and causes of 
medical error, diagnostic failures have been consistently understudied and poorly 
emphasised (Kuhn 2002). Since medical diagnosis precedes and therefore influences 
16 
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further patient management, errors in diagnosis may fundamentally change the direction 
of care, resulting in significant patient harm, related to both the immediate diagnostic 
process as well as treatment decisions made in the distant future. While patient safety 
initiatives have focussed on the readily available solution of computerised physician 
order entry systems (CPOE) to minimise medication error, the significant burden of 
diagnostic delays and misdiagnoses in both inpatient and ambulatory care has been 
neglected. A number of reasons have been proposed to explain this oversight. Errors in 
diagnosis are notoriously difficult to identify from medical chart review, particularly in 
the absence of a clear record of the cognitive processes involved during decision 
making; once errors have been discovered, it can also be a challenging task to assign 
causation and preventability. During chart review, it is often difficult to identify the 
specific individual and system-related factors leading up to a diagnostic mishap, and in 
the absence of a clear definition, sometimes it may not even be possible to agree on 
whether a diagnostic error has occurred (Graber 2005). Despite these limitations, 
diagnostic error is an important area of patient safety that merits further research, not 
least due to its considerable impact on patient morbidity and mortality (Health Grades 
2004). 
L2.2.1 Incidence of diagnostic error 
To date, there has been no prospective study to identify errors in diagnosis and to 
quantify the impact of these errors in terms of patient harm. Therefore, the true 
incidence and consequences of diagnostic error are unclear, and cannot be ascertained 
from one study or examined from a single perspective. Overall, available data 
consistently suggests that the rate of diagnostic error ranges from <5% in perceptual 
specialities such as radiology and pathology to 10-15% in most other fields. Incidence 
may also vary from setting to setting, with a higher rate demonstrated in the emergency 
department. 
Currently available data comes from five key sources: studies of medical adverse events 
leading to harm, studies of incident reports and potential adverse events, studies of 
malpractice claims, autopsy studies, and surveys of patients and health professionals. 
1.2.2.1. A Studies of medical adverse events 
17 
Introduction 
General medical error studies demonstrated that diagnostic failures occur in 8-10% of 
hospitalised patients. AME related to diagnosis occurred in 9% of patients hospitalised 
in New York State in 1984. Causes of error included failure to use indicated tests or act 
on test results, order appropriate diagnostic tests, and delays in reaching a diagnosis 
(Leape, Brennan et al. 1991). Similar results were observed in the QAHCS - failure of 
cognitive function such as the 'failure to synthesise, decide and/or act on available 
information' resulted in 16% of adverse events related to human error; 76% were 
judged preventable and one quarter led to serious permanent disability. Diagnostic 
delays accounted for 57% of all delays in this study; 87% were considered highly 
preventable, and a third led to permanent disability (Wilson, Harrison et al. 1999). The 
Canadian Adverse Event Study reported an incidence of 11 %, although specific data 
were unavailable to judge preventability and consequence (Baker, Norton et al. 2004). 
The proportion of error attributable to a breakdown in the diagnostic process, and its 
impact, is summarised in Table 1.3. 
Table 1.3: Summary of diagnostic error rates from general medical error studies 
HMPS Colorado UK New Zealand 
Overall diagnostic error rate 8.1% 6.9% 0.6% 8% 
Preventability (%) 75 93.8 100 78 
Permanent disability (%) 47 20.1 n/a n/a 
1.2.2.1. B Studies of incident reports 
Weingart et al used voluntary, confidential reports from house officers working on 
medical wards to identify actual and potential adverse events. 26.4% of events were 
related to diagnosis (inadequate evaluation in 16.4%; errors in making a diagnosis in 
6.4%; and delayed consultation in 3.6%). Diagnostic delays were responsible in nearly 
40% of all patients with an adverse outcome (Weingart, Ship et al. 2000). Similarly, in 
an Australian general practice study, physicians reported 28 diagnostic error incidents 
per 100 reports. The majority of diagnostic errors were missed diagnoses (42%), with 
misdiagnoses (27%), delays in diagnosis (22%) and diagnostic procedure-related 
complication (13%) accounting for the remainder. 13% of the patients died and a further 
8% had a severe permanent disability (Bhasale 1998). A summary of similar studies is 
shown in Table 1.4 (Makeham, Dovey et al. 2002; Chaudhry, Olofinboba et al. 2003). 
18 
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Table 1A Summary of diagnostic error rates from studies in small populations 
Author (Date) Context/Design Diagnostic error Comments 
rate 
Bhasale (1998) Incident reports by GPs in 28% Missed diagnoses (42%); 
Australia misdiagnoses (27%); delays 
(22%) 
Weingart (2000) Reported adverse events 26.4% 16.4% inadequate 
from house officers working evaluation; 6.4% errors in 
on medical wards diagnosis; 3.6% delayed 
consultation 
Makeham (2002) GP reports from 6 countries 14% in Australia; Patient harm in 32% overall; 
12% from other unclear how many due to 
countries diagnosis 
Chaudhry (2003) Reports from attending 19% Reports included near 
physicians working on misses and adverse events 
medical wards 
Disease- specific rates of misdiagnoses and delayed diagnoses have also been reported. 
In one study, the diagnosis of a ruptured abdominal aortic aneurysm was missed on the 
first visit in 61% cases, with significant mortality as a consequence. Ruptured 
aneurysms were most frequently misdiagnosed as urinary tract obstruction or infection, 
spinal disease, and diverticulitis (Lederle, Parenti et al. 1994). The diagnosis of chest 
pain has always been a clinical minefield. In a large study of patients with chest pain, 
Pope demonstrated an emergency department diagnostic error rate of 2.1 % in patients 
with a myocardial infarction. The risk-adjusted odds ratio for mortality was 1.9 in this 
subset of patients compared to the patients who were accurately diagnosed (Pope, 
Aufderheide et al. 2000). Table 1.5 summarises the results of a number of other disease- 
specific diagnostic error studies (Steere, Taylor et al. 1993; Lederle, Parenti et al. 1994; 
Craven 1996; Mayer, Awad et al. 1996; Edelman 2002; Goodson and Moore 2002; 
Kowalski, Claassen et al. 2004). 
Table 1.5: Summary of key disease-specific diagnostic error studies 
Author (Date) Disease studied Diagnostic 
error rate 
Comments 
Steere (1993) Lyme disease 57% Over-diagnosis was common in this 
condition. 
Craven (1994) Glaucoma 21.7% Mainly examined malpractice claims for 
missed diagnoses in glaucoma 
Mayer (1996) Symptomatic 25% 48% deteriorated before starting definitive 
cerebral aneurysm treatment 
Edelman (2002) Diabetes mellitus 18% Blood glucose readings meeting criteria 
for diagnosis of diabetes, but no record 'in 
medical notes 
Goodson (2002) Breast cancer 10% Missed diagnoses (5%); misreading 
mammogram (3%) 
Kowalski (2004) Subarachnoid 12% Most patients misdiagnosed as migraine or 
haemorrhage tension headache 
19 
Introduction 
1.2.2.1. C Studies of malpractice claims 
A significant proportion of claims that leading to successful legal compensation involve 
missed and delayed diagnoses or misdiagnosis (Bartlett 1998). In a recent study of 
closed malpractice claims involving 307 diagnostic mishaps in ambulatory care, it was 
reported that 59% of errors harmed patients (35% resulted in serious harm; 18% in 
death). Breast and colorectal cancer were the most common diseases involved (Gandhi, 
Kachalia et al. 2006). A similar analysis in the emergency department showed that 65% 
of claims associated with misdiagnoses resulted in patient harm (serious harm 30% and 
death 25%). Failure to order an appropriate test, failure to take an adequate history and 
perform a physical examination, and incorrect interpretation of a diagnostic test were 
the most common reasons for errors (Kachalia, Gandhi et al. 2007). Other studies have 
provided similar figures (Kravitz, Rolph et al. 1991; Flannery 1992; Silk 2001; Phillips, 
Bartholomew et al. 2004). A summary is shown below. 
Table 1.6: Summary of diagnostic error rates from studies of malpractice claims 
Author (Date) Context Diagnostic Comments I 
error rate 
I 
Flannery (199 1) 
Kravitz (199 1) 
Malpractice claims 
in Minnesota 
Malpractice claims 
in four specialities 
27% Cancer, thrombosis, 
fracture/dislocation, infection and lack 
of attendance were main diagnoses 
3-8% Failure to perform diagnostic tests or 
track test results 
Silk (2001) GP negligence 63% UK general practice sample 
claims 
Phillips (2004) Malpractice claims 
m primary care 
34% Some diseases associated with a high 
risk of diagnostic error 
1.2.2.1. D Autopsy studies 
Medical autopsies have traditionally been used as gold standard tests to diagnose 
conditions that were not discovered during ante-mortem care. A recent systematic 
review of autopsy studies and diagnostic error showed that 37 out of 53 studies showed 
class I errors (diagnoses that 'would', 'could', 'might' or 'possibly' have changed 
patient outcome, if known ante-mortem). Median class I error rate from these studies 
was 9% (range: 0-27%). A national extrapolation of the results indicated that national 
class I error rates could be as high as 6.7% (Shojania, Burton et al. 2003). Similarly, Tai 
et al showed a 20% diagnostic discordance rate between ante-mortem diagnosis and 
post-mortem findings. In 45% of these patients, knowledge of the diagnosis would have 
changed outcome significantly by modification of the treatment provided (Tai, El- 
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Bilbeisi et al. 2001). In a paediatric study of autopsy in the intensive care unit, Cardoso 
showed that class I errors occurred with a frequency of 12%. Unexpected findings in 
this group included viral or fungal infection and pulmonary embolism (Cardoso, 
Bourguignon et al. 2006). 
1.2.2.1. E Surveys of patients and health professionals 
There is substantial evidence that the public perceives diagnostic error to be a major 
problem. A Harris poll commissioned by the NPSF found that 2 out of 5 people (40%) 
had personally experienced medical error related to a misdiagnosis (Golodner 2004). In 
a telephone survey of 767 patients who had been seen in one of 12 emergency 
departments, 22% reported concerns that a misdiagnosis had occurred during their 
emergency department visit (Burroughs, Waterman et al. 2005). 
L2.2.2 Relationship between diagnostic error andpatient harm 
While there is considerable evidence of patient harm resulting from misdiagnoses, 
missed diagnoses and diagnostic delays, it is important to note that not all breakdowns 
in the diagnostic process result in adverse events. Indeed, the association between errors 
in the diagnostic process and adverse patient outcomes is complex and often difficult to 
tease out. Based on a model used to delineate the relationship between medication errors 
and patient safety, three inter-related sets can be identified in the relationship between 
diagnostic errors and harm (Bates 1996). This model was used by Schiff to analyse the 
impact of diagnostic error as part of a multi-institutional project for the AHRQ (Schiff, 
Kim et al. 2005); it is used throughout this thesis to explain the relationship between 
process errors, misdiagnoses (or missed diagnoses and diagnostic delays) and patient 
adverse events leading to harm (Figure 1.1). 
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Figure I. I: Relationship between diagnostic process errors, misdiagnoses and adverse events 
Advers( 
c process 
ors 
Misdi 
1. Errors in the diagnostic process only e. g. failure to examine the abdomen in patient with abdominal pain. 
2. Misdiagnosis resulting from a diagnostic process error e. g. missed diagnosis of appendicitis as a result of not 
examining the abdomen in a patient with abdominal pain. 
3. Adverse event occurring from a misdiagnosis as above e. g. peritonitis from a ruptured appendix as a result of a 
missed diagnosis of appendicitis. 
4. Patient harm from a diagnostic process error e. g. perforation of colon from colonoscopy done on the wrong 
patient. 
5. Misdiagnosis with no fault identifiable in the process e. g. incidental discovery of carcinoma of colon on autopsy. 
6. Adverse event due to misdiagnosis but no process error e. g. atypical presentation of myocardial infarction such 
as with no chest pain. 
7. Patient adverse event not related to misdiagnosis or breakdown in the diagnostic process e. g. death from 
correctly diagnosed myocardial infarction. 
L2.2.3 Factors responsiblefor diagnostic error 
Diagnosis has always remained the exclusive preserve of a physician; therefore, much 
of the research conducted over the past few decades into the cognitive psychology of 
diagnostic problem-solving focussed on the individual physician (McGuire 1973; 
Kassirer 1989; Bowen 2006). Diagnostic errors were attributed to an individual's 
cognitive failures; solutions were often sought in medical educational interventions or 
meta-cognitive approaches (Croskerry 2000; Graber 2003; Groves, O'Rourke et al. 
2003). Early work from Kassirer and recent publications from Graber have led to a 
more comprehensive understanding of the causes for diagnostic mishaps. Diagnostic 
errors were classified into 'no-fault' errors (where no fault can be attributed to the 
medical team, i. e. atypical or delayed clinical presentation), system-related errors, and 
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cognitive errors related to the individual clinician's decision making (Kassirer and 
Kopelman 1989; Graber, Franklin et al. 2005). This approach has led to the adoption of 
a more comprehensive view of diagnostic error, shifting the emphasis from the 
individual alone to the individual as part of a tightly knit healthcare system. 
One of the most powerful heuristics in medication safety to help localise where errors 
occur has been delineation of the steps in the medication-use process (prescribing, 
transcribing, dispensing, administering and monitoring). A similar approach has been 
described by Schiff et al in their AHRQ report on diagnostic error. The process of 
medical diagnosis was divided into the following stages: access/presentation, history 
taking/data collection, physical examination, testing, assessment, referral and follow-up 
(Schiff, Kim et al. 2005). This framework allows the study of diagnostic errors in a 
structured fashion and simplifies the identification of the factors responsible for errors 
at each stage in the process. An expanded version of this taxonomy, with further details 
against each stage, is shown in Figure 1.2. 
Figure 1.2: Stages of the diagnostic process 
Stages at which diagnostic errors occur 
I Access or clinical presentation 
History taking 
Physical examination 
Testing 
Ordering 
Performing 
Processing 
Assessment 
Hypothesis generation 
Hypothesis weighting 
Ref , erral or consultation 
Follow-up 
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1.2.2.3. A Clinical presentation and information gathering 
Delayed presentation by patients and inequitable access to healthcare constitute 
important factors leading to diagnostic delays and missed diagnoses, accounting for 9- 
10% of such errors in ambulatory care (Gandhi, Kachalia et al. 2006). Similarly, failure 
to elicit critical pieces of history from the patient, misinterpretation of history and 
physical signs, and suboptimal weighting of vital pieces of information have been 
shown as common causes for error. In a study of diagnostic error conducted at five large 
academic medical centres over 5 years, Graber identified 548 different system-related or 
cognitive factors from a review of 100 cases. 12% of cognitive errors were associated 
with faulty information gathering, related to incomplete history or physical 
examination. Moreover, errors in faulty information gathering were commonly 
associated with other cognitive and system-related errors (Graber, Franklin et al. 2005). 
Diagnostic tests form an important part of clinical information used to generate 
diagnostic hypotheses. Ordering the wrong test, delays in ordering tests or failure to 
order the right tests in the correct sequence may all contribute to diagnostic errors. In a 
study of 79 diagnostic errors in an emergency department, Kachalia et al found that the 
most common attributable cause was failure to order the appropriate laboratory tests 
(58%). Performance of the test may be affected by various system-related errors such as 
mix-up of samples, incorrect processing of samples, erroneous test results, and delayed 
communication of the test results to the clinician. This step is usually amenable to 
system-wide interventions. In a study of the use of an automated alerting system that 
communicated abnormal test results immediately by alphanumeric pager to the ordering 
clinician, thus reducing delays in clinicians accessing vital test results, it was shown that 
over a6 month period, physicians responded to 58% of the pager alerts within 15 
minutes and used the system over 2300 times a month (Kuperman, Teich et al. 1996; 
Poon, Kuperman et al. 2002). Clinician processing of available test results may also 
lead to breakdown in the diagnostic process. Examples include delayed or failed actions 
and incorrect interpretation of the test result. Such errors occur in 6% of cases (Graber, 
Franklin et al. 2005). 
1.2.2.3. B Assessment 
A significant proportion of errors, irrespective of setting, occur due to faulty synthesis 
of the information collected during history, physical examination and test ordering. 
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Early work from Kassirer, Gorry and others contributed enormously to the 
understanding of the cognitive aspects of diagnostic decision making, and indicated that 
the information processing step can be split into two stages for further examination - 
hypothesis generation and hypothesis weighting (Gorry and Barnett 1968; Gorry and 
Barnett 1968; Kassirer 1989; Kassirer and Kopelman 1989; Arocha, Patel et al. 1993; 
Patel and Kaufman 1994). Recently, a third stage has been emphasised - the importance 
of recognising the urgency and seriousness of some diagnoses and prioritising them 
above other more plausible but less serious diagnoses (Schiff, Kim et al. 2005). 
Elstein described diagnostic reasoning as a classic example of complex decision making 
under uncertain conditions (Elstein, Kleinmuntz et al. 1993; Elstein and Schwartz 
2002). Traditional theorists postulated that medical diagnosis occurred as a hypothetico- 
deductive process. In this paradigm, clinicians generated a list of diagnostic hypotheses 
to explain initial clinical findings based on their knowledge and clinical experience, 
sought further information from evolving changes in patient condition, and constantly 
modified the list to fit newly available evidence, until a definitive diagnosis was 
eventually made (Nurcombe and Fitzhenry-Coor 1987). The problem-based approach 
gained popularity in later years (Kilroy 2004). More recently, the relevance of the 
hypothetico-deductive model during real life decision making has been questioned 
(Croskerry 2003). It is postulated that while clinicians may often resort to a 
hypothetico-deductive approach during unfamiliar clinical situations, the majority of 
routine diagnostic decision making relies on the use of rules of thumb (heuristics) as 
part of a fast and frugal technique designed to maximise the efficiency of the diagnostic 
process, a model with its basis in pattern recognition (Moskowitz, Kuipers et al. 1988; 
Elstein 1999). While, for the most part, these heuristics work in the clinician's favour, 
they predispose the decision maker to inherent biases, leading ultimately to diagnostic 
errors. Kassirer described some of these biases in early studies; Croskerry recently 
reviewed a number of cognitive biases in diagnostic decision making in the emergency 
department (Kassirer and Kopelman 1989; Kassirer and Kopelman 1990; Croskerry 
2002). A list of some of the salient biases is provided in Table 1.7. 
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Table 1.7: List of salient cognitive biases occurring during diagnostic decision making 
Anchoring The tendency to perceptually lock onto salient features in the patient's initial 
presentation too early in the diagnostic process, and failing to adjust this 
initial impression in the light of later information. 
Availability The disposition to judge things as being more likely, or frequently occurring, 
if they readily come to mind. Thus, recent experience with a disease may 
inflate the likelihood of its being diagnosed. Conversely, if a disease has not 
been seen for a long time (is less available), it may be under-diagnosed. 
Confirmation bias The tendency to look for confirming evidence to support a diagnosis rather 
than look for disconfirming evidence to refute it, despite the latter often being 
more persuasive and definitive. 
Diagnosis momentum Once diagnostic labels are attached to patients they tend to become stickier 
and stickier. What might have started as a possibility gathers increasing 
momentum until it becomes definite, and all other possibilities are excluded. 
Framing effect How diagnosticians see things may be strongly influenced by the context in 
which the problem is framed, e. g., physicians' perceptions of risk to the 
patient may be strongly influenced by whether the outcome is expressed in 
tenris of the possibility that the patient might die or might live. 
Multiple alternative bias A multiplicity of options on a differential diagnosis may lead to significant 
conflict and uncertainty. The process may be simplified by reverting to a 
smaller subset with which the physician is familiar but may result in 
inadequate consideration of other possibilities. 
Outcome bias The tendency to opt for diagnostic decisions that will lead to good outcomes 
rather than those associated with bad outcomes. Physicians may express a 
stronger likelihood in their decision-making for what they hope will happen 
rather than for what they really believe might happen. This may result in 
serious diagnoses being minimized. 
Overconfidence bias A universal tendency to believe we know more than we do. Overconfidence 
reflects a tendency to act on incomplete information, intuitions, or hunches. 
Too much faith is placed in opinion instead of carefully gathered evidence. 
Premature closure A powerful bias accounting for a high proportion of missed diagnoses. It is 
the tendency to apply premature closure to the decision making process, 
accepting a diagnosis before it has been fully verified. The consequences of 
the bias are reflected in the maxim: "When the diagnosis is made, the 
thinking stops". 
Search satisfying This bias reflects the universal tendency to call off a search once something 
is found. Co-morbidities, second foreign bodies, other fractures, and co- 
ingestants in poisoning may all be missed. 
Sutton's slip The diagnostic strategy of going for the obvious is referred to as Sutton's 
law. The slip occurs when possibilities other than the obvious are not given 
sufficient consideration. 
Sunk costs The more clinicians invest in a particular diagnosis, the less likely may be to 
release it and consider alternatives. For the diagnostician, the investment is 
usually time and mental energy and, rarely, ego. Confirmation bias may be a 
manifestation of such an unwillingness to let go of a failing diagnosis. 
Triage cueing The triage process occurs throughout the health care system, from the self- 
triage of patients to the selection of a specialist by the referring physician. 
Many biases are initiated at triage, leading to the maxim: "Geography is 
destiny. " 
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1.2.2.3. C Referral and follow-up 
Failure or delay in ordering an appropriate referral or consultation can also lead to 
diagnostic error. Graber also reported a number of instances where patient follow-up 
was not arranged, thus resulting in a delayed diagnosis (Graber, Franklin et al. 2005). 
1.2.3 Summary 
Medical error is unfortunately a frequent occurrence in both hospital and ambulatory 
settings. Studies indicate that diagnostic error, resulting from individual or system 
failures at one or more stages of the medical diagnostic process, is an often neglected, 
but significant, cause of patient morbidity and mortality. Human cognitive as well as 
various system-related factors contribute to the occurrence of diagnostic error. Several 
strategies to improve human reasoning such as meta-cognitive and educational 
approaches have been described, although none have an established evidence base to 
support widespread adoption in practice. The success of computerised decision support 
systems in reducing other forms of medical error offers the most promise; decision 
support systems have the advantage of providing immediate, context- specific advice at 
the point of care during decision-making, with the effect of promoting best practice in a 
consistent and continuous manner. 
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L3 Clinical decision-support systems 
Clinical deci sion- support systems (CDSS) are computerised tools that have been 
proposed as a key solution towards the reduction of medical error and improvement in 
the quality of healthcare delivery (Bates, Cohen et al. 2001). Numerous CDSS have 
been developed over the past decades, although their implementation in clinical 
practice, adoption by clinicians, and consequently the realisation of their full potential, 
has been limited to a few sites. 
1.3.1 Definition 
Shortliffe defined CDSS as "any computer program designed to help health 
professionals make clinical decisions" (Shortliffe, Perreault et al. 2000). This broad 
definition covers a number of systems that function at a general level, leaving the 
interpretation of the information provided to the clinician, and making no effort to 
advise the user what particular information is necessary to resolve a clinical problem. 
Examples include hospital information systems such as the HELP system (Gardner, 
Maack et al. 1992), information-retrieval systems such as PubMed (National Library of 
Medicine), and alerting tools that accompany many clinical-laboratory systems. 
Wyatt described CDSS as "computer based tools that use explicit knowledge to 
generate patient-specific advice or interpretation" (Wyatt 2000). This definition only 
includes advanced computerised tools that use two or more pieces of patient data to 
provide advice tailored to the individual patient, e. g. a system intended to offer 
antibiotic prescription advice for a patient with an infection (Shortliffe, Davis et al. 
1975) or a diagnostic tool that provides a list of diagnostic possibilities for a given 
patient's clinical features (Miller, Masarie et al. 1986). In order to maintain uniformity, 
the latter definition is used to describe CDSS in the remainder of this thesis. 
The key components of a CDSS include a: 
a. Knowledge base that contains the medical facts or rules in computer-readable 
format 
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b. Inference engine that represents the algorithms used to generate patient- specific 
advice, and 
c. User interface that the users interact with , in order to enter information and 
view the system's recommendations. 
The key components of a CDSS, and their inter-relationships, are shown in Figure 
. 3. 
Figure 1.3: Typical components of a clinical decision support system 
Patient data 
I 
User interface I Patient-specific advice 
Inference engine 
Knowledge Base 
The performance of a computerised system depends on the efficient functioning of each 
of the three crucial components, as well as the way they interact with each other. The 
strength of an extensive knowledge base may be lost if the inference engine does not 
provide sufficiently specific advice personalised to the patient, or if the user interface 
forces a prolonged and complicated interaction with the system (Wyatt 2000). 
1.3.2 Types of CDSS 
Over the years, decision support systems have evolved to support different types of 
patient care decisions (Denekamp 2007). CDSS may be classified according to the 
nature of decision supported: diagnosis, drug-prescription, selection of treatment 
choices, preventive care interventions and others (Table 1.8). 
Table I. S: Types of clinical decision support based on system function 
Intended function Example(s) 
Diagnostic advice Diagnosis of abdominal pain e. g. de Dombal system 
Drug prescription Commercial prescriber order entry systems 
Choice of treatment NIYCIN system used to advise on appropriate antibiotic choices 
Preventive care tasks Reminding clinicians to order mammograms 
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It is also possible to categorise CDSS with respect to the mode by which their primary 
function is fulfilled (Randolph, Haynes et al. 1999), as summarised in Table 1.9. 
Table 1.9: Decision support systems categorised by the mode of advice provision 
Mode of advice Example 
Alerting Highlighting abnormal laboratory results 
Reminding Reminders to schedule a mammogram 
Critiquing Rejecting a prescription for parenteral. nutrition 
Interpreting Providing a result for an electrocardiogram 
Predicting Severity of illness scoring systems 
Diagnosing Suggesting a differential diagnosis for chest pain 
Assisting Selection of antibiotic choices 
Suggesting Adjustment to mechanical ventilator settings 
A given CDSS may fulfil many different functions within the same decision-making 
domain. The QMR system for diagnostic assistance in internal medicine provides 
diagnostic suggestions in response to a clinical query. It can also be interrogated in a 
critiquing mode, and functions as an information retrieval system by providing 
information about diseases in an educational environment (Miller and Masarie 1989). 
1.3.3 Role of CDSS in the reduction of medical error 
The use of clinical decision-support to assist clinicians' decision-making has been 
described as one of the most promising approaches to the reduction of medical error 
(Chaudhry, Wang et al. 2006). There is now considerable evidence from systematic 
reviews that the use of CDSS can improve physician behaviour and, to a lesser extent, 
influence patient outcomes. In a recent review of controlled clinical trials assessing the 
impact of CDSS in various clinical settings, Garg et al showed that 62 out of 97 studies 
(64%) that assessed changes in physician behaviour, and 7 out of 52 studies (13.5%) 
that assessed patient outcomes, demonstrated clear benefits (Garg, Adhikari et al. 2005). 
The types of CDSS that influenced clinician performance strongly assisted clinicians in 
drug-dosing or preventive care decision making, rather than diagnosis. Garg's review 
included forty additional studies in comparison to an earlier review (Johnston, Langton 
et al. 1994), pointing to the increasing use and evaluation of CDSS in healthcare since 
the early 1990s. 
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L3.3.1 Impact of CDSS on medication error 
There is strong evidence that CDSS reduce drug prescribing errors. In a landmark study, 
Bates studied more than 6700 admissions to a large tertiary centre in Boston. In phase I 
of their study, baseline data were collected on non-intercepted serious medication 
errors. In phase 2 (intervention phase), all units participating in the study used a CPOE 
system to prescribe medications, while a random half also had a team intervention 
designed to reduce dispensing and drug administration errors. The CPOE enabled 
electronic prescription, drug-allergy checking, drug-drug interaction checking and drug- 
laboratory checking as decision-support functions, and was integrated into the hospital's 
Integrated Computing System. When identical units were compared from phase I to 
phase 2, non-intercepted serious medication errors had reduced by 55%. Importantly, 
the team + CPOE intervention did not confer any additional advantage over CPOE 
alone in the reduction of preventable adverse drug events (Bates, Leape et al. 1998). 
Since this early study, other authors have confirmed the utility of CPOE in the reduction 
of medication errors (Evans, Pestotnik et al. 1998; Cordero, Kuehn et al. 2004; Potts, 
Barr et al. 2004). A recent systematic review of the impact of CPOE systems on 
medication error and adverse drug events showed that there was an overall positive 
effect on safety, although the majority of studies included were non-randomised in 
nature (Eslami, Keizer et al. 2007). 
L3.3.2 Impact of CDSS on preventive care 
Provision of preventive care reminders by CDSS has been shown to consistently reduce 
errors of omission. In a large randomised controlled study performed at the Regenstrief 
Institute for HealthCare in Indianapolis, USA, the investigators showed that 
computerised reminders resulted in significantly higher adjusted ordering rates for 
pneumococcal vaccination (35.8 % vs. 0.8%), influenza vaccination (51.4% vs. 1%), 
prophylactic heparin (32.2% vs. 18.9%) and prophylactic aspirin at discharge (36.4% 
vs. 27.6%) (Dexter, Perkins et al. 2001). In a similar multiple site study in ambulatory 
care clinics in the Veterans Affairs system, Demakis showed that resident physician 
compliance with pre-defined standards of care was significantly higher in the group that 
was provided computerised reminders (58.8% vs. 53.5%). Standards of care covered a 
wide range of medical conditions such as diabetes, coronary artery disease, peripheral 
vascular disease, anticoagulation, atrial fibrillation and myocardial infarction (Demakis, 
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Beauchamp et al. 2000). Numerous examples of preventive care decision support 
systems have been described in the literature, with similar effects on physicians' clinical 
practice (Ornstein, Garr et al. 1991; Overhage, Tierney et al. 1996; Tang, LaRosa et al. 
1999). 
L3.3.3 Factors associated with success of CDSS 
In their systematic review, Garg et al studied the factors responsible for CDSS success 
in changing clinical practice and found that systems in which users were provided 
advice in the workflow demonstrated greater impact than systems that functioned in 
standalone fashion. The authors also showed that the success of CDSS was related to 
local champions, who were usually the system developers themselves (Garg, Adhikari 
et al. 2005). In a similar vein, other authors have shown that automatic provision of 
decision support as part of clinician workflow, provision of recommendations rather 
than just assessments, provision of decision support at the time and location of decision 
making, and computer-based decision support constituted significant factors that led to 
the success of CDSS (Kawamoto, Houlihan et al. 2005). 
1.3.4 Diagnostic decision support systems 
Interest in the concept of computerised diagnostic decision- support was sparked by a 
seminal paper on how computers might assist in the process of medical diagnosis 
(Ledley and Lusted 1959). A number of diagnostic decision support systems (DDSS) 
were subsequently developed and evaluated, both for general medical use and for use in 
specific diseases. Many were described as 'expert' systems and designed to function 
like expert diagnosticians. Interest in diagnostic systems waned when systematic 
reviews in the 1990s demonstrated that they had failed to assume a central role during 
diagnosis in clinical practice despite years of research, and showed little impact on 
improving healthcare processes or patient outcomes (Langton, Johnston et al. 1992). A 
brief summary of DDSS is provided with a review of the salient technical approaches 
adopted during system development. 
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L3.4.1 DDSSfOr specific clinical problems or diseases 
The early computerised systems employed a number of different reasoning strategies to 
provide diagnostic advice: clinical algorithms, pattern-recognition techniques, Bayesian 
statistics (probabilistic reasoning), symbolic reasoning (expert systems) and decision- 
analysis. Bayesian principles were commonly used in the development of some of the 
most successful and well-known DDSS, and are commonly employed during medical 
decision making (Diamond 1999). 
1.3.4.1. A Cardiac problems 
A significant amount of research focussed on the use of DDSS in cardiovascular 
problems such as hypertension, chest pain, congenital heart disease, and coronary artery 
disease. One of the first computerised systems that used Bayesian reasoning was 
developed by Warner in the late 1950s to provide specific advice for the diagnosis of 
congenital heart disease. The knowledge base was constructed from data drawn from 
1035 patients, from literature review, and from experts' estimates. Diagnoses 
ascertained at cardiac catheterisation or autopsies were used as the gold standard. A 
matrix of 50 different findings was associated with 33 congenital heart lesions. For a 
given set of clinical features, diagnostic suggestions were provided by the system after 
calculation of the statistical probabilities using Bayes theorem (Warner, Toronto et al. 
1961). During evaluation, the diagnostic accuracy of this system matched that of three 
congenital heart disease experts (Toronto, Veasy et al. 1963). 
The correct identification of a cardiac cause of chest pain (e. g. acute myocardial 
infarction) has been a key objective for a number of DDSS. In 1984, Pozen reported the 
evaluation of a predictive instrument to help emergency physicians reduce the number 
of unnecessary admissions to coronary care units (CCU). Using data derived from 2801 
patients, a diagnostic aid was developed for bedside use on a handheld calculator. In a 
multicentre trial, physicians' diagnostic accuracy for cardiac ischaemia improved when 
the aid was used, and unnecessary admissions to CCU decreased by 30% (Pozen, 
D'Agostino et al. 1984). In 1989, Wyatt reported a study on the use of ACORN, a 
hybrid Bayesian and rule-based DDSS for chest pain. The system had a false negative 
rate of 25% and a false positive rate of 20% for 174 cases when tested against the gold 
standard. However, in a randomised study involving 150 patients, the authors failed to 
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demonstrate a significant difference between the study and control groups (Wyatt 1989). 
In a more recent large multicentre controlled study of the use of an acute cardiac 
ischernia time-insensitive predictive instrument (ACI-TIPI), Selker showed that 
unnecessary admissions to CCU reduced by 4%. The instrument used basic details such 
as age, sex and whether chest or left arm pain was the main symptom, combined this 
with computerised electrocardiogram recording, and calculated the probability of acute 
cardiac ischaernia (Selker, Beshansky et al. 1998). A review of computerised systems 
for the interpretation of electrocardiograms for chest pain indicated a median accuracy 
of 91.3% (compared to cardiologists at 96%), although the best systems performed as 
well as the specialists (Willems, Abreu-Lima et al. 1991). 
Fraser recently described the Heart Disease program (HDP), designed to assist 
physicians in diagnosing heart disease, particularly conditions leading to heart failure. 
The knowledge base was organized as a causal network of relations including causal 
probability and temporal and severity constraints; the diagnostic algorithm handled it as 
a generalization of a Bayesian Belief Network. In an observational study of 114 cases, 
the HDP demonstrated higher sensitivity (53% vs. 34.8%) and comprehensiveness 
(57.2% vs. 39.5%) compared to physicians (Fraser, Long et al. 2003). 
1.3.4.1. B Abdominal problems 
One of the first Bayesian systems to be used at multiple clinical sites was the Leeds 
abdominal pain system developed by De Dombal and associates in the 1970s (de 
Dombal, Leaper et al. 1972). This system was developed to support triage of patients 
who presented to the emergency room with abdominal pain, the main function of the 
tool being to establish surgical versus non-surgical diagnoses. In their initial report, the 
authors included clinical findings and the correct diagnoses from 600 patients with 
acute abdominal pain to derive probabilistic estimates of common surgical conditions 
such as appendicitis, pancreatitis, cholecystitis and diverticulitis (de Dombal, Horrocks 
et al. 1971). The system was later developed to include data from over 6000 patients 
with abdominal pain from 13 countries. In a large multicentre study of over 16 000 
patients with acute abdominal pain, Adams et al showed that the overall diagnostic 
accuracy for surgical causes of abdominal pain improved from 45.6% in the baseline 
period to 65.3% when the system was used. Negative laparotomy rates fell by almost 
50%, as did perforation rate among patients with appendicitis (Adams, Chan et al. 
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1986). In Lithuania, Bogusevicius used data from 503 patients with bowel obstruction 
to develop a Bayesian diagnostic aid, which accurately diagnosed the cause of small and 
large bowel obstruction in 88.7% and 95.8% of cases respectively (Bogusevicius, 
Pundzius et al. 1999). In a prospective randomised study, the authors showed that 
although diagnostic accuracy rate did not differ between the DDSS and radiological 
studies, a correct diagnosis of bowel obstruction was made more rapidly with the 
system (I hour vs. 16 hours) (Bogusevicius, Maleckas et al. 2002). 
1.3.4.1. C Other clinical entities 
Aronsky described one of the most successful integrated DDSS for the diagnosis of 
community -acquired pneumonia in the emergency department from Tennessee. Data 
from 32 000 patients was used to train the Bayesian network to discriminate patients 
with pneumonia from other disorders, based on minimal data entry by the nurse or 
physician. The system was integrated into the electronic record system used in the 
emergency department, allowing automatic collection of the data items required for 
probability calculations. The system was shown to achieve a sensitivity and specificity 
of 95% and 96.5% respectively (Aronsky and Haug 1998). 
AI/RHEUM was developed for the diagnosis of rheumatological conditions by Bernelot 
Moens in 1991. Knowledge in this system was represented as evidential weights of 
findings. Simple weights were calculated as the logarithm of likelihood ratios on the 
basis of 1,000 consecutive patients from a rheumatological clinic (Bernelot Moens and 
van der Korst 1991). The authors validated the performance of the system in 1570 
consecutive patients with rheurnatological conditions. Average sensitivity and 
specificity for all 26 diagnoses present in the knowledge base were 67% and 98% 
respectively (Bernelot Moens 1992). The same system was adapted for paediatric 
rheumatology and studied by Athreya et al on 94 consecutive children. Al/RHEUM 
made the correct diagnosis in 92% of the cases when the diagnosis was available in the 
knowledge base of the system (Athreya, Cheh et al. 1998). A brief description of some 
of the disease-specific DDSS developed over the past few decades is provided in tabular 
fashion below: 
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Table 1.10: Examples of disease-specific diagnostic decision support systems 
Clinical entity Reasoning model Description 
Haernatological diseases Bayesian 40 diagnoses were represented in the knowledge 
(Engle, Flehinger et al. base. Validated in a set of 31 patients, with 
1976) reasonable accuracy. 
Depressive illness Rules-based A screening module integrated into an electronic 
(Rollman, Hanusa et al. ambulatory care record provided alerts to 
2002) physicians 
Diagnosis from urogram Bayesian Subjective probabilities were used to model the 
(Fryback and Thornbury database. Compared to inexperienced radiologists, 
1976) the system showed greater accuracy to distinguish 
between cyst, turnour and normal variants. 
Chest pain (Baxt and Skora Artificial Neural This DDSS showed a sensitivity and specificity of 
1996) network 96% for myocardial infarction among 1070 
patients with anterior chest pain 
Lymph node diseases Expert system An expert system that assists surgical pathologists 
(Heckerman and Nathwani in the diagnosis of lymph node diseases. 
1992) 
Detection of turnour mass Digital computer- Over 10 000 mammograms were read by the 
in mammograms (Gilbert, aided detection computerised system and by radiologists. 6.5% 
Astley et al. 2006) more cancers were detected by a single reading of 
the system versus double reading by experts. 
Neurological diagnoses Anatomy based A neurology diagnostic aid that uses anatomical 
(Citro, Banks et al. 1997) causal reasoning relationships in its knowledge base to pinpoint the 
location and thus narrow a differential diagnosis. 
Abdominal pain (Fathi- Fuzzy expert Rule-based, heuristic and case-based reasoning are 
Torbaghan and Meyer system used in this fuzzy expert system to diagnose the 
1994) cause of abdominal pain. 
L 3.4.2 General medical DDSS 
In contrast to the domain-specific examples of DDSS described above, general medical 
diagnostic tools aim to provide advice to clinicians in a wide range of scenarios in broad 
domains such as internal medicine and paediatrics. Many such systems were developed, 
some still commercially available, although none are in widespread clinical use (Weed 
and Hertzberg 1985; Hoffer, Feldman et al. 2005). The majority of systems used hybrid 
models of reasoning, albeit with a strong reliance on Bayesian principles (i. e. quasi- 
probabilistic), and were collectively described as 'expert' systems, since they were 
designed to function like a diagnostic expert. A brief review of two salient DDSS is 
provided. 
1.3.4.2. A INTERNIST- I/Quick Medical Reference (QMR) 
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The INTERNIST- I system was developed by in the 1970s (Miller, Pople et al. 1982). It 
was the precursor to the more widely used QMR system, which was developed in the 
1980s as a version of INTERNIST that could run on a personal computer (Miller, 
Masarie et al. 1986). 
Knowledge base and inference engine 
The main feature of both systems was an extensive computer-readable medical 
knowledge base containing >600 unique diseases and 4500 clinical findings, created 
and regularly updated by medical experts. Each disease was linked to 75-100 findings, 
and >4000 links were created between the 600 disorders in the database, based on 
causal, temporal and probable inter-relationships (Masarie, Miller et al. 1985). The 
system developers found it impossible to develop a true Bayesian system, since each 
clinical finding was associated with more than one disease, and conditional probabilities 
were not available for most of the diseases/findings in the knowledge base. Instead, an 
ad hoc scoring scheme was used to encode the relationships between specific findings 
and diseases as well as between diseases. During the creation of the knowledge base, a 
list of pertinent findings described for each diagnosis was first created through literature 
review and case discussions. Each finding was assigned a frequency weight (FW) and 
an evoking strength (ES), numbers that reflected the relationship between the finding 
and a disease (see 
Table 1.11). Each finding was also assigned an import value to a) represent the idea that 
some findings had limited significance while others had serious implications and must 
be explained and b) to handle the problem of 'red-herring' findings. Using these 
numerical scores, the program performed a simple calculation in response to the set of 
findings entered by the user, and provided a list of initial diagnoses for consideration. 
Table 1.11: Frequency weight and evoking strength of findings in the QMR knowledge base 
Score Frequency weight Evoking strength 
0 Non specific finding 
I Finding occurs rarely in disease Diagnosis is a rare cause of finding 
2 Finding occurs in substantial minority of cases Diagnosis causes a substantial minority of 
of the disease instances of disease 
3 Finding occurs in roughly 50% of cases of the Diagnosis is the most common, but not 
disease exclusive, cause of the listed finding 
4 Finding occurs in substantial majority of cases Diagnosis is the main cause of the finding 
of the disease 
5 Finding occurs always in disease Finding is pathognomonic of the diagnosis 
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As expected, the creation and regular maintenance of this extensive knowledge base 
was a difficult task. Myers dedicated 10-12 full person-years to the INTERNIST 
project, as did hundreds of medical students and fellows in computer medicine (Miller, 
McNeil et al. 1986). INTERNIST was stored on a mainframe computer at the 
University of Pittsburgh, which limited its accessibility; QMR was distributed on CD- 
ROM on physicians' PCs, which led to problems in disseminating the latest database to 
users. 
T T-- 
user interface 
Data entry was by means of a controlled vocabulary of terms present within the 
database, in the format prescribed by the system developers. It was not possible to use 
synonymous terms or phrase variations to search the database. Results were provided as 
a list of diagnostic suggestions. Notes against each suggestion indicated what additional 
clinical data would further support the diagnosis. 
1.3.4.2. B DXplain 
In 1987, Barnett reported a new diagnostic decision support system developed in the 
computer science laboratory of the Massachusetts General Hospital. The main aim of 
the system was to provide an easily usable diagnostic tool that would suggest to 
practising clinicians a list of possibilities to consider. The system was distributed 
through the telecommunications network of the AMA to physicians across USA 
(Barnett, Cimino et al. 1987). 
Knowledge base and inference engine 
The medical knowledge base was constructed from Current Medical Information and 
Terminology (CMIT), an AMA publication containing information on 3000 distinct 
diagnoses, disorders and conditions. A controlled vocabulary of words and phrases was 
generated from term lists contained in the CMIT, and similar terms linked together in a 
hierarchical manner. Since the database was stored centrally, and accessed by users on a 
network, updates to the knowledge base were immediately available to users. As of 
1987, DXplain contained 2000 diseases and 4700 terms, with 65000 relationships 
specified between them (Barnett, Hoffer et al. 1991). On average, each disease was 
associated with 35 terms. The underlying knowledge base model was influenced 
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associated with 35 terms. The underlying knowledge base model was influenced 
strongly by the INTERNIST system, although terms could not only support a given 
diagnosis, they could also refute other diagnoses. Similar to the INTERNIST, terms 
were scored for term importance, term frequency and term-evoking power. Based on the 
numerical values assigned to these relationships, the system generated a list of 
diagnostic suggestions. 
User interface 
Data entry was by means of a controlled vocabulary, although the system recognised 
common abbreviations, incorporated a spell check function, matched input terms to 
synonyms or similar terms in the database, and provided alternative options when exact 
matches were not found. Diagnoses were presented to the user as 'common' and 'rare' 
diagnoses. In addition, 'serious' diagnoses (that may require immediate attention) were 
highlighted. Figure 1.4 shows a screenshot from DXplain. 
Figure 1.4: Screenshot from DXplain 
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Examples of other DDSS developed and evaluated over the past few decades include 
ILIAD, MEDITEL, PKC and a number of commercial systems such as DiagnosisPro 
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1989; Warner 1990). These systems were developed on similar lines to the examples 
described above. 
1.3.5 Summary 
Clinical decision support systems have been shown to be an effective technological 
solution to the problem of medical error, particularly in the areas of preventive care and 
drug prescribing. However, diagnostic decision support systems have remained a 
notable exception to this rule. A number of disease- specific, as well as general medical, 
diagnostic systems have been developed and evaluated over the past few decades, 
although few have shown significant effects on physician behaviour or patient 
outcomes. Uncertainty continues to exist regarding the precise role of decision support 
systems and the most optimal means of using them in clinical practice. Without further 
research into these questions, it may be difficult to demonstrate how the use of 
computerised aids could reduce the frequency of diagnostic error. 
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L4 The Isabel diagnostic decision support system 
The Isabel system was first developed in 2001 as a Web-based diagnostic aid for 
paediatric practitioners (www. isabel. org. uk). The primary aim of the system was to 
provide users with a list of diagnostic suggestions for consideration during the initial 
workup of children presenting acutely to emergency departments and wards (Fisher, 
Tomlinson et al. 2003). Over the past few years, the system has evolved to support 
decision-making in all age groups and currently covers the full range of medical and 
surgical problems. 
1.4.1 Origins 
The system was conceived in 1999 by parents of Isabel Maude, a 3-year-old child who 
received and recovered from a prolonged period of intensive care at St Mary's Hospital 
in London. Her initial diagnosis of toxic shock syndrome from Group A Streptococcal 
super-infection of chickenpox lesions was delayed by local hospital staff, leading to 
multi-organ failure and the need for critical care (Ahuja 2001). Recognising the 
cognitive and system-wide deficiencies they had experienced first-hand, her parents 
established the Isabel Medical Charity. The charity's aim was to develop a 
computerised tool that would help clinicians consider rare and serious, but potentially 
treatable, conditions in the diagnostic workup. A medical team, led by Dr Britto from St 
Mary's Hospital, was set up to provide expert advice on the development of the system, 
and to validate the system in clinical practice (Britto 2004). 
1.4.2 Development process 
The working prototype evaluated in this thesis was developed over a period of 12 
months in 2000 and was released on the website in 2001 (version 1.0). The main aims 
of the development process were to a) produce a diagnostic aid that could be used by 
clinicians with little or no computer background; b) ensure that the system was 
universally accessible to clinicians around the world; c) use an easily available high 
quality medical knowledge base; d) enable users to seek and receive meaningful advice 
in a matter of seconds; e) serve as a source of reference material and seamlessly 
integrate the provision of medical knowledge with diagnostic advice. 
41 
Introduction 
L4.2.1 Knowledge base 
The main consideration during creation of the knowledge base was to avoid building a 
new complex database along the lines of the expert system model, which would involve 
many years of effort. Instead, readily available, reliable information pertaining to 
diagnoses was directly obtained from standard sources. The Isabel database was 
constructed from raw electronic text (plain text) from medical textbooks. In the first step 
of this process, a hierarchical classification of 3500 diseases was generated from the 
table of contents of one textbook (Nelson's Textbook of Paediatrics, 16 th edition, 
Elsevier). Figure 1.5 depicts part of the hierarchical diagnostic tree, with pre-existing 
relationships between disease entities. 
Figure 1.5: Screenshot of diagnostic tree within the Isabel knowledge base 
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Unformatted and uncoded text pertaining to each diagnosis in the tree was copied from 
the textbook into the database, and pasted, without any modifications, by a research 
nurse under the appropriate disease headings. Once text from one textbook was 
completed, another was used as the source. Where new disease labels were necessary to 
accommodate text from the new source, they were created within the same overall 
diagnostic tree model. Four textbooks were used - Nelson's Textbook of Pediatrics, 
Forfar and Arneil's Textbook of Paediatrics, Jones and Dargan Churchill's Pocket Book 
of Toxicology and Rennie and Roberton Textbook of Neonatology. At the end of this 
process, text relating to the same disease, from different sources, was collated under the 
same label in the database. Each diagnosis in the database was linked to one or more 
age groups in which the disease was usually seen (newborn, infant, child and 
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adolescent). This step was performed by the medical team, based on consensus expert 
opinion and a review of the text associated with the disease. A similar process was used 
to tag disease headings under the infectious diseases category with the appropriate 
geographical region(s) in which they were prevalent, based on World Health 
Organisation guidelines (e. g. North America, South East Asia). The entire database was 
thus created within a period of a few months. 
L4.2.2 Inference engine 
In order to utilise readily available text from medical textbooks as the source of 
knowledge, and to simplify rapid data entry by users, natural language processing 
software (NLPS) was used as the inference engine. The software used was 
commercially available (Autonomy, UK, www. autonomy. com) and had been 
extensively used in the industry for information management (Reuters Plus 2000). 
Autonomy employed advanced statistical algorithms to carry out Bayesian inference on 
unstructured text in order to extract a document's digital essence and encode the unique 
signature of key concepts within each document to generate a document profile. 
Concept agents were used to match document profiles with similar concepts as 
contained in the input text. By aggregating all the text related to one specific diagnosis 
under a single diagnostic label within the diagnostic tree, it was possible for the 
software to generate a unique signature of key concepts for each diagnosis (disease 
profile). Disease profiles included clinical findings described in the text as well as other 
terms unrelated to the clinical presentation. This profile was constantly modified with 
the addition of text from each additional source used to populate the database. When a 
user typed in clinical findings from a patient in free text, the inference engine generated 
a concept map, searched all disease profiles for a matching concept signature, and 
displayed the relevant diagnoses. Since the entire database was indexed every 24 hours, 
retrieval of matching diagnoses was achieved within milliseconds. 
L4.2.3 User interface 
The over-riding aim of system development was to ensure that the user interface was 
kept as simple as possible. After selecting the age (and geographical region) of the 
patient from drop-down menus, users entered clinical data by typing their search query 
into a free text box, which accepted any combination and amount of natural language 
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text. Optimal results were only obtained when numerical values were entered as 
appropriate text (e. g. a white cell count of 20 x 109/L to 'elevated white cell count). In 
order to convert non-medical terminology into medical terms automatically without any 
user effort,, an intermediate synonym filter was created within a 4-week period, 
consisting of common non-medical terms and matching medical terms. Synonyms were 
derived from expert opinion and analysis of entries input by volunteer subjects, and 
included medical abbreviations and spelling errors. Examples of terms included in the 
synonym filter included WBC (white blood cell), NAD (normal), hypoglycemia 
(hypoglycaemia), high temperature (fever, pyrexia) and vomtng (vomiting). Figure 1.6 
shows a screenshot of the data entry page. 
Figure 1.6: Screenshot of the Isabel system clinical data entry page 
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When the search query was submitted, the results page was displayed, containing 10-12 
diagnostic suggestions. Results were not arranged in order of likelihood, since there was 
no coded information on the clinical probability of diseases and findings in the 
database. Instead, diagnoses were sorted and displayed by the body system to which 
they pertained (respiratory, gastrointestinal etc. ) in an attempt to facilitate a system- 
based approach to diagnosis. Further reference material, such as explanatory text, 
images and related clinical pitfalls, could be accessed by clicking on each disease name 
shown on the results page. Figure 1.7 is a screenshot of the results page. 
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Figure 1.7: Screenshot of results displayed by the Isabel system 
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Remember: if the output appears irrelevant, try again using alternative terms. 
L 4.2.4 System architecture and delivery platform 
The entire Isabel system was designed as a Web-based decision support system. Since 
worldwide accessibility was a specific aim of the project; the system was made 
available to registered medical practitioners over the Internet at www. isabel. org. uk. The 
central component of the system was the Autonomy Dynamic Reasoning Engine TM 
(DRE), which was hosted on a dedicated web server. The database was created in 
MySQL and the dynamic web pages were created using Javascript. 
L4.2.5 Candidate's role in the development of the system 
The candidate was one of 5-6 members of the core team led by Dr Britto working on 
system development from 2000-2003. The candidate's role was to formulate ways 
through an iterative process in which AutonoMyTM could be used to intelligently search 
and provide clinically relevant results; implementation of the clinical filters for age 
group, gender and geographical region to refine the raw results; development of the 
synonym file to allow greater user flexibility in terms of data entry; contribution to the 
user interface; and liaison with the software developers to implement these features. 
From 2001, the candidate was also the lead for the program of clinical evaluation of the 
system as described in this thesis. 
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1.4.3 Novel features 
The Isabel system followed a novel development process, and was deliberately designed 
to be different from expert diagnostic systems. 
L4.3.1 Intendedpurpose 
The Isabel system was primarily conceived as a reminder tool (similar to a diagnostic 
checklist) for the busy clinician, rather than as a diagnostic oracle or to provide a 
comprehensive differential diagnosis (Greenough 2002); the main aim was to reduce 
errors of omission in diagnosis. These key principles were based on an informal needs 
analysis of users in the acute setting, and aimed to replicate the success of CDSS that 
followed a reminder model. It was intended that the clinician's re-examined their own 
diagnostic plan following DDSS advice, and made changes to their plan if reminded of 
serious or more plausible diagnoses that had been overlooked. Although it was 
recognised that this process involved an active decision by the clinician to seek decision 
support and analyse the suggestions provided, it was hypothesised that the ease of use 
and rapidity with which advice was made available in a standalone system would 
encourage even busy clinicians to use Isabel frequently. 
L4.3.2 Design 
Isabel presented novel features in the knowledge base, inference engine and the user 
interface. Previous medical DDSS utilised large, complex databases that took years to 
develop and maintain, as illustrated by the INTERNIST/QMR system (Giuse, Giuse et 
al. 1995). In contrast, the Isabel database consisted of raw descriptive text arranged 
within a hierarchical model of diseases. Since electronic text was readily available from 
book publishers, the process of attaching pieces of text to relevant disease 'hooks' took 
less than a year to complete. However, no coded information on the statistical 
probability of diseases was used. Whereas the diagnostic algorithms in other DDSS 
used relatively simple calculations based on the numerical values attached to findings 
and disorders, the Autonomy software was complex NLPS which applied powerful 
proprietary pattern-matching algorithms on text. 
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Whereas users were forced to use a controlled vocabulary to enter clinical data into 
expert systems (although advanced features in some systems expedited data entry). the 
Isabel system tolerated free form narrative text entry in any form or quantity, making it 
easier for busy clinicians to access diagnostic decision support. However, this mode of 
data entry raised significant questions about how the inference engine would cope with 
the vast heterogeneity in data entered by different clinicians. In addition, the Isabel 
system displayed diagnostic suggestions arranged by body system rather than by clinical 
likelihood, prompting concerns about whether physicians would find this approach 
useful (Ramnarayan and Britto 2002). 
1.4.4 Summary 
The Isabel system represents a newer generation of diagnostic aids that utilises 
ubiquitously available web-based technologies and sophisticated natural language 
processing software to circumvent the main limitations of 'expert' systems. Its search 
interface is more closely related to Internet searching rather than a conventional 
inference engine. Deployment as a web application rather than as standalone system 
allows real time changes to the database to be propagated to worldwide users instantly. 
With recent explosion in the availability of electronic medical content, it is no longer 
necessary to recreate a structured medical knowledge base specifically for the purpose 
of building a diagnostic system. Future DDSS will become efficient and successful by 
intelligently searching existing medical knowledge resources in any location (online or 
offline) and in any form (coded or uncoded knowledge) to provide rapid, timely and 
context- specific advice to clinicians. Isabel's intended purpose, based on the reminder 
model of decision support successful in the reduction of error in preventive care and 
drug prescription, also represents a departure from the traditional diagnostic system 
model. Structured evaluation from a clinical perspective was therefore considered vital 
to provide useful insights into how the Isabel system, and by extension other decision 
aids, could assist clinicians in the reduction of diagnostic error. 
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IIJ Generalprinciples of evaluation 
Evaluation can refer to the qualitative description of a system's development process as 
well as a quantitative assessment of its performance and impact on users, the 
organisation in which they work and the patients they manage. Evaluation of decision 
support systems is essential to quantify potential benefits and to reveal unexpected 
adverse effects, as well as for medico-legal reasons and regulatory requirements (Wyatt 
1997). 
Most DDSS have been evaluated, usually by system developers themselves. Miller 
highlighted that the research methodology adopted during the evaluation of any DDSS 
should be considered from five separate perspectives: a) the current level of system 
maturity and the stage of its development; b) the purpose of the study and the specific 
end-user information needs being studied; c) the criteria used to define efficacy; d) the 
ability of the study design to elucidate the limits of the knowledge base and system 
functions; and e) the capacity of the study design to explain any negative outcomes 
(Miller 1996). The entire cycle of system development, evaluation and monitoring of 
safety in practice can be surnmarised as shown in Figure 11.1. 
Figure IM: Stages in the cycle of development and evaluation of DDSS 
Focus on users, setting Focus on system itself 
Define requirements Evaluate system structure 
Evaluate system performanc 
Evaluate impact 
Monitor safety 
Adapted from Wyatt et al, 1997 
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11.1.1 Early stages of system evaluation 
Depending on the stage of system maturity, evaluation can be formative (results are fed 
back to the developers to assist in producing a suitable system) or summative (results 
inform end-users about the benefits of a mature system). Preliminary system evaluations 
usually involve testing the feasibility, safety, structure, reliability and performance of 
DDSS in an in vitro environment, intended to shield clinicians and patients from 
unanticipated adverse effects (Friedman and Wyatt 1997). 
II. I. I. ] Structure of the knowledge base 
Since the quality of the advice provided is mainly determined by the quality of the 
knowledge base, early evaluation is usually focused on this component - is the 
information contained within the knowledge base reliable, up to date, at the correct level 
of detail, comprehensive, consistent and machine-readable? The source of the 
information contained within the database and any intermediate representation used are 
also examined. Example: The knowledge base of the QMR system was generated from 
expert opinion and review of medical literature. This knowledge was represented as a 
computer-readable set of relationships and scores within the database. The process of 
keeping the QMR knowledge base up to date and the tools used to achieve this has been 
described in detail (Giuse, Giuse et al. 1991; Giuse, Giuse et al. 1995). 
11.1.1.2 System performance evaluation 
Having checked that the knowledge base is robust, the next step in the evaluation of a 
DDSS is to ascertain how the database and the inference engine work together (system 
performance). Various characteristics can be examined, such as speed, accuracy of 
advice, ability to explain advice, and the breadth and depth of the conditions covered. 
Example: Berner reported the system performance characteristics of four diagnostic 
systems, ILIAD, QMR, Dxplain and MEDITEL. None of the systems contained all 105 
final diagnoses - the comprehensiveness of the knowledge bases ranged from 73 to 
91%. System accuracy in terms of including the correct diagnosis in the set of 
suggestions ranged from 52 to 71% (Berner, Webster et al. 1994). 
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11.1.2 Evaluation of system impact 
Even if the DDSS under scrutiny possesses a robust knowledge base, performs 
accurately and reliably, and covers a wide range of diseases, good advice may not be 
sufficient on its own to change decision making in the real world. To influence doctors' 
decisions, their actions, and thus patient care, the advice needs to be available to 
clinicians at the right time in a convincing, understandable form. Impact studies can be 
performed in an experimental environment (which requires fewer resources, and is safer 
for patients) or in the field in the forin of clinical trials (which allows a more realistic 
interpretation of results and can examine the effect of systematic, technical, socio- 
cultural and environmental factors) (Wyatt and Spiegelhalter 1991). Example: Friedman 
studied the effects of ILIAD and QMR on clinicians' diagnostic reasoning in the in vitro 
setting with a set of simulated cases (Friedman, Elstein et al. 1999). Diagnostically 
challenging cases were used by clinicians with various levels of experience (internists, 
residents and medical students). Subjects analysed the cases, entered data into the 
systems using system-specific controlled vocabulary, and made changes to their 
decisions after examining the DDSS advice. Correct diagnoses appeared in subjects' 
hypothesis lists for 39.5% of cases prior to consultation and 45.4% of cases after 
consultation, although this was achieved as a net balance between positive consultations 
(correct diagnosis present after consultation but not before) and negative consultations 
(correct diagnosis present before consultation but not after). 
There have been few assessments of the impact of general medical DDSS on users' 
decision making in their natural environment. Example: Bankowitz's study assessed the 
impact of QMR on diagnostic decisions undertaken by house staff in patients without a 
clear diagnosis even after admission to hospital. Despite 6 months' follow-up, a final 
diagnosis was established in only 20 out of 31 patients. Advice from the DDSS resulted 
in changes to the differential diagnoses generated by the ward staff in 26 cases 
(Bankowitz, McNeil et al. 1989). Similarly, in a study of MEDITEL-PEDS, the time to 
final diagnosis was 1.9 days when computer advice was provided to physicians versus 
2.8 days when no such advice was available (Wexler, Swender et al. 1975). Both studies 
used a consultation model (as opposed to a 'hands-on' model), in which physicians 
were provided a print-out of diagnostic advice from the system, rather than interacting 
with the system themselves. 
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11.1.3 Challenges in the evaluation of DDSS 
Despite considerable progress in the evaluation of CDSS, and increasing evidence of 
their beneficial effects on healthcare processes, evaluation of diagnostic systems has 
lagged behind, hampered by a number of challenges. None of the general medical 
DDSS described have been shown to improve healthcare processes or patient outcomes. 
11.1.3.1 Purpose of DDSS 
Despite many years of research, it is not still clear what clinicians expect from (and how 
they would use) DDSS in clinical practice - to assist them to make the 'correct' 
diagnosis, generate a good quality differential diagnosis, act as a reference textbook of 
disease information, to critique or reinforce their own diagnostic hypotheses or as a 
diagnostic checklist to ensure safe patient assessment. Early DDSS such as I-NTERNIST 
were primarily developed in response to a surge of academic interest in diagnostic 
decision making and related cognitive processes (Miller 1984; Guo, Lincoln et al. 1991; 
Bordage 1994; Nendaz and Bordage 2002). These 'expert' systems intended to serve as 
a replacement for the physician, an approach that moved the entire focus of 
development onto system accuracy and performance. The user was perceived to be a 
passive participant during medical diagnosis, their role exclusively to enter clinical data 
into the computer. As the socio- technical limitations of this approach became obvious, 
the 'Greek oracle' model of diagnostic decision support was replaced with a more 
prosaic one, in which the DDSS acted merely as an adjunct to the clinician's own 
diagnostic skills (Miller and Masarie 1990). In this paradigm, the performance of the 
user-system combination became more important than that of the unaided physician or 
the system. Some authors suggested that the utility of diagnostic systems lay primarily 
in their educational value (Miller and Masarie 1989; London 1998). Changing 
expectations and a lack of clarity on the optimal role of DDSS in the clinical arena 
meant that evaluations frequently resulted in negative outcomes because the aims and 
purpose of the study were not clearly framed. 
H. 1.3.2 Choice of outcome measures 
DDSS evaluations have been seriously handicapped by the fact that optimal outcome 
measures have yet to be identified, a deficiency that partly stems from a lack of clarity 
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about the purpose of the system. Berner recently summarised the challenges in selecting 
the right outcome measure; a review of various options indicated that none of them 
could be used in isolation to provide a clear and comprehensive view of either DDSS 
performance or impact. Options included the presence of the 'correct' diagnosis in the 
system's advice, quality of the differential offered, offering suggestions for test-clinical 
management, user acceptance and satisfaction, and popularity of the DDSS (Berner 
2003). 
11.1.3.3 Issues related to study design 
Controversy still exists regarding the relative importance of quantitative study 
methodologies such as randomised studies in elucidating the effects of decision support. 
The evaluation of the impact of a DDSS may be influenced by various factors, unrelated 
to the system's or subjects' performance, such as technical infrastructure, barriers to 
adoption of technology, a culture of innovation in the department, workload, resource 
limitations, and the presence of a clinical champion. It appears that a qualitative study 
design or other methodologies such as ethnographic field studies, record and playback 
techniques and socio-technical analyses, are as important as a quantitative design 
(Kaplan 2001). Biases that are less important in other areas of evaluation can also 
seriously affect DDSS evaluations. Notable examples include the Hawthorne effect 
where the subjects' performance improves simply because of the fact that they are being 
studied (Wickstrom and Bendix 2000), the checklist effect where collection of data in a 
structured fashion may itself be the cause of improvement rather than system advice 
(Adams, Chan et al. 1986), and contamination in a randomised study where the effect 
size is reduced because the same physicians treat both study and control patients, and 
apply the educational benefit gained from CDSS use in the study group to patients in the 
control group (Diwan, Eriksson et al. 1992). 
11.1.3.4 Understanding reasons forfailure 
Subjects may use DDSS functions with widely varying expectations. Studies that focus 
purely on one aspect of system function may have to make compromises with respect to 
other system or user-related factors to have a meaningful result. Likewise, when 
assessing the results of an evaluation, it is important that all factors that influence the 
chosen outcomes are examined in detail, whether DDSS-related (inadequate knowledge 
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base, poor user interface or faulty inference engine), user-related (lack of training or 
experience with system, failure to understand system function or inadequate medical 
knowledge), or others (inability to gather sufficient data, absence of reliable gold 
standard). Lack of attention to these aspects has affected many DDSS evaluations 
(Miller 1996). 
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11.2 Plans for evaluation of the Isabel system 
In order to understand how the Isabel system performed against a wide range of clinical 
cases, how it would be used by clinicians and how it would affect their decision- 
making, a clear evaluation process was planned to answer these questions even as the 
system was being developed. A formal program of incremental, step-wise evaluation of 
the Isabel system was proposed in both the formative and summative phases (Figure 
11.2). 
Figure 11.2: Step-wise evaluation program planned for the Isabel system 
FORMATIVE EVALUATION 
Needs analysis -o * Initial design 4 o- Prototype(s) 
ITERATIVE TESTING .*I 
Best or final prototype 
SUMMATIVE, EVALUATION 
Evaluation of structure and function 
(System performance) 
Evaluation of impact Evaluation of impact 
on users in a simulated P, on users in a clinical 
setting trial 
Evaluation of impact on patients ................ 
Disseminate and monitor 
During the formative phase of version 1.0 (2000-2001), the feasibility of applying 
AutonoMyTM to medical textual content derived from textbooks, with the purpose of 
providing diagnostic advice in response to a natural language query, was studied in an 
informal, iterative process. As each chapter of the textbook was entered into the 
database, numerous search queries were input, and diagnostic advice examined by the 
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medical team. Satisfactory results at each stage were followed by the addition of more 
text, until text from all four sources was entered into the database. During this process, 
the consistency of advice (by entering the same data multiple times) and speed of the 
system was also tested informally. The reliability of the knowledge sources was implicit 
in the fact that they were reputed textbooks, used by millions of medical under- and 
post-graduate students. The structure of the knowledge base, as it evolved, was 
examined as part of the development process. One of the limitations of using a 
proprietary inference engine was that although document profiles and disease profiles in 
the database could be examined by the medical team, profiles could not be modified 
manually (profiles were only updated automatically when text was modified/added 
within the database). Comprehensiveness of the database was achieved by including all 
chapters from the textbooks used; despite this, the medical team felt that some topics 
such as surgical paediatrics and genetic syndromes were under-represented in the 
knowledge base. 
The Isabel system was used frequently by clinicians. From July 2001 to January 2004, 
30 GB of data was transferred in and out of the system (mean 34 MB/day); over 10 
million individual pages had been requested from the server (>1 1,000/day) by 14 000 
registered users over the same period (Ramnarayan, Tomlinson et al. 2004). A survey 
by Briggs reported on the popularity of the system among users. 4436 users were 
invited to participate in an email survey; 518 complete responses were analysed. The 
authors concluded that the Isabel system was popular, and cited systemic hurdles such 
as lack of computers as the main reasons for poor usage among some respondents 
(Briggs and Fitch 2005). 
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H. 3 Summary 
Despite the various methodological challenges involved in assessing the value of 
decision support systems from a clinical perspective, evaluation remains a vital part of 
the ongoing process of quality assurance and improvement integral to the development 
of decision aids. The medical literature provides many examples where the benefits 
suggested by a decision tool during its development were not realised when the tool was 
implemented in the field. Without a structured and sequential evaluation process, it is 
unlikely that lessons related to the success or failure of computerised decision support 
systems would be learnt in a systematic fashion. The focus of the remainder of this 
thesis is on the evaluation of the Isabel system and the insights gained from its use by 
clinicians. 
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IIIJ Background 
The evaluation of system performance against expected standards is a crucial step both 
during the development of a decision support system and following the creation of an 
initial working prototype. During the formative phase, the main intention of system 
performance testing is to continually refine the system's advice. Once a fully 
functioning prototype is available for general release, a more formal evaluation, using 
representative cases with 'gold standard' advice, aims to provide prospective users with 
detailed information on the system's capabilities (Wyatt 1997). 
The methods used to assess performance depend on the anticipated setting and the 
expected purpose of system use. During the evaluation of a diagnostic system, a number 
of characteristics such as speed, accuracy, comprehensiveness and relevance of advice, 
explanatory capacity and safety are assessed. A well-conducted system performance 
evaluation provides useful insights into how each of the key DDSS components 
(knowledge base, inference engine and user interface) function, and how well the 
individual components interact with each other (Friedman and Wyatt 1997). 
111.1.1 Previous system performance evaluations 
Since most 'expert' systems aimed to provide the correct diagnosis, they were evaluated 
using diagnostic accuracy as a prominent measure. Other measures of diagnostic 
performance such as comprehensiveness and relevance of advice were introduced by 
Berner during a performance evaluation of four widely used DDSS (Berner, Jackson et 
al. 1996). 
The INTERNIST system was one of the earliest general diagnostic systems to be 
evaluated. The authors selected 19 diagnostically challenging cases from the 1969 set of 
clinico-pathological cases from the New England Journal. Of the 43 major diagnoses, 
the system accurately diagnosed seventeen. Reasons for incorrect diagnoses included 
knowledge base errors (incomplete information in database, incorrect database entries, 
or failure to represent severity) and computer program faults (lack of temporal 
reasoning or failure of diagnostic algorithm) (Miller, Pople et al. 1982). INTERNIST's 
successor, QMR, has been evaluated by its developers in a number of studies. 
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Bankowitz showed that QMR displayed the final diagnosis as the top ranked suggestion, 
and within its list of 15 suggestions, in 60% and 85% of diagnostically challenging 
cases respectively. In this study, data were used from 20 patients, who were followed up 
for 6 months to ascertain a definitive diagnosis (Bankowitz, McNeil et al. 1989). 
Accuracy of the QMR system in displaying the correct diagnosis was recently examined 
by external investigators. Lemaire used data abstracts from 154 patients admitted with 
an unclear diagnosis, in which an objectively proven final diagnosis was available at the 
end of hospital stay. The mean diagnostic accuracy (presence of the correct diagnosis 
within the top five diagnoses) was 38%. The authors concluded that the accuracy rate 
was not high enough to safely use QMR prospectively in clinical practice (Lemaire, 
Schaefer et al. 1999). In a recent study from an emergency department, QMR displayed 
the final diagnosis among its top 20 diagnostic suggestions in only 52% of cases. When 
only the top ten and top five diagnoses were examined, accuracy rate fell to 44% and 
32% respectively. Each case took 20-40 minutes to input into the system, primarily due 
to the amount of data as well as the need to use a system-specific controlled vocabulary 
during data entry (Graber and VanScoy 2003). 
The performance of a general paediatric DDSS (MEDITEL-PEDS) was tested in 1974. 
Data were included from 31 patients with a single known final diagnosis, which was not 
part of the physician's differential diagnosis at admission. The system displayed the 
correct diagnosis in 21 cases within the top 30 diagnoses displayed by the computer 
program. In an additional five cases, the top ranked diagnosis was nearly synonymous 
with the final diagnosis; the system was thus reported to be 84% accurate (Swender, 
Tunnessen et al. 1974). The modified Al/RHEUM system for the diagnosis of paediatric 
rheumatological disorders was examined recently. When data from 94 patients was 
entered into the program, the system displayed the final diagnosis in 80% of cases. 
Fifteen final diagnoses were not present in the system's knowledge base; the authors 
reported a 92% accuracy rate when these cases were excluded from analysis (Athreya, 
Cheh et al. 1998). 
In a study of four diagnostic systems (ILIAD, QMR, MEDITEL and DXplain), a 
number of different metrics other than accuracy were used to assess system 
performance. 105 diagnostically challenging cases with known final diagnoses were 
used as case material. An expert panel was independently used to provide a 'gold 
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standard' differential diagnosis. The correct diagnosis was present within the list of 
system suggestions in 52-71% cases; the comprehensiveness of the various knowledge 
bases ranged from 73-91%. Other metrics used as outcome measures included the mean 
rank of the correct diagnosis, relevance score (mean proportion of system diagnoses that 
an expert panel found reasonable to consider), comprehensiveness score (mean 
proportion of panel-approved diagnoses present in the system's list), and additional 
diagnosis score (number of system diagnoses considered to be relevant by the panel in 
retrospect). The authors showed that relevance and comprehensiveness scores ranged 
from 0.2 to 0.5 across the DDSS, and that an additional two diagnoses suggested by the 
system were found to be relevant by the panel per case (Berner, Webster et al. 1994). 
One of the key characteristics of the performance evaluations described above was that 
they were conducted retrospectively, i. e. the final diagnosis was known by the time the 
system was tested. The Leeds abdominal pain system was one of the earliest Bayesian 
systems to be evaluated prospectively. During a system performance evaluation, 304 
patients admitted with acute abdominal pain were studied, where a final diagnosis was 
gathered after patient follow-up in hospital. Data entered into the computer program 
was the same as was available to the admitting team. The diagnostic accuracy of the 
system was shown to be 92%. The authors reported other aspects of diagnostic 
performance such as 'certainty' and reliability of diagnosis. On average, the system was 
85% 'certain' as to the final diagnoses and 99% reliable in terms of identifying non- 
specific abdominal pain as the final diagnosis (de Dombal, Leaper et al. 1972). 
111.1.2 Aims and study considerations 
Summative system performance testing of the Isabel system was undertaken using 
version 1.0 of the software. The aims and intended study methodology were influenced 
by a number of different considerations: 
a) One of the key aims of the performance evaluation was to identify whether the 
application of natural language processing software to raw content derived from 
medical textbooks would result in relevant diagnostic suggestions being displayed 
rapidly. Although this question was partly tested by the system developers during 
the formative phase, it had not been tested against a wide range of search terms and 
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across all the textbooks. This point was of utmost importance to clinicians, who 
expected to use Isabel to assist in their medical decisions in the future. 
b) We planned to use the prospective study design, in which although final diagnoses 
were gathered after several days in hospital, data entered into the system was data 
available to clinicians at the time of patient assessment. Since the performance 
evaluation was at an early stage of system maturity, and the results could not be 
predicted, the tool's accuracy was not tested in the clinical environment by 
prospective users. 
c) It was intended that a wide variety of hypothetical as well as real cases would be 
used to test the tool across a diverse range of scenarios. The study was therefore 
planned in two consecutive stages in two different settings. 
d) The primary purpose of the diagnostic aid was to remind clinicians of important 
diagnostic possibilities, not to provide a definitive diagnosis. The capacity of the list 
to ensure safe patient care was one of the main outcomes of interest. However, it 
was clear that Isabel advice would be suboptimal if, while other important diagnoses 
were suggested, the final diagnosis was not. Therefore, the system's accuracy in 
terms of displaying the final diagnosis was also studied. 
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111.2 Materials and Methods 
This initial phase of the Isabel system evaluation was planned and performed at St 
Mary's Hospital Campus of the Imperial College School of Medicine. 
111.2.1 Diagnostic reminder tool prototype 
During the development of the system, only the technical developers and the study 
investigators had access to the Isabel prototype. Public access to registered medical 
practitioners was enabled only after the results of the study had been analysed 
(www. isabel. org. uk). The investigators accessed the system using a secure log-in 
procedure. These steps were undertaken to ensure that clinicians participating in data 
collection would not use the diagnostic aid to change the clinical management of their 
patients. A brief summary of the various components of the system at the time of the 
study (version 1.0) is provided below: 
111.2.1.1 Knowledge base 
Four reputed textbooks were used to derive the medical content for the knowledge base. 
Table 111.1: Textbooks used in the knowledge base during system performance testing 
Textbook name Speciality covered 
Nelson's Textbook of Pediatrics (I 6th Edition 2000, Elsevier, USA) Paediatrics 
Forfar and Ameil's Textbook of Paediatrics (5th Edition 1998, Churchill Paediatrics 
Livingstone) 
Jones and Dargan Churchill's Pocket Book of Toxicology (2001, Churchill Toxicology 
Livingstone, UK) 
Rennie and Roberton Textbook of Neonatology (3rd Edition 1999, Churchill Neonatology 
Livingstone, UK) 
More than 3000 individual diagnostic entities were present in the database during the 
study. Each diagnosis in turn was linked to multiple text documents (each less than 100 
KB in size) with a description of the clinical findings, investigation and treatment of the 
disease. Since only four textbook sources were used, there were three documents against 
each diagnosis on average, although some diseases contained only one text document. 
Each disease entity in the database was assigned a clinical weighting for its likelihood 
in each age group, geographical region and gender by the medical team involved in 
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system development. The weighting was binary in nature (i. e. disease 'seed or *not 
seen' in a particular setting). Geographical regions were based on the World Health 
Organisation (WHO) classification. 
Table 111.2: Clinical weighting scores for one disease entity: Group B Streptococcal meningitis 
Age group Newborn 4 Infant 4 Child x Adolescent x 
Western Europeý Eastern Europe4 South East Asiaý Far East Asiaý 
Geographical region Middle East4 
- 
Australasiaý North Africa4 South AfricaN' 
North AmericaT Ctrl America4 South Americaý I Central Africa 
Gender Male Female 4 
111.2.1.2 Inference engine 
Version 4 of AutonoMyTM software was used as the NPLS engine; it used patented 
algorithms to search through unstructured textual content to extract a document's digital 
essence, identify and encode the unique signature of key concepts within a document, 
and create concept agents to match document profiles with similar ideas as the input 
text. By aggregating text related to one specific diagnosis under a single label within the 
diagnostic tree, it was possible for the software to generate unique disease profiles. A 
raw set of results, generated initially based on the degree of match between disease 
profile and search query, was purely a textual match, uninfluenced by the clinical 
probability. Final diagnostic results were provided after subsequent application of the 
clinical filter for age group. 
111.2.1.3 User interface 
On accessing the tool, the user first specified the patient age group (newborn, infant, 
child or adolescent), following which the clinical findings of the case were entered into 
a free text box. These features would normally be gathered from the clinical history, 
physical examination and results of initial investigations, and constitute a summary of 
the available clinical information. To maximise the tool's performance with natural 
language data entry, certain rules were specified: 
a) Search terms had to be entered in appropriate medical terminology, rather than 
in 
lay terms, since the database consisted of medical textbooks e. g. 'shock' rather than 
shut down'. 
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b) Spelling had to be accurate, whether British or American in style. 
c) Results of laboratory tests had to be expressed in words e. g. 'leucocytosis' or 
ý elevated white cell count' for a blood white cell count of 36.7 x 106/ ýtL. 
Data were then submitted to the inference engine and a fresh web page displaying the 
results from Isabel was produced. This list was generated from the search results 
produced by AutonoMyTM, but filtered by age group on the basis of the weighting 
assigned to each disease. Between 10 and 15 unique diagnoses were usually displayed 
for consideration, classified on the basis of the body systems to which they pertained 
(e. g. Respiratory, Metabolic etc. ). The diagnoses were not ranked in order of clinical 
probability, reinforcing the function of the tool as a 'reminder' system. If and when 
more clinical findings became available, they could be entered into the search box to 
further refine the diagnostic possibilities offered. The figures below illustrate the early 
user interface used in system version 1.0. 
Figure 111.1: User interface during system performance testing: clinical data entry 
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v. -- 
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Figure 111.2: User interface during system performance testing: diagnostic reminders 
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111.2.2 Study design and conduct 
The study was conducted in two consecutive stages, one for hypothetical cases and the 
other for cases based on real patients. Since no patient data were collected and the entire 
study was conducted in a laboratory environment, ethical review was waived. 
111.2.2.1 Stage I- hypothetical case scenarios 
Data collection for this study was conducted in August 2000 within the department of 
Paediatrics at St Mary's Hospital, London. Clinicians with varying levels of experience 
(consultant, registrar, and senior house officer) were contacted to provide hypothetical 
case histories of acute paediatric cases. For each case, they were asked to specify the 
patient's age group (newborn, infant, child or adolescent), provide a summary of the 
clinical features in their own words and a list of the correct or expected diagnosis/es. 
Doctors were asked to specify clinical findings in medical terminology and to interpret 
results of initial investigations in words. This was done so that the entire case history 
could be pasted directly into the search box rather than requiring further modification by 
system developers. During the creation of hypothetical cases, clinicians were instructed 
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to base them on examples of real life cases they had encountered in the past or examples 
of cases from books or journals with a known final diagnosis. No patient identifiable 
data were used. 
111.2.2.2 Stage II - real life cases 
Data were collected from four acute paediatric units, two teaching hospitals (St Mary's 
Hospital, London and Addenbrookes Hospital, Cambridge) and two large district 
general hospitals (Kingston Hospital, Surrey and Royal Alexandra Hospital, Brighton) 
in the period October-December 2000. Junior doctors working within these departments 
(senior house officers and registrars) prospectively collected data on children presenting 
to the acute paediatric units on a paper form. Only data regarding the patient age group, 
a summary of clinical features at initial presentation in the clinician's own words and 
the working diagnosis/es were collected. The final diagnosis for each patient, as decided 
by the clinical team at the end of hospital stay (or at the end of the clinical assessment in 
the emergency room), was gathered from the discharge summary. No patient 
identifiable data were collected. Subjects were asked to specify clinical findings in 
medical terminology and to interpret results of initial investigations in words. 
At the end of the entire data collection process, the age group and the clinical features of 
each case were entered into Isabel as provided by the junior doctors (as far as possible), 
without modifying the content or spelling. This approach tried to preserve the inherent 
user-variability in summarising clinical findings. Despite this, some cases needed minor 
changes in wording and conversion of numerical results into descriptive terms by the 
study investigators to allow data entry into the Isabel tool. Results generated by the tool 
for each case were extracted for analysis from system logs. Between 10 and 15 results 
were produced for each case. 
111.22.3 Expertpanel 
All cases collected in stage 11 were also examined by a panel of two paediatric 
consultants, who worked together to produce a consensus list of 'must-not-missý 
diagnoses for each case. These diagnoses were judged to be important enough to have 
formed part of the examining physician's diagnostic list to ensure a safe workup. The 
panel were unaware of the final diagnoses for each case. 
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111.2.2.4 Outcome measures 
A number of different outcome measures were used to assess system performance from 
various perspectives: 
a) Diagnostic accuracy: The presence of the correct diagnosis (for real cases) or all 
expected diagnosis/es (for hypothetical cases) within the system's results. 
b) Comprehensiveness ratio: To function as a safe tool, it was expected that the 
expert panel's entire list of 'must-not-miss' diagnoses would be present within the 
list of suggestions produced by the diagnostic aid. The proportion of the panel's list 
of diagnoses that was present in the Isabel set of results was defined as the 
comprehensiveness ratio. The maximum possible value was 1.0 (i. e. all 'must-not- 
miss' diagnoses present in the Isabel list). 
c) Relevance ratio: In order to enable users to pick out relevant suggestions from a list 
of 10-15 diagnostic possibilities, the 'signal-to-noise' ratio has to be maximised. 
The relevance ratio was defined as the ratio of matching 'must-not-miss' diagnoses 
(provided by the expert panel) in the system's list to the total number of diagnostic 
suggestions offered by Isabel. Ideally, all 'must-not-miss' diagnoses would be 
present in Isabel's list, and the Isabel list would only consist of 'must-not-miss' 
diagnoses. However, since 10-15 diagnoses were displayed for each case, the 
relevance ratio was variable between cases. Only cases from stage 11 (real cases) 
were used in the above two analyses. 
d) Usage time: Time taken to enter clinical data into the system and generate a 
diagnostic suggestion list, while using a 56 KBps modem connection to connect to 
the Internet server where the Isabel system was hosted. 
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IH. 3 Results 
111.3.1 Case material 
99 hypothetical cases were provided by 13 clinicians in stage I of the evaluation. 119 
forms were collected for stage 11,19 of which were incomplete. These constituted forms 
in which no diagnoses were entered and where the clinical features section included the 
working diagnosis in the wording; junior doctors provided complete data on 100 cases. 
The clinical characteristics of cases collected in stages I and 11 are summarised in Table 
IV. 3 and Table IVA to provide an indication of the spectrum and frequency of 
final/expected diagnoses as well as various specialities covered during the evaluation. 
111.3.2 Clinical data 
In stage I, clinicians provided an average of 4.5 terms or phrases per case for data entry 
into the system. In the majority of cases, three clinical features were included. In 
response, subjects expected an average of two diagnoses to be displayed by the system, 
although in most cases a single diagnosis was expected. In stage 11, clinical terms 
collected on the datasheets were considerably more (mean 6 phrases or terms per case). 
Most cases had a single final diagnosis, although supplementary diagnoses were 
available in ten cases. The vast majority of terms did not need to be modified to suit 
data entry into the Isabel system. 
111.3.3 Diagnostic accuracy 
Out of the 99 hypothetical cases that were used to test Isabel performance, the expected 
diagnosis/es were present in the list of possibilities in 90 cases (91% accuracy). In some 
cases, the clinicians expected a single diagnosis, and in some others, multiple diagnoses 
were expected by the clinicians. All expected diagnoses were used in calculating 
diagnostic accuracy. 
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Table IV. 3: Final diagnoses expected by clinicians among hypothetical cases 
Primary diagnosis expected by paediatrician and number of forms 
Acute Graft versus host disease 1 Juvenile psoriatic arthritis 1 
Acute pyelonephritis 1 Juvenile spondyloarthropathy 1 
AIDS 1 Kawasaki disease 3 
Aspergillosis 1 Leptospirosis 1 
Bacterial meningitis 1 Lyme disease 2 
Bacterial pneumonia 1 Malaria 7 
Blastomycosis 1 Measles 1 
Brucellosis 1 Meconium aspiration syndrome 1 
Campylobacter 1 Meningitis 2 
Cat-scratch disease 1 Meningococcal disease 3 
Cellulitis 1 Meningococcus 1 
Chlarnydia pneumoniae 1 Mumps 2 
Chlamyclia trachomatis 1 Mycoplasma infection 1 
Chronic granulornatous disease 1 Necrotising enterocolitis 1 
Congenital CMV 1 Nonpolio enterovirus infection 1 
Crohn disease 1 Osteomyelitis 1 
Croup 3 Parotitis I 
Dermatomyositis 1 Pauciarticular juvenile chronic arthritis 1 
E Coli 0157 and HUS 1 Periorbital cellulitis 1 
EBV infection 1 Pneumonia 1 
Endocarditis 1 Polio 1 
Endotracheal tube obstruction 1 Rheumatic fever 1 
Enteric fever 1 RSV Bronchiolitis 1 
Enteroviral infection 1 RSV infection 1 
Erythema Infectiousurn 1 Scarlet fever 1 
Gastroenteritis 1 Sepsis 1 
Gram Negative septicaernia 1 Shigella 1 
Haemolytic disease of newborn 1 Staphylococcal Scalded skin syndrome 1 
Hand, foot and mouth disease 1 Staphylococcal toxic shock 1 
Herpes simplex gingivostornatitis 1 Stills Disease (Systemic JCA) 1 
Herpes zoster (Shingles) 1 Subacute sclerosing panencephalitis 1 
HIV 2 Systemic sclerosis 1 
Human Herpes Virus infection 1 TB Pneumonia 1 
latrogenic blood loss 1 Toxic shock syndrome 4 
Impetigo 1 Tuberculosis 1 
Infant botulism 2 Urinary tract infection 2 
Infant of a diabetic mother 1 Varicella zoster (Chicken pox) 
1 
Infection mononucleosis (Glandular fever) 1 Viral encephalitis 
1 
Infectious mononucleosis 1 Viral URTI 
1 
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Table IVA: Final diagnoses for cases based on real patients in stage 11 evaluation of system 
Derformance 
System Final diagnosis (n=55) Primary diagnosis Supplementary diagnosis 
Allergy Allergic reaction 2 
Egg allergy 1 
Urticarial reaction 
Dermatology Erythema multiforme 2 
Staphylococcal infection 1 
Endocrine Diabetes 1 
Diabetic ketoacidosis 2 
Gastroenterology Foreign body ingestion 1 
Non specific gastritis 1 
Non-specific abdominal pain 2 
Pyloric stenosis 1 
Haernatology Sickle Cell Crisis 2 
Infection Acute gastroenteritis 
Cellulitis 1 
Cervical lymphadenitis 1 
Enteroviral infection 2 
Infected insect bite 1 
Mycoplasma infection 
Osteomyelitis 1 
Otitis media 2 
Pneumococcal meningitis 2 
Pneumonia 7 
Preauricular Abscess 1 
Preseptal cellulitis 2 
Roseola Infanturn 1 
Rotavirus infection 1 
Rubella 1 
Scalded skin syndrome 1 
Septic arthritis 1 
Steven Johnson Syndrome 1 
Streptococcal infection 1 
Tonsillitis 2 
Toxic Shock Syndrome 1 
Upper respiratory tract infection 2 
Viral illness 9 
Viral meningitis 
Neonate Opiate withdrawal 1 
Nephrology Nephrotic syndrome 1 
Urinary Tract Infection 1 
Neurology Febrile convulsion 1 
Vasovagalattacks 1 
Respiratory Acute severe asthma 1 
Acute sinusitis 
Asthma 5 
Bronchiolitis 5 
Croup 2 
Laryngomalacia 1 
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Respiratory Syncitial Virus 
bronchiolitis 12 
Viral induced wheeze 5 
Rheumatic Acute exacerbation of SLE 
Henoch-Schonlein purpura 2 
Kawasaki Disease 
Skeletal Diskitis of L1/L2 
Slipped Upper Femoral 
Epiphysis 
Surgical Appendicitis 1 
*Some patients had more than one final diagnosis (for example, one child had a primary diagnosis of 
Urinary Tract Infection as well as a supplementary diagnosis of Asthma) 
Out of the 100 cases from real patients, all had a final diagnosis. Only the primary 
diagnosis was used to calculate accuracy. The final diagnosis was present in the list of 
Isabel diagnostic suggestions in 83/100 cases. Further analysis showed that in 13 cases, 
the final diagnosis provided by the clinician was non-specific (such as "viral illness"). 
Since the Isabel database was created from textbooks, which do not mention non- 
specific diagnoses, these diagnoses were not present in the database. When these cases 
were excluded from analysis, the final diagnosis was displayed in 83/87 cases (95% 
accuracy). The four cases in which the final diagnosis was covered by the knowledge 
base but absent in the system output were: Stevens-Johnson syndrome, Respiratory 
Syncitial Virus bronchiolitis, erythema multiforme and Staphylococcal cellulitis. 
Recognising that non-specific diagnoses are often made in routine clinical practice, 
these instances were examined further. In 10/13 cases, Isabel suggested diagnoses that 
were nearly synonymous with a 'viral illness', such as roseola infantum, Ebstein-Barr 
virus and enteroviruses. Figure IV. 3 summarises the results of diagnostic accuracy 
testing. 
111.3.4 Comprehensiveness and safety 
For each case, the differential diagnostic tool suggested a maximum of 15 diagnoses 
(range 10-15, mode 15). For each case, the expert panel provided a median of two 
diagnoses (range 1-4). The mean comprehensiveness ratio across all 100 real cases was 
0.81 (i. e. on average, 81% of all 'must-not-miss' diagnoses were included within the 
Isabel list). For 73 cases, the comprehensiveness ratio was 1.0 (i. e. the diagnostic tool 
displayed all 'must-not-miss' diagnoses). In an additional 15 cases, at least half of the 
gold standard was present (comprehensiveness ratio 0.50). 
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Figure 111.3: Outcome of all cases collected for both stages of system performance evaluation 
STAGE I EVALUATION 
99 forms collected for analysis 
Complete data in all forms 
STAGE 11 EVALUATION 
126 forms collected for analysis 
26 forms 100 forms 
excluded due to included in final 
incomplete data analysis 
Single Multiple Final diagnosis Final diagnosis 
diagnosis diagnoses present in absent in 
expected as expected as 
database in 87 database in 13 
cases cases 
final diagnosis final diagnosis 
Final diagnosis presented in 90 cases Final diagnosis presented in 83 cases 
111.3.5 Relevance 
Even if the maximum number of 'must-not-miss' diagnoses were present in the list of 
15 suggestions, the maximum relevance ratio for a case would not exceed 0.27 (4/15 
diagnoses), an anomaly due to the fact that Isabel always displayed 15 suggestions. 
Relevance ratios for all cases were therefore indexed to this value and expressed as a 
proportion of 0.27 (calculated relevance ratio); mean calculated relevance ratio across 
all 100 cases was 0.45 (95% Cl 0.39-0.5 1). 
111.3.6 Usage time 
Over a 56 K-Bps modem connection, ISABEL results took less than I second to display 
in all cases in both stages. Time taken by the study investigators to enter clinical data 
into the system (interrogation time) was variable depending on the level of detail 
entered, and ranged from 30 sec to 2 min. 
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111-4 Discussion 
The main objective of a system performance evaluation is to compare DDSS 
performance to its expected function and behaviour. In the case of Isabel, the objective 
was to demonstrate that the system would display clinically relevant and important 
reminders for a wide variety of cases quickly in response to a short free text search 
query. In this respect, the results of the evaluation showed that Isabel system fulfilled all 
its expected functions. 
111.4.1 Proof of concept 
One of the main purposes of the study was to test the hypothesis that applying 
proprietary natural language processing software to text-based medical content would 
generate relevant diagnostic suggestions for consideration in a broad range of cases. The 
development approach involved differed significantly from previous knowledge bases, 
where intricate relationships were first established between clinical findings and 
diseases, and numerical scores used to represent clinical likelihood and the evoking 
strength of findings within a quasi -probabilistic model (Shortliffe, Perreault et al. 2000). 
Whereas the expert system model was intended to allow the system to reason in a 
manner similar to the clinician, the former only aimed to serve as an adjunct to the 
user9s own cognitive reasoning. NLPS was used to extract relevant concepts from the 
text contained in the Isabel medical knowledge base, which was grouped together under 
disease headings in a hierarchical structure. Since Autonomy has never been used in 
healthcare for this specific purpose, although it has been used by large corporations to 
organise their corpus of uncoded textual information, it was encouraging to demonstrate 
that it was possible to deliver relevant diagnostic suggestions in a format suitable for a 
physician's consideration. 
Autonomy developers suggested that using different versions of text referring to the 
same disease would improve performance. Using multiple document sources, rather 
than a single textbook, would enrich the disease profile created by the software. 
Diversity was achieved by using multiple textbooks as the source material; it is possible 
that the addition of other sources such as journal articles or reviews would have 
enhanced the validity of the disease profiles so that a wider range of user queries could 
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be handled. However, with a database consisting of only four paediatric textbooks, it 
was possible in this study to generate diagnostic suggestions that matched an expert 
panel's list of 'must-not-miss' diagnoses in nearly 75% of cases. It was clear during 
system development that although medical input was not needed at the time of creating 
the textual database, expert involvement was necessary to modify the database to fine- 
tune the raw output generated. Clinical weighting was applied to each disease on the 
basis of its prevalence for age group, gender and geographical region, a modification 
that was vital to achieving the results shown in this surnmative evaluation. 
The results of this study have also shown that it is possible to achieve comparable 
diagnostic accuracy to expert systems such as QMR and DXplain, even though the 
underlying knowledge base was built much more rapidly. One of the most vexing issues 
cited during expert system development is the problem of maintaining the database - 
updates required months of effort, since they required additional literature review or 
expert opinion. Considerable research has gone into developing methodologies and 
computer tools to assist in maintaining disease profiles in the QMR knowledge base and 
other similar DDSS (Giuse, Giuse et al. 1991; Giuse, Giuse et al. 1991; Giuse, Giuse et 
al. 1993). On the other hand, updates to the Isabel system are straightforward - when a 
new edition of a textbook became available, its text was used to simply replace old text 
in the diagnostic tree. 
111.4.2 Diagnostic accuracy 
Traditional expert systems attempted to closely replicate the human processes involved 
in diagnostic decision making. Human efforts at making medical diagnoses involve, 
among others, some implicit method of assigning a priori and posterior probabilities to 
clinical findings and reconciling patterns learnt or observed from clinical experience 
(Levy, Sherwin et al. 2007). Thus, expert systems, such as the De Dombal abdominal 
pain system and QMR, which utilised probabilistic or related techniques to generate 
diagnostic suggestions, focussed on providing the 'correct' diagnosis within the top 
ranked suggestions. Since the Isabel system is primarily intended to remind clinicians of 
important diagnoses, rather than to definitely identify the 'correct' diagnosis, it was not 
important to rank results in order of clinical likelihood. However, this difference in 
system function limited the comparison of Isabel's performance with other DDSS 
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evaluations. In particular, Maisiak reviewed all outcomes used to measure the 
performance of a diagnostic system, and concluded that presence of the correct 
diagnosis at a higher position within a ranked list of suggestions was a sensitive 
measure (Maisiak and Berner 2000). In defence of the Isabel model, probabilistic 
reasoning has its limitations in clinical practice - low base-rate events are assigned 
lower probability estimates during clinical encounters, even if they have enormous 
clinical significance, a key factor leading to diagnostic errors of omission (Schiff, Kim 
et al. 2005). We hypothesised that omission errors result not only from poor knowledge, 
but also from loss of a checklist function at a time when clinicians are busy or fatigued 
during clinical work. It has been demonstrated that using simple checklists to process 
medical tasks leads to a significant improvement in clinical care (Hales and Pronovost 
2006). 
Although the primary function of the Isabel tool was to remind clinicians to consider 
important diagnoses, it was crucial that the tool generated accurate diagnoses in its 
output. The use of a known final diagnosis as the gold standard is therefore useful to 
ensure that even inexperienced clinicians remain clinically safe while using the system. 
Isabel demonstrated a diagnostic accuracy rate of over 90% in both hypothetical and 
real cases. In comparison to clinicians' baseline performance, where accuracy rates of 
60% have been reported in a general population based on necropsy findings or results of 
specific diagnostic tests (Gruppen, Woolliscroft et al. 1996), Isabel accuracy seems 
impressive. The accuracy of systems such as Dxplain, Iliad, QMR and Meditel were 
shown to be between 50 and 70% when tested against a set of challenging cases 
(Berner, Webster et al. 1994). In some evaluations, cases with final diagnoses that were 
absent from the system's knowledge base were excluded from analysis. The study 
described in this chapter also presented similar issues - 13% of cases used in stage 11 
had non-specific final diagnoses. Even when these were included in the analysis, the 
diagnostic accuracy of the system was shown to be 83%, comparable to results obtained 
from the evaluation of other diagnostic systems in clinical use. 
111.4.3 Comprehensiveness and relevance 
Alternative outcome measures were used in this study to examine system performance 
from more than one perspective. These included the comprehensiveness and relevance 
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scores described in 1994 (Berner, Webster et al. 1994). Comprehensiveness is similar to 
the concept of sensitivity, and describes how many 'true' diagnoses are displayed by the 
system in its advice. A highly sensitive system would include all relevant diagnoses. 
The opinion of a medical expert panel was used to provide the 'gold standard'. an 
acceptable step when the true gold standard is unavailable (Hripcsak and Wilcox 2002). 
The expert panel was instructed to provide 'must-not-miss, diagnoses, rather than all 
plausible diagnoses; the importance of this approach was related to the main purpose of 
Isabel. A measure of safety was thus introduced into the diagnostic workup. The Isabel 
system showed a mean sensitivity of 81%, a result that compares well with previously 
published data. 
The relevance ratio is akin to the concept of specificity, reflecting how focused the 
diagnostic suggestion list is. Relevance is an important measure to examine, because 
users may reject a system that displays important diagnoses but also provides many 
other trivial possibilities that detract from the value of the relevant suggestions. Since 
most DDSS display fixed numbers of suggestions, irrespective of the complexity of the 
case, the relevance ratio is also dependent on the number of 'gold standard' suggestions 
provided by the expert panel. Our relevance ratios were quite small since the gold 
standard list from the expert panel consisted of less than five suggestions in all cases, 
while the system displayed between 10 and 15 diagnoses. Testing the performance of 
the system with varying numbers of diagnostic suggestions revealed that a maximum of 
10 diagnostic suggestions retained a comprehensiveness ratio of >0.75, and improved 
the raw relevance ratio to 0.40. 
111.4.4 Usage time 
One of the main design features of the Isabel system was to permit free text data entry 
so that rapid diagnostic advice could be provided. Use of controlled vocabularies in the 
evaluations of other diagnostic systems resulted in longer user-system interaction times 
than seen in this study (Graber and VanScoy 2003). When tested by the developers over 
a dial-up Internet connection, the Isabel system took less than 1 second to generate its 
advice. Overall interrogation time varied between 30 seconds and 2 minutes. In 
comparison, Barnett reported that the usage of DXplain to deliver diagnostic results 
when used by system developers took around 3.5 minutes (Barnett, Cimino et al. 1987). 
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111.4.5 Limitations 
Although the current study fulfilled the purpose of testing system performance, a 
number of weaknesses could be identified with the methodology and approach 
a. Despite multiple clinicians providing case material, it was possible that the case 
mix in the validation sample was not fully representative. The hypothetical cases did not 
represent the complete spectrum of paediatrics and may not have tested the true limits of 
the tool or clarified the system's limitations. Similarly, the number of real cases used to 
test the system may have been insufficient to ensure a complete evaluation of the 
system's capability, especially in the specialities of neonatal paediatrics, oncology and 
paediatric surgery. In addition, this study was conducted in a hospital setting, and the 
capabilities of the tool may not be immediately obvious for users working in a primary 
care or ambulatory setting. 
b. Although a relevance score was calculated, the current design did not address 
the quality of the other Isabel diagnoses that did not feature in the 'gold standard' list. It 
is possible that although the final diagnosis and the 'must-not-miss' diagnoses were 
present in the list of suggestions, the other suggestions were grossly misleading, a 
finding that might cause users to lose confidence in the system. It is equally possible 
that other valuable suggestions in the Isabel list may not have been included by the 
expert panel. The Additional Diagnoses score, used by Bemer to describe diagnoses that 
the panel found relevant when DDSS suggestions were examined in retrospect by them, 
may have been useful in this regard. 
C. The current study design was intended to conduct a preliminary evaluation of 
the performance of the tool. No attempt could be made to extrapolate these results to 
routine clinical use since the tool was separated from the intended user and their natural 
environment. 
d. Since the tool is not prescriptive in its advice and relies on the discriminatory 
capacity of individual clinicians, it is possible that inexperienced doctors using the tool 
either in a primary care or hospital setting might cause an increase in referrals and 
investigations. This aspect could not be tested without an impact assessment. 
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111.4.6 Summary and future work 
The system performance evaluation described in this chapter demonstrated that the 
Isabel system functioned at an acceptable level of diagnostic accuracy and 
comprehensiveness, comparable to previous reports of expert systems. These results 
prove the concept that natural language processing can be adapted for use in the 
medical domain to develop decision support systems. However, numerous questions 
about the usability and impact of the Isabel system remained unanswered at this stage, 
and could not be clarified in the current study. The main body of the research work 
described in the subsequent chapters aims to answer these questions. The impact of 
Isabel use on clinicians' decision making was tested both in an experimental setting 
and in clinical practice. 
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IV. ] Research context 
It is clear that adverse events attributable to medical errors are frequent in modem 
healthcare, occurring in 5-15% of hospitalised inpatients and once every 1000-5000 
consultations in primary care. Diagnostic errors have been overshadowed by the recent 
attention on medication errors, yet result in significant preventable morbidity and 
mortality. Although exact figures are not available due to paucity of large prospective 
studies, 10-15% of medical patients may experience a diagnostic error, especially in 
primary and emergency care settings. Predisposing reasons for these errors are human 
cognitive failures as well as system-related deficiencies. The promise of computerised 
decision support systems in reducing medical errors in areas such as preventive care and 
prescription ordering has not been replicated for diagnosis despite years of research into 
the development of several diagnostic expert systems. 
Isabel is a novel web based diagnostic reminder system that utilises natural language 
processing to search uncoded medical text. Its ability to search in free text and utilise 
any available medical knowledge resource (online or offline) makes it easy to use and 
implement. In a system performance evaluation, Isabel provided rapid and accurate 
advice, displaying the 'correct' diagnosis in between 91 and 95% of cases drawn from 
hypothetical scenarios as well as real clinical material. However, its primary objective, 
i. e. to reduce clinicians' diagnostic errors, has not been tested in a rigorous evaluation. 
Evaluation is crucial to convince clinical users of computer systems that a decision aid 
provides accurate, dependable, consistent advice, and to understand the limitations of 
the system. During the evaluation of Isabel, it was expected that a number of unique 
challenges associated with the evaluation of other CDSS, such as absence of validated 
scores for measurement of outcomes and uncertainty regarding optimal study design, 
would be encountered. Two main research questions were framed for the research 
program and applied to a summative evaluation of the Isabel system (version 1.0). 
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IV. 2 Research questions 
IV. 2.1 What is the effect on clinicians' decision making when they use 
the system during acute assessment in a simulated environment? 
Null hypothesis: Use of the Isabel system will not improve the quality of diagnostic 
decisions made by subjects of various grades processing a set of simulated cases. 
Clinicians unfamiliar with a diagnostic system will not all interact in the same manner 
with it or derive the same degree of benefit from system use. The main aim of this part 
of the planned impact evaluation was to explore the effects of diagnostic system use on 
subjects' decision making using a balanced set of cases in an experimental setting. 
Another aspect of interest was the heterogeneity expected from free text data entry, and 
its impact on the consistency of Isabel diagnostic advice across different users. 
IV. 2.2 What is the effect on junior doctors' decision making when they 
use the system during acute assessment in a clinical environment? 
Null hypothesis: Use of Isabel by junior doctors working in an acute paediatric setting 
will not improve the quality of their diagnostic workup. 
This stage of the evaluation aimed to study how inexperienced clinicians would interact 
with the system in a busy clinical environment characterised by time pressure, workload 
and significant diagnostic uncertainty. Since the effects of system use on decision 
making in this setting would influence patient care, it was important to study in detail 
the patient subgroup in which users sought and benefited from diagnostic advice, as 
well as understand reasons for failure. 
In order to answer both the research questions, accurate and sensitive measurement of 
the quality of decision making was essential. Since an off-the-shelf objective and 
sensitive metric was unavailable, the development and validation of a new score was 
required and this was undertaken as the first step in the evaluation process. 
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V. ] Background 
Miller first proposed the idea that "the ultimate unit of evaluation should be whether the 
user plus the system is better than the unaided user with respect to a specified task or 
problem" (Miller 1996). This view shifted the focus of evaluation from the system to 
the user and the effects of the user's decisions on patient care. A number of diagnostic 
systems have been studied with regard to their influence on clinical practice; for the 
most part, these studies focussed on changes in healthcare processes during clinical 
assessment (diagnostic decision making) rather than 'downstream' markers of the 
quality of care such as patient outcomes (diagnostic errors). Even so, few studies were 
able to convincingly demonstrate a positive effect on physician behaviour (Hunt, 
Haynes et al. 1998). 
Numerous explanations have been proposed to account for these disappointing results. 
One reason may be related to the heterogeneity of outcome measures used to quantify 
the clinical benefits of DDSS consultation. There are no standard, validated, 'off-the- 
shelf metrics, such as those commonly available to researchers working in other areas, 
to measure the quality of diagnostic decision-making (Friedman 1999). Variability in 
the choice of outcome measures may also have resulted from uncertainty about the 
precise manner and clinical scenario in which DDSS might be expected to help users. In 
addition, the outcome measures used were far from comprehensive, and examined only 
the proximate effects of system consultation, i. e. on diagnostic decision-making. 
Important effects, intentional or otherwise, on test-ordering and treatment decisions, 
resulting from the diagnostic workup planned, were not measured (Berner 2003). Since 
the impact of DDSS consultation would be seen on all aspects of clinical decision- 
making, resulting in changes to patient care, an objective and comprehensive score was 
required to measure the quality of clinical decisions made during acute assessment. 
This chapter describes various scoring systems used during previous DDSS evaluations, 
their evolution, their limitations, the case for a comprehensive outcome measure, and 
the methodology adopted during this research program to develop and validate such an 
objective metric. 
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V. 1.1 Outcome measures used to evaluate the impact of DDSS 
The evolution of outcome measures used to assess the impact of DDSS on diagnostic 
reasoning closely mirrors a shift in philosophy about the intended purpose of these 
systems in clinical practice. 
V. IJJ Assisting the user to reach the correct diagnosis 
Early evaluations focused on the ability of users to reach the 'correct' diagnosis and 
how this could be improved by the use of diagnostic systems. Diagnostic tests (findings 
at surgery, biopsy or autopsy) were used as the 'gold standard' diagnoses. 
In the largest study of its kind, the Leeds abdominal pain system was evaluated in a 
multi-centre study in the UK. 4075 patients with acute abdominal pain were studied in 
the baseline period prior to software implementation, and 16 737 in the study period. 
Initial diagnostic accuracy rate (match between the working diagnosis of the first 
clinician to assess the case and the definitive diagnosis) increased from 45.6% to 65.3% 
when the DDSS was used; accuracy by the surgical team after investigations also rose 
from 57.9% to 74.2% (Adams, Chan et al. 1986). These findings are shown graphically 
in Figure V. I. 
Figure V. 1: Diagnostic accuracy rates for individual hospitals using the De_Dombal system 
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In a similar study of MEDITEL-PEDS, cases without a definitive diagnosis were 
studied. The admitting team's initial diagnostic accuracy was 55%, which rose to 74.6% 
by the time of hospital discharge in the group offered diagnostic advice from the 
system. However, since there was significant clinical input into this group after 
admission, it could not be demonstrated that the system alone was responsible for the 
improvement (Wexler, Swender et al. 1975). 
V. 1.1.2 Assisting the user to generate a quality differential diagnosis 
As it became clear that the true benefit from DDSS may result from helping users to 
generate a good quality differential diagnosis rather than predict the correct diagnosis, 
considerable research has gone into exploring the factors involved in making a 
differential diagnosis a 'good' one (Miller and Masarie 1990). Elstein suggested in a 
pilot study of the effects of a diagnostic DSS on users of three grades (attending 
physicians, residents and medical students) that the position of the 'correct' choice 
within a differential diagnosis containing six diagnoses (rank order 6) was a sensitive 
method to assess the quality of diagnostic decision making among subjects. The authors 
used this measure alone in their study, and found no effect of subjects' grade on the 
quality of the differential diagnosis produced (Elstein, Friedman et al. 1996). Maisiak 
studied the responsiveness of various outcome measures in terms of detecting 
differences in diagnostic quality at states of high and low performance, and showed that 
rank order measures were the most responsive (Maisiak and Berner 2000). 
V. 1.1.2. A Berner's scores 
Berner used a convenience sample of QMR users (mainly internists and family 
physicians) to assess the effects of system use on their diagnostic performance. Three 
sets of eight cases, stratified by diagnostic difficulty and potential of QMR to produce 
high-quality information, were used to test the subjects. The authors used metrics from a 
previous system performance evaluation of four diagnostic systems, and applied them, 
on this occasion, to the quality of the differential diagnosis produced by the users. An 
expert panel provided 'gold standard' judgements on the appropriateness of diagnostic 
suggestions, including those listed by any of the subjects during their analysis of a case 
(Berner, Maisiak et al. 1999). Three discrete measures of quality were studied. 
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Accuracy 
The average accuracy for each physician-generated diagnostic workup was calculated as 
the proportion of cases for which the correct case diagnosis was listed by the physician. 
This concept is analogous to the diagnostic accuracy measure described earlier. 
Relevance 
The relevance score for a physician's diagnostic workup was computed as the 
proportion of the diagnoses considered appropriate by the panel. This concept is 
analogous to specificity - if a significant proportion of the physician's diagnoses were 
appropriate choices, the list is highly relevant and focussed. 
Comprehensiveness 
The comprehensiveness score was calculated as the proportion of appropriate diagnoses 
that a sub . ect had included in their differential diagnosis for a case. This concept is 9 
analogous to sensitivity - if all appropriate diagnoses were included in the subjects' 
diagnostic workup, it is 100% sensitive. 
V. 1.1.2. B Friedman's composite score 
As opposed to a set of discrete indicators of diagnostic performance, Friedman et al 
used a single composite score to measure the quality of a diagnostic list based on the 
presence of the correct diagnosis, its location in a ranked set, and the plausibility of 
incorrect diagnoses (Friedman, Elstein et al. 1998). Diagnostically challenging cases 
were used, and again, the focus of the measurement was the diagnostic workup provided 
by subjects who used the DDSS, rather than the system itself. A maximum of six 
diagnostic possibilities were allowed in each subject's list. Friedman postulated that the 
quality of a subject's diagnostic list possessed two main components: Plausibility and 
Location. The quality score (QS) was calculated as: 
QS = wp (PO + wi (LO 
where wp and w, are weights given to the Plausibility Component (PC) and Location 
Component (LC). 
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The plausibility rating of each diagnostic hypothesis proposed per case by all subjects 
(that attempted the case) was independently judged by an expert panel. The rating 
ranged from 7 [correct diagnosis] to I [completely implausible diagnosis]. An average 
rating was used when individual members of the panel provided different ratings. The 
rating for location was pre-assigned according to where the correct diagnosis (or near- 
equivalent) was present in the subject's diagnostic list (6 for the correct diagnosis at the 
top and 0 if the correct diagnosis was absent). The procedure for scoring is illustrated 
using the following example of a diagnostic suggestion list generated by one subject: 
Diagnostic suggestion Plausibility 
rating 
Plausibility 
Com onent Weight 
Weighted 
plausibility rating 
Polymyositis 5.1 6 30.6 
Muscular pain 4.2 5 21 
Correct diagnosis 7 4 28 
Osteoarthritis 4 3 12 
Rheumatoid arthritis 3 2 6 
PYOMYOSitis I I I 
The Plausibility Component was calculated as the sum of the weighted plausibility 
ratings divided by the total plausibility component weights (98.6/21 = 4.7). The 
Location Component was 4, reflecting the position of the correct diagnosis on the list at 
position 3. Thus, 
QS = 4.7 + 4, i. e. 
QS = 8.7 (out of a possible total of 13) 
V. 1.2 The need for a modified quality score 
An objective, reliable and valid outcome measure was necessary in order to sensitively 
assess changes in the quality of subjects' clinical decision making before and after 
system consultation. For reasons unique to the design and intended purpose of the Isabel 
system, as well as those pertinent to the proposed study design of the impact evaluation, 
it was felt that none of the previously described scores were sufficiently comprehensive 
and sensitive enough to be used as outcome measures in the current program of 
research. In addition, there were weaknesses in all previously described approaches that 
could have been improved upon as part of the Isabel evaluation. 
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V. 1.2.1 Intendedpurpose and system design 
It was expected of expert systems to either assist in reaching the 'correct' diagnosis or 
to generate a good quality differential diagnosis. Unfortunately, the measurement of the 
success of either approach required knowledge of the 'correct' diagnosis. The Isabel 
system was designed primarily as a reminder system for acute practice. Assessments 
conducted in the acute setting are characterised by limited clinical information, making 
it impossible to reach a definitive diagnosis straightaway. For this reason, the main aim 
of Isabel use was to minimise diagnostic process errors rather than to accurately 
diagnose patient conditions. This approach, focussing on reducing clinical risk, differs 
from the purpose for which expert systems were designed. The user interface design, 
which made it possible for clinicians to enter in free text, as much or as little data as 
they chose, reflected these practical realities. Busy clinicians are likely to avoid seeking 
decision support unless advice is provided rapidly; the Isabel system was designed to 
make it possible to seek advice easily, even in routine practice. To highlight its function 
as a source of reminders, diagnostic suggestions generated by Isabel were not ranked in 
order of clinical likelihood; instead they were grouped by body system. This 
fundamental departure from the purpose and design of previous diagnostic systems 
made the use of existing scoring systems difficult without considerable modification. 
V. 1.2.2 Suitability for planned Isabel impact study design 
It is possible that, since evaluation of the effects of previous DDSS were conducted 
primarily in the laboratory environment, an academic and artificial approach to 
diagnostic workup was adopted by investigators. Rigid rank-ordering of diagnoses is 
uncommon in clinical practice, especially during acute assessment. Since our planned 
impact study focussed on the impact of Isabel use during routine clinical assessment in 
an acute paediatric setting, a rank-ordered list was unlikely to be generated by subjects 
in real life. The frequent absence of a 'gold standard' diagnosis in real life also made it 
impossible to use any of the previous metrics which relied on knowledge of the 
'correct' diagnosis to compute the quality score (Wexler, Swender et al. 1975). In the 
acute setting chosen for the current evaluation, an initial diagnostic plan is often 
generated with incomplete and evolving data; the main emphasis is on considering the 
most appropriate set of diagnoses ('high frequency-highly plausible-high 
impact') 
rather than on identifying the single 'correct' diagnosis at this stage. 
The 
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appropriateness of a diagnosis included in the workup is not based on plausibility alone, 
but on numerous other factors such as likelihood, seriousness of the diagnosis and 
implications for further test ordering. Therefore, it was felt that the choice of outcome 
measure for our study would need to be considerably different from the previously used 
scores, necessitating the development and validation of a new score to measure the 
quality of clinical decision making. 
A significant weakness was identified in the scores used by Berner. The 
Comprehensiveness score and Relevance score did not depend on how appropriate each 
of the 'appropriate' diagnoses were - since there was no weighting, a highly appropriate 
diagnosis contributed the same value to the score as a less appropriate one. The 
composite score used by Friedman also demonstrated shortcomings. The Location 
component relied on a maximum of six diagnostic suggestions per case arranged in rank 
order. In the acute setting, many diagnoses (with varying levels of appropriateness) may 
be suitable for some cases, depending on the amount of data available at initial clinical 
review. 
One of the main failings of all previous scoring systems was that they did not consider 
the effects of decision support on processes other than diagnostic decision making. It 
was hypothesised that the full clinical impact of a DDSS would manifest in changes in 
physicians' diagnostic plans as well as in real and measurable changes to the patient's 
clinical management in terms of test-ordering and treatment. Any new score that aimed 
to determine the impact of a diagnostic aid would have to examine its effects from these 
two separate but related perspectives. 
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V. 2 Concepts used in development of a new quality score 
The aim of this part of the research was to develop two inter-related scores to 
sensitively measure the quality of clinical assessment at a single discrete point during 
clinical decision making. The Diagnostic Quality Score (DQS) was intended to measure 
the quality of a diagnostic workup list; the Management Quality Score (MQS) aimed to 
objectively measure the quality of an action plan consisting of tests and treatments 
following the generation of a diagnostic workup. 
The concepts that underpinned the development of the new scoring system were derived 
from three sources: 
a) the existing discrete scores used by Berner 
b) the plausibility component used by Friedman and 
c) the opinions of expert clinicians (at consultant and registrar level in acute 
Pediatrics) of what contributed towards a high quality diagnostic and clinical 
management plan. Fictitious examples of diagnostic and clinical management 
plans, based on samples derived from the validation described in chapter 111, were 
used to elicit clinicians' judgements on the quality of diagnosis and treatment 
planning. 
V. 2.1 Quality of entire plan vs. individual component items 
Since each diagnostic hypothesis list (or clinical management plan) usually consisted of 
many individual diagnoses (or tests and treatments), one of the main concepts involved 
in the development of DQS and MQS related to the distinction between the quality of 
the entire list as opposed to the quality of each individual item present in the list. The 
factors that influenced the quality of individual items within a list were different from 
factors that contributed to the quality of the entire clinical plan itself. 
V. 21.1 Quality of individual items in theplan (diagnoses) 
When assessed in isolation, the quality of a diagnostic suggestion within the diagnostic 
workup was hypothesised to depend on its: 
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a) clinical likelihood: how frequently the diagnosis was encountered in real life 
practice 
b) plausibility: to what degree the diagnosis accounted for (all) the clinical features 
of the case 
c) impact: how much the diagnosis affected patient clinical management, either in 
terms of initiating appropriate therapy, the adverse consequences of missing the 
diagnosis, how it altered patient prognosis, or had implications beyond the 
individual patient. 
Plausibility alone is not an adequate measure of the quality of a diagnostic suggestion, 
especially in an emergency setting, where the main focus was not getting the 'correct 
diagnosis', but on ensuring that all appropriate diagnoses are considered in order to 
minimise the risk of missing significant ones. These diagnoses were termed "high 
frequency-high plausibility - high impact" diagnoses. This approach is relevant to 
clinical decisions made in the acute setting, and differs from decision making at later 
stages of patient assessment, when more complete patient information is available. For 
example, the diagnosis of bacterial meningitis may not adequately explain the 
presenting features of fever, irritability and red tympanic membranes in a young infant 
presenting to the emergency department, but its inclusion in the workup would be 
considered highly appropriate, due to its life-threatening nature and the fact that 
appropriate therapy will need to be instituted urgently. 
V. 21.2 Quality of individual items in the management plan (tests and 
treatments) 
The quality of an individual item in a clinical management plan was hypothesised to 
depend on its: 
a) appropriateness: how much value the individual test or treatment added to 
reaching a conclusive diagnosis or initiating specific management in the clinical 
scenario 
b) impact: its potential to cause clinical harm 
c) cost effectiveness: the perceived cost-benefit ratio for the test or treatment 
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V. 2.1.3 Quality of the entire plan (diagnostic workup and clinical management 
plan) 
It was postulated that the quality of the entire decision plan was not a simple arithmetic 
sum of the quality of individual items comprising it. The plan quality was determined 
by the following factors: 
a) The weighted quality of individual items: The quality of the plan ought to be heavily 
influenced by the presence of high quality individual items within it and less so by 
the presence of other items. Therefore, the overall plan quality was based on a 
weighted sum of the quality of each individual item. This meant that the 
contribution of a high quality diagnosis was much more than the contribution of a 
low quality diagnosis within the same plan. 
b) Comprehensiveness: This factor accounted for how inclusive the plan was, and 
whether it contained all the items judged to be appropriate and relevant? The 
concept was analogous to the idea of sensitivity. 
C) Relevance: how focussed the plan was, and did it contain large numbers of 
inappropriate and irrelevant items? This factor was analogous to the concept of 
specificity. 
V. 2.2 Accuracy versus appropriateness 
The quality of and the objective of formulating a diagnostic workup and a clinical 
management plan vary from setting to setting. In the emergency setting, where decision 
making is based on limited information and can have significant consequences, the key 
aim is to ensure that "high frequency-high plausibility-high impact" diagnoses, and the 
most appropriate tests and treatments, are considered. This approach is adopted because 
it is impractical to reach the 'correct diagnosis' at this stage with a high degree of 
certainty unless a specific diagnostic test can be performed immediately. Conversely, in 
an inpatient setting, especially with the availability of more clinical information, the 
purpose of a diagnostic workup veers towards accuracy i. e. to identify the 'correct' 
diagnosis. 
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Most earlier studies of DDSS were previously based in experimental settings, where the 
focus was more on the cognitive processes involved in getting the diagnosis right and 
less on the consequences of the decisions taken. In these studies, a final diagnosis was 
known for the cases processed by the subjects. In contrast, in the real life setting, it is 
not possible to judge initial decision making on the basis of the definitive diagnosis, 
rather, the quality of the initial decisions rely on appropriate patient management, with 
minimal patient harm, which may or may not be concordant with the eventual 'correct' 
diagnosis. 
V. 2.3 Summary 
The new score was intended to: 
1. measure the appropriateness (rather than accuracy) of decision making as an 
indicator of quality when judging each individual item in a plan 
2. weight the contribution of individual items to the overall plan, and 
3. judge the overall plan with respect to how comprehensive and relevant it was. 
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V. 3 Scoring process 
A pilot study was conducted to test the feasibility of scoring the quality of diagnostic 
workup and clinical management plan using the concepts described above. The 
methodology validated during the pilot study was applied to generate scores for 
decision plans produced by all subjects in the Isabel simulated field evaluation 
described in detail in chapter VI. 
V. 3.1 Pilot study 
Five fictitious cases were scripted by the candidate based on real cases seen in an earlier 
Isabel validation study (chapter 111). Each case described the patient's initial 
presentation to an emergency setting in 100-200 words, with ample non-salient findings 
to eliminate positive diagnostic cues. No single 'correct' diagnosis was expected from 
the subject. An example of one case is shown below: 
Table V. 1: Example of a simulated case used in the pilot study used to derive a quality score 
A 10-year old boy was rushed into Casualty with acute onset dyspnoea. He had been well until 12 hours 
previously, then developed a fever and a cough. He seemed well with it for about 8 hours and then 
became acutely short of breath. His past medical history was not available. His uncle, who had brought 
him in, said that he had been in his home country, Nigeria, until 2 weeks ago, when he had come for a 
month's holiday in the UK. On examination, he was febrile T= 38.5 C, pulse rate 140/min, BP 100/70, 
Sa02 80 % in air and 95 % in 5 L/min mask 02. Capillary return was 4 sec. His RR was 69/min and he 
seemed to be in significant respiratory difficulty. His chest was normal on examination. He was conscious 
and oriented, although he could hardly speak sentences. There were no neurological signs, his neck was 
supple and his urine dipstix was normal. 
Eight subjects assessed three out of five cases each, selected in random fashion. During 
case analysis, the subjects used a trial website (http: //trial. isabel. org. uk) to record their 
diagnostic workup and clinical management plan prior to consulting the Isabel system. 
They were then instantly shown suggestions from the DDSS for the case; subjects could 
then amend (add/delete items) their pre-Isabel diagnostic workup and management plan 
if they wished. This was also recorded on the website (post-Isabel). A full description of 
this process is detailed in chapter VI as part of the methodology used in the simulated 
field study. The result of this exercise was that each subject generated a pre-Isabel and a 
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post-Isabel diagnostic workup and clinical management plan for each case attempted. 
Table V. 2 shows this in more detail. 
Table V. 2: Example of pre- and post-DDSS consultation decisions for the case in table V. 1 
Pre-DDSS Post-DDSS 
Diagnoses Acute severe asthma Acute severe asthma 
Bacterial pneumonia Bacterial pneumonia 
Lymphoid interstitial Lymphoid interstitial 
pneumonitis pneumonitis 
Pneumocystis pneumonia PCP pneumonia 
Pleural effusion Pleural effusion 
Pneumothorax Pneumothorax 
Tuberculosis 
Sepsis and Shock 
Allergic/anaphylactic respiratory 
response to medication 
Tests Full blood count Full blood count 
C-reactive protein C-reactive protein 
Chest X-ray Chest X-ray 
HIV test HIV test 
Mantoux test 
Treatments Admission to high dependency Admission to high dependency 
or intensive care unit or intensive care unit 
Oxygen saturation monitoring Oxygen saturation monitoring 
Mask oxygen Mask oxygen 
Salbutamol nebulisers Salbutamol nebulisers 
Intravenous fluids Intravenous fluids 
Intravenous antibiotics 
The main focus of scoring was decision plans submitted by the subjects rather than 
results generated by the DDSS itself. The steps employed in the pilot study to score the 
quality of each pre- and post-Isabel diagnostic workup and clinical management plan 
were applied without modification to the scoring of decision sets generated in the 
simulated field study. 
V. 3.2 Construction of a clinical expert panel 
Since subjects were not expected to provide a single 'correct' diagnosis, it was 
necessary to convene an expert panel to provide 'gold standard' decisions regarding 
diagnoses and clinical actions, given the limited amount of information from the case. 
im In the pilot study, the panel was constituted by two paediatric registrars, 
both with >5 
years clinical experience. 
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In the main study, two consultant paediatricians formed the expert panel (>3 years in 
their current grade, overall > 10 years clinical experience). 
V. 3.3 Scoring process: step I Oudging the quality of individual items) 
In this step, the quality of each individual diagnosis, test and treatment was assigned a 
score. The process was performed in multiple stages. 
Stage 1: The expert panel was provided the text from all cases used by subjects in the 
study (five in the pilot study). Each panel member worked independently and suggested 
a list of 'must-not-miss' diagnoses and clinical actions for each case. Neither panel 
member was privy to their colleague's suggestions. 
Stage 2: For each case, two master lists were created - one with diagnoses and the other 
with tests and treatments. The master list was an aggregate of items suggested by all 
subjects who had attempted the case, either in the pre- or post-Isabel consultation stage, 
and the 'must-not-miss' suggestions provided by individual panel members. This 
procedure ensured that anyone examining the master list could not trace the origin of the 
suggestion (i. e. whether suggested by panel member or subject). In addition, the master 
list was short, since it avoided duplicates of the same diagnosis or clinical action. The 
aggregation process was performed by the candidate, which ensured that clinically 
equivalent or similar terms were consistently treated as synonyms. An example of the 
creation of a master list is shown in Figure V. 2. 
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Figure V. 2: Creation of a fictitious aggregate list from panel members' and subjects' suggestions 
Panel member A- suggestions 
Asthma 
Pneumonia 
Chest x ray 
Antibiotics 
Panel member B- suwzestions 
Pneumonia 
Asthma 
Chest x ray 
Bloodfilm 
Blood culture 
Aggregate list 
Asthma Antibiotics 
Lung cyst Bloodfilm 
Pneumonia Blood culture 
Bronchiolitis Chest x ray 
Pertussis Discharge patient 
Subject I- pre-DDSS list 
Asthma 
Pertussis 
Chest x ray 
Discharge patient 
, 
Subject I- post-DDSS list 
Asthma 
Bronchiolitis 
Lung cyst 
Antibiotics 
Discharge patient 
Diagnostic suggestions are in normal font, management suggestions are in italics 
Stage 3: Two weeks after the expert panel members provided their own suggestions, the 
aggregate list was sent to the panel for scoring. Each panel member worked 
independently, and scored each item on the aggregate list using a visual analogue scale 
and instructions shown in Figure V. 3 and Figure VA Panel members were provided 
anchoring scores to improve the reliability of the process. 
Figure V. 3: Scale for diagnostic suggestion ratings and proposed weighting scheme 
Unlikely and clinically insignificant Most likely and/or clinically significant 
Score each item based on: how well the diagnosis fits the clinical features and how plausible the diagnosis is 
(likelihood), whether it is treatable, life-threatening and how it might impact on further test ordering (clinical 
significance). 
Inappropriate and clinically dangerous Appropriate and clinically significant 
Score each item based on: how appropriate and non-redundant the test/step is (appropriateness) and how cost- 
effective it is and whether performing the test/step would lead to clinical harm to the patient (clinical 
significance) 
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For diagnoses, a score of 0 was defined as a diagnosis that was irrelevant for decision 
making and did not account for the clinical features of the case. A score of 4 was 
defined as the diagnosis/es that most likely accounted for the clinical presentation of the 
case (high frequency-high plausibility diagnoses) and/or diagnosis/es that were serious, 
and required appropriate test-ordering and treatment selection ('high impact' 
diagnoses). More than one diagnosis could be scored 0 or 4. For clinical actions, the 
scale spanned a value of 0, with negative and positive scores on either side. A score of - 
2 was defined as a clinical action that was construed as clinically inappropriate and 
dangerous to the patient. A score of +2 was defined as a clinical action that was crucial 
to further patient workup (e. g. a diagnostic test or specific treatment step). A score of 0 
was reserved for items that did not result in any patient harm and were completely 
irrelevant to further workup with trivial cost versus benefit ratio. 
Using this guidance, the panel first scored the diagnoses and actions matching the 
anchor descriptions. The remainder of the items were subsequently scored on the visual 
analogue scale using the anchors. A single meeting was organised at the completion of 
scoring for panel members to discuss differences in scoring, and to clarify doubts 
regarding the scoring process itself. If differences could be resolved by consensus 
following discussion, discrepancies were attributed to lack of clarity regarding scoring 
technique or ambiguity within the case description itself. A summary of all steps 
involved in the first stage of scoring is illustrated in Figure V. 5. 
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Figure V. 5: Graphical depiction Of entire scoring scheme 
Cases 
Subject Panel 
decisions suggests 
System Responses from all 
generates list 
I 
sources combined 
Scored by panel on scale Subject decides 
for appropriateness again 
Subjects' pre-system and post- Reference standard 
system list of suggestions (responses scored >0) 
Compare 
Subjects' performance 
Schematic conventions described by Hripcsak G et al, 2002 are used. Rectangles represent tasks and measurements; 
ovals represent actions; and the diamond represents a simple task such as tallying. The grey shaded box indicates a 
step that did not directly contribute to the procedure 
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V. 3.4 Scoring process: step 2 (weighting the contribution of individual 
suggestions to overall plan quality) 
In this step, the panel scores assigned to each item on the aggregate list was weighted 
using the empirical scheme as shown in figures below: 
16 
Unlikely and clinically insignificant Most likely and/or clinically significant 
Score each item based on: how well the diagnosis fits the clinical features and how plausible the diagnosis is 
(likelihood), whether it is treatable, life-threatening and how it might impact on further test ordering (clinical 
Figure V. 7: Weighting scheme applied to clinical actions 
-8 -1 01 +8 
Inappropriate and clinically dangerous Appropriate and clinically significant 
Score each item based on: how appropriate and non-redundant the test/step is (appropriateness) and how cost- 
effective it is and whether performing the test/step would lead to clinical harm to the patient (clinical 
significance) 
The main aim of this step was to ensure that the contribution of highly appropriate 
suggestions considerably outweighed the contribution of less appropriate diagnoses or 
clinically dangerous actions to a plan. Likewise, it was intended that failure to consider 
a crucial item must highly disadvantage the subject's overall plan score. 
For each subject's diagnostic workup and clinical action plan (pre- and post-Isabel 
consultation) a DQS and MQS were calculated. DQS was calculated as a weighted sum 
of the scores assigned to each individual diagnosis present within the diagnostic workup 
(total weighted score, TWS). In case of items where there were differences between 
panel members' scores, an average of their weighted scores was used. Similarly, MQS 
was calculated as the weighted sum of the scores assigned to each individual clinical 
action within the clinical management plan. 
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V. 3.5 Scoring process: step 3 (ensuring relevance) 
With the steps taken so far, the total weighted score of a plan with many irrelevant 
suggestions would be the same as for a plan without any irrelevant suggestions. Since 
the quality of a focussed plan depended on containing only relevant items, an additional 
step was undertaken during the scoring process. A value equivalent to the number of 
irrelevant diagnoses and irrelevant tests and treatments (items rated 0 on the expert 
panel scoring, no) was subtracted from the total weighted score (TWS) for diagnostic 
workup and clinical management plan (TWS-no). 
TWS-no = TWS -n items scored 0 
V. 3.6 Scoring process: step 4 (comprehensiveness) 
The final step in the scoring process was to ensure that the plans were comprehensive 
and covered all appropriate diagnoses and clinical actions. A list of all items scored >0 
by the expert panel was compiled per case, and this set was defined as the 'appropriate' 
set of diagnoses and clinical actions. A subject's diagnostic workup or clinical 
management plan was defined as comprehensive if it contained all items in the 
4appropriate' set. To achieve this, the weighted sum of the scores of all items included 
in this 'appropriate' set was first computed (TWSas). The final DQS and MQS of a 
subject's plan were then expressed as a proportion of the weighted sum of the 
cappropriate' set. 
Final DQS = TWS-no / TWSafor diagnoses 
Final MQS = TWS-no / TWS,, for clinical action plans 
Figure V. 8 illustrates the creation of a TWS,,, and how DQS and MQS were computed 
for one subject's diagnostic and clinical management plans. 
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Figure V. 8: Example of a TWS,,, and scoring procedure for one subject's post-DDSS diagnostic and 
management plan 
Items in aggregate list Score assigned by panel Weighted score 
Asthma 4 16 
Bronchiolitis 3 9 
Pneumonia 3 9 
Sickle chest crisis 3 9 
Pneumothorax 2 4 
Pneumocystis pneumonia I I 
TWS,,, for diagnoses 48 
IV ANTIBIOTICS 2 +8 
CHEST RADIOGRAPH 2 +8 
ADMISSION TO WARD 2 +8 
HAEMOGLOBIN 
ELECTROPHORESIS 
1 +1 
NASOGASTRIC TUBE 1 +1 
PERNASAL SWAB 1 +1 
TWS. s for clinical actions 28 
Sug . gestions in diagnostic plan Weigh ed score 
Asthma 16 
Bronchiolitis 9 
Lung cyst 0 
Total weighted score (TWS) 25 
Irrelevant suggestions scoring 0 (NO) I 
DQS: (TWS-no) -- TWSas* 0.50 
Suggestions in management plan Weighted score 
ANTIBIOTICS +8 
DISCHARGE PATIENT -1 
Total weighted score (TWS) +7 
Irrelevant suggestions scoring 0 (NO) 0 
MQS: (TWS-no) -. - TWS,,, * 0.25 
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V. 4 Validation of score 
The scores derived as part of the work described in this chapter needed to be validated 
before they could be used as outcome measures for the simulated field study. 71 
subjects' assessments of six cases, representing 190 unique pairs of diagnostic workups 
and clinical management plans, were drawn from the simulated study (described in 
detail in chapter VI). Each pair consisted of a pre-Isabel and a post-Isabel consultation 
plan. Tests of reliability and validity were applied to the sample workups. 
VAI Reliability 
Reliability is a measure of the precision of the index. Both inter-rater reliability and 
intra-rater consistency were examined. 
V. 4.1.1 Intra-rater consistency 
During expert panel review, the members were first provided with the text from the 
cases. They suggested a list of 'must-not-miss' diagnoses and clinical actions for each 
case independently. These suggestions were incorporated into a master list of diagnoses 
and clinical actions by combining with subjects' suggestions. In a secondary review, the 
panel members were asked to score the items contained within the master list according 
to the scales described above after a period of two weeks. Intra-rater consistency was 
assessed by examining the panel members' scores for their own initial suggestions 
(provided prior to the creation of the aggregate list). Out of the 41 'must-not-miss' 
suggestions suggested by the first expert panel member prior to the scoring process, 39 
were subsequently assigned the highest score on the relevant scale (95.1 %). The second 
panel member scored 45 out of 54 original suggestions highly, suggesting slightly worse 
consistency during the secondary review process (83.3%). 
V. 4.1.2 Inter-rater reliability 
Ratings from each panel member for 252 unique diagnoses and 350 clinical actions 
drawn from the master lists for six cases were used for this analysis. Reliability was 
determined via an index of inter-rater agreement (the intraclass correlation coefficient 
[ICC]; two-way random effects model using individual ratings; SPSS Inc., Illinois, 
104 
Development and validation of quality scores 
USA). ICC for all diagnoses' scores was 0.79 (95% Cl 0.74-0.83, p<0.01); for all 
management item scores it was 0.72 (95% Cl 0.67-0.77, p<0.01), both suggesting good 
inter-rater agreement. 
Further analysis was performed by classifying the diagnostic suggestions dichotomously 
using a cut-off score for 'appropriateness' ('appropriate': ý3, 'inappropriaW <3). There 
was excellent chance-corrected agreement between the raters (kappa statistic 0.84,95% 
CI 0.79-0.89). When management suggestions were classified similarly (appropriate: 
ý! I, inappropriate: <1), chance-corrected agreement between panel members was good 
(kappa statistic 0.58,95% CI 0.51-0.64). The inter-rater reliability of the DQS and MQS 
depended only on establishing the reliability of the panel scoring procedure, since only 
mathematical calculations were used in subsequent steps to derive the DQS and MQS 
from Panel scores. 
V. 4.1.3 Summary 
The scoring system possessed good intra-rater and between-rater reliability, implying 
that the scoring system can be generalised for use by other expert panels. 
V. 4.2 Validity 
Validity is the extent to which the score measures what it intends to measure (accuracy) - 
Validity of the scoring system was assessed by, examining the face, content, concurrent 
and construct validity of the scores. 
V. 4.2.1 Face validity 
Face validity was examined by the candidate to ensure that there were no obvious 
discrepancies between visual inspection and the scores assigned to sets of diagnoses and 
clinical actions. Diagnostic workups that seemed 'good' should have high scores and 
sets that appeared 'bad' should have scored poorly. Assessment of face validity by the 
candidate revealed no instances where the scores seemed counter-intuitive. 
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V. 4.2.2 Content validity 
Ten paediatricians, of different grades and levels of experience, who were not involved 
in the development of the score, were instructed to review the factors contributing to 
diagnostic and management plan quality. They also assessed each factor individually 
and indicated whether other factors were involved in contributing to the quality of a 
diagnostic workup and clinical management plan. Sets of diagnoses and clinical actions 
were used as examples during this process. This consultation established that the four 
main concepts used to develop the scoring system were comprehensive and relevant to 
measuring the quality of a diagnostic and management plan, thus ensuring adequate 
content validity. 
V. 4.2.3 Construct validity 
Sets of diagnoses and management plans constructed before Isabel consultation were 
examined for construct validity. The extent to which the scores discriminated between 
medical students (expected to perform badly) and consultants (expected to perform 
well) was measured, as well as how well the scores discriminated between subjects' 
plans for common cases (higher scores) and unusual cases (lower scores). We analysed 
this by comparing the mean scores of the medical student group and the consultant 
group and computed the difference between their mean scores in standard deviation 
units. We examined mean scores of common and unusual cases in similar fashion. The 
mean DQS and MQS for medical students were much lower compared to the 
consultants (30.15 vs. 41.59; 28.9 vs. 38.87 respectively: a difference of 0.83 SD units 
for both). Mean DQS for unusual cases was much lower compared to mean DQS for 
common cases (all users, 31.62 vs. 46.34: difference of 0.86 SD units). 
V. 4.2.4 Concurrent validity 
Concurrent (or criterion) validity was assessed from two separate views. In the first, the 
validity of the panel's scores was tested by comparing the conclusive diagnosis (as 
established at the end of hospital stay) of each case to its rating during the panel scoring 
process. This 'correct' diagnosis was present in the aggregate list for all cases; the panel 
assigned it the highest score in 22/24 cases (92%), indicating a high degree of criterion 
validity for the panel. Secondly, in the absence of an established score for the quality of 
decision plans, concurrent validity of the DQS and MQS was established by comparing 
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the score with a subjective impression of plan quality elicited from a panel of general 
paediatricians. Thirty sets of differential diagnoses and management plans were selected 
at random from the study data, ensuring that high-scoring, mid-scoring as well as low- 
scoring sets were included in equal proportion. These were sent by email to ten general 
paediatric consultants chosen at random from the Isabel user database. Subjects were 
asked to score overall quality on a scale from 0-5. The extent to which the DQS and 
MQS correlated with these scores was tested by using the Spearman rank correlation 
test. 
Correlation between the subjective impression of overall plan quality and corresponding 
DQS and MQS derived from the equations described previously showed a Spearman 
correlation p 0.64 (95% Cl 0.36-0.81, p<0.001). When only the DQS was tested, 
correlation improved to ap0.75 (95% CI 0.24-0.94, p<0.01), when only MQS was 
tested p was 0.62 (95% Cl 0.24-0.83, p<0.001). 
Figure V. 9: Correlation between DQS and MQS with median subjective score for quality 
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When the correlation between the DQS and MQS was examined, there was a positive 
correlation (Pearson's correlation co-efficient 0.51; 95% Cl 0.39-0.60, p<0.01; r2 0.26). 
This co-efficient signifies moderate correlation according to Colton: 0-0.25 - little or no 
correlation; 0.25-0.50 - fair correlation; 0.50-0.75 - moderate to good correlation; 
>0.75 - good to excellent correlation. 
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V. 4.2-5 Sensitivity analysis 
Since the weighting scheme and the steps used in the scoring process were empirically 
determined, sensitivity analysis was carried out to identify whether all the steps used in 
computing the score were necessary in order to ensure adequate reliability and validity. 
Concurrent validity was assessed separately for three out of six cases used in the 
validation sample. Scores were first computed using an arithmetic sum of the individual 
ratings, as opposed to the weighted sum. 
For DQS and MQS together, Spearman p dropped to 0.34 (95% Cl -0.15 to 0.70), for 
DQS alone it was 0.49 (95% Cl -0.53 to 0.93). When the step that ensured relevance of 
the plan (involving the subtraction of no from TWS) was eliminated, correlation 
dropped to p 0.54 (95% Cl 0.09-0.80). These findings are shown graphically in Figure 
V. 10 and Figure V. 11. 
Figure V. 10: Correlation between median subjective score and DQS and MQS when weighting of 
individual item scores was not applied 
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Figure V. 11: Correlation between median subjective score and raw DQS and MQS without 
subtracting irrelevant items 
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V. 5 Discussion and summary 
In this part of the evaluation of the Isabel system, a reliable and valid composite scoring 
metric was developed for the measurement of quality of a clinical assessment plan in an 
acute medical setting. The score can be used as an outcome measure in our planned 
simulated field study (chapter VI) as well as in other medical informatics studies that 
attempt to quantify the benefits of diagnostic decision support through changes in 
diagnostic quality as well as in clinical management. It may also prove useful in 
medical education exercises which use case simulations to assess the performance of 
examinees. 
V. 5.1 Main features of the new scoring system 
Compared to previous scores used for the assessment of the quality of subjects' 
diagnostic reasoning, a number of unique features make the new score a useful addition 
to the medical informatics literature. These features are surnmarised in Table V. 3. 
Table V. 3: Main characteristics of proposed scoring system 
1. Complete composite score can be calculated when the 'correct' diagnosis is unknown 
2. Contribution of any number of diagnoses or management steps can be considered 
3. Assesses the quality of clinical 'actions' prompted by diagnostic decision support 
4. Assesses quality as a function not just of plausibility; quality is defined as 'appropriateness' of 
decision-making 
V. 5.1.1 Needfor the 'correct' diagnosis 
The scoring system described in this chapter attempts to measure diagnostic quality by 
examining the appropriateness of decision making at a fixed point in time, rather than 
the ability to predict the definitive diagnosis, usually established only after specific 
diagnostic tests. 
Many previous evaluations were conducted in an academic setting, rather than 'on the 
frontlines', with the aim of studying the effects of DDSS diagnostic reasoning on 
simulated cases with a known final diagnosis. In a sense, these studies were 
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retrospective in nature, assessing the impact of computerised tools for cases that had 
already undergone extensive diagnostic testing to establish the definitive diagnosis-, as 
such, all cases had a final diagnosis. The case material used was usually derived either 
from patients with complex multiple conditions or patients with atypical presentations 
of rare diseases, essentially representing diagnostically challenging cases (Berner. 
Webster et al. 1994). In these cases, it was therefore appropriate, and possible, to 
measure the extent to which the DDSS could help the clinician reach the known final 
diagnosis. In the real setting, however, as demonstrated in the few studies that examined 
DDSS impact in prospective fashion, a final diagnosis could be established in less than 
75% of cases despite months of investigations among patients presenting with a 
complex diagnostic conundrum at admission (Wexler, Swender et al. 1975; Bankowitz, 
McNeil et al. 1989). A substantial proportion of cases were excluded from analysis 
because the final diagnosis was not available to assess the effects of DDSS advice on 
clinicians' decision making. 
The Isabel tool was intended to be used during an acute presentation, where a 
conclusive diagnosis was unlikely to be available immediately. In this setting, the 
system may be more useful for clinicians as a reminder tool to prompt the consideration 
of important diagnoses and relevant diagnostic tests in order to reach the definitive 
diagnosis. Any score that requires a 'correct' diagnosis as the gold standard may be 
impossible to evaluate in this setting in a prospective manner, and falsely undervalue 
the clinical utility of a DDSS. Our scoring system uses an expert panel to provide the 
'gold standard' to measure the diagnostic and other decisions made by the subjects, and 
avoids the need for a 'correct' diagnosis altogether. The use of an expert panel to 
provide 'silver' standard judgements when a perfect 'gold' standard is not available has 
been described previously (Hripcsak and Wilcox 2002). 
V. 5.1.2 Limit on the number of diagnoses 
Since Friedman and others relied on a rank-ordered list of diagnostic possibilities to 
provide an indicator of diagnostic performance, an arbitrary limit of six items was 
placed on the number of diagnoses subjects could include in their workup (Friedman, 
Elstein et al. 1998). While this may be an acceptable step in a laboratory-based study, it 
is unlikely to be so in a real life environment. In fact, rigid rank-ordering is seldom 
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perfonned in clinical practice. In particular, since diagnostic assessment in an acute 
setting is usually performed at an early stage, with limited clinical information, it is not 
possible to restrict the number of appropriate diagnoses in the hypotheses list. The aim 
is to be all-inclusive and rule in as many serious and likely diagnoses as may be 
necessary to achieve a safe workup. The current scoring system described did not need 
to place a limit on the number of diagnoses in the list, since rank-ordering was not used 
to calculate the score. 
V. 5.1.3 Clinical actions 
Our proposed scoring system is the only one that takes into account the quality of 
actions generated as a result of the diagnostic decisions made by the clinicians. Since 
actions have direct consequences for the patient, even though the process of diagnosis 
itself does not, it seems logical that the effects of diagnostic decision support on test- 
ordering and treatment decisions are studied closely. This important aspect of quality 
has been neglected in previous studies, although the need for this approach has been 
highlighted (Friedman, Elstein et al. 1999; Berner 2003). In a study of QMR, changes 
engendered in test ordering as a result of diagnostic decision support were analysed, but 
the quality of the changes was not. After the use of the program in 31 cases, the medical 
team reported that they would obtain an additional laboratory test in 10 cases, change 
the order of planned tests in two cases and eliminate a lab test in one case (Bankowitz, 
McNeil et al. 1989). 
V. 5.1.4 Appropriateness of decisions 
Scoring systems in the past have focused on the plausibility of a diagnosis as a key 
determinant of quality. While the ability of a proposed diagnosis to explain the patient's 
signs and symptoms is important, less plausible diagnoses may also be appropriate to 
consider if they cause serious patient harm if missed. Easily treatable conditions (e. g. 
infections) may take a prominent position in the diagnostic workup even if they seem 
less plausible. This concept has been explained further by Schiff in the AHRQ report on 
diagnostic errors (Schiff, Kim et al. 2005). By specifically focusing on this aspect 
during the scoring system development, the panel was instructed to score individual 
diagnoses and clinical actions on the basis of plausibility, likelihood and potential 
impact on patient safety. This concept was also important in the acute setting, where the 
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absence of adequate information at presentation necessitates the consideration of the 
ý safe' diagnoses and performance of the 'safe' tests for the patient at that time. 
V. 5.2 Use of the expert panel 
An expert panel was used to provide 'gold standard' decisions against which the 
subjects' decisions were measured, and was central to the new scoring system 
procedure. While there is substantial evidence to support the use of experts to provide 
judgements when an adequate 'gold standard' is not available or cannot be used, the 
reliability and validity of the panel itself may need to be ascertained and demonstrated 
wherever possible (Miller 2002). 
In the current score development process, the expert panel exhibited a high degree of 
criterion validity. Since all the cases used in the simulated field study had a definitive 
diagnosis, although that was not the focus of measurement, it was possible to show later 
that the panel had scored these diagnoses highly on the scale. Blinding the panel 
members as to the final diagnoses at the time of scoring avoided 'outcome bias' (or 
'hindsight bias'), which may have compromised the quality of the panel's opinion 
(Dawson, Arkes et al. 1988). Intra-rater reliability, in which each panel member's 
opinion remains consistent when the same cases are rated on multiple occasions, is an 
important attribute; lack of consistency poses a serious threat to panel judgements. We 
studied the scores assigned by panel members to the items that they themselves had 
suggested as 'must-not-miss' diagnoses and actions two weeks previously. We found 
that in the majority of cases, panel members scored their own previous suggestions 
highly, confirming consistency in their opinion. Intra-rater reliability also confirmed 
that the scoring instructions provided to the panel were clear and unambiguous. 
While using the panel's opinion as the 'gold standard', it was recognised that sometimes 
appropriate diagnoses and actions may be missed by the panel. In Berner's original 
study of four diagnostic systems, when the expert panel was asked to retrospectively 
review DDSS suggestions, an average of two diagnoses per case were selected as being 
appropriate for inclusion in the 'gold standard' (Berner, Webster et al. 1994). In order to 
account for this limitation, in the current study, an aggregate list was created for each 
case, by merging all diagnoses and actions suggested by both the panel and subjects. In 
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this fashion, any 'gold standard' item missed by the panel in their first-pass review 
would be identified in the second round of scoring, as long as one of the subjects had 
included it in their workup. Although we avoided merging diagnoses suggested by the 
DDSS into the aggregate list for logistical reasons, this final step may have further 
enhanced the quality of the 'gold standard'. Friedman used a methodology similar to 
ours in their study of diagnostic reasoning using ILIAD and QMR (Friedman, Elstein et 
al. 1999). 
Since two members formed the expert panel, it was crucial that their decisions were 
concordant with each other. In this study, agreement was better for diagnoses than for 
management items. This finding was consistent with the reported level of agreement for 
judging appropriateness of test ordering during a peer review process (Bindels, Hasman 
et al. 2003). Despite being provided the same cases as the subjects, and detailed scoring 
instructions, it was likely that there were differences in the approach with which the 
panel judged decisions. In particular, deciding the appropriateness of decisions at a 
fixed, single point in time in the acute setting was difficult; most discrepancies between 
panel members originated from disagreement about whether a particular test/step would 
be appropriate at the point of decision making. Major differences were resolved by 
discussion at the end of the panel scoring process. 
V. 5.3 Diagnostic and management quality scores 
Two separate but inter-related scores were developed to measure the quality of decision 
making in an acute setting, and seemed to measure related aspects of clinical 
performance as evidenced by the moderately positive correlation. Intuitively, a greater 
correlation between the two scores might be expected; a subject scoring a high DQS for 
a case should also score a high MQS. However, when decision-making is measured at 
one fixed point in time, as in the current study, management plans may not vary greatly 
between subjects even when diagnostic suggestions may have varied. For example, a 
simple management plan consisting of basic tests and supportive treatment could easily 
be the ideal choice for most clinical scenarios in the immediate term. A non-specific 
diagnosis of 'something weird neurological' could still prompt the physician to perform 
appropriate tests such as a CT scan. Despite these limitations, it is conceivable that a 
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high DQS at one point in time might favourably influence actions in the future by 
helping the clinician to reliably interpret the results of initial tests or treatments ordered. 
During the development of the score, the scale for diagnoses treated them as 
'judgements' and management items as 'actions'. It was hypothesised that only an 
4action' - which might affect care and cause patient harm - deserved a negative score. 
'Judgements' that were not followed up by an inappropriate 'action' were not penalised. 
in order to magnify the positive and negative effects of actions, a weighting scheme was 
used. Overall plan quality was calculated as a weighted sum of individual ratings - this 
step enabled differential contribution of appropriate versus less appropriate decisions. 
The Unites States National Board of Examiners (NBME) has previously used weighted 
scoring schemes to assess performance in their case simulations. The scores were shown 
to be reliable and valid for measurement purposes. They demonstrated adequate face 
validity and construct validity by satisfactorily differentiating consultants' plans from 
those of medical students', and plans generated in easy cases from scores for difficult 
cases. 
V. 5.4 Limitations 
Despite the encouraging reliability and validity of the two scores described in this study, 
a number of limitations can be addressed with future work. One of the most sensitive 
measures to assess diagnostic performance, rank-ordering, could not be included as part 
of this score development. Although we postulated that ranking was only useful to 
indicate the choice of further management steps, and was irrelevant when the quality of 
clinical 'actions' was directly measured as part of the diagnostic assessment, it may 
have been instructive to examine its role in ensuring validity. 
Despite the creation of an aggregate list of diagnoses and management items for each 
case from merging suggestions from panel members and subjects, it is possible that the 
list did not include all appropriate decisions. We hypothesised that the number of new 
relevant items would diminish as a function of the number of new subjects who assess a 
case. A median of 37 diagnostic suggestions were included in the aggregate list per case 
in our study. This posed a logistical problem for the panel - they had to score 
between 
20 and 65 diagnoses and a similar number of management items 
for each case. 
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Friedman reported a similar phenomenon with their scoring system and calculated that 
an average of 28 subjects had to work a case to exhaust all plausible diagnostic 
suggestions (Friedman, Gatti et al. 2002). One of the other problems with the need for 
an aggregate list was that data analysis and scoring was not possible until all subjects 
had completed all their cases. 
It is possible that other investigators may find that the scoring system described is 
overly complex, involving a number of steps. However, the quality of clinical reasoning 
in a broad domain such as paediatric medicine is an abstract concept, without a clear 
gold standard. The steps described in the development of the scoring system were 
necessary in order to satisfy validity requirements. 
V. 5.5 Summary and future work 
In this chapter, the development and validation of metrics to objectively measure the 
quality of diagnostic and clinical management during an acute assessment was 
described. The metrics have been shown to be reliable and valid, indicating that they 
can be used as sensitive outcome measures during the planned impact evaluations of 
Isabel. The scores can be generalised to other settings, and used in any future studies 
evaluating the diagnostic performance of human subjects or computer-based systems. 
The next step in the sequential evaluation of Isabel is an impact evaluation in an 
experimental setting. 
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VI. 1 Background 
It is not possible to conclude that a decision support system is capable of changing 
clinical practice by evaluating its performance in isolation (Wyatt and SPiegelhalter 
1990). A number of decision aids which performed satisfactorily when tested by system 
developers or expert users have failed to change physicians' behaviour and decision 
making significantly in the hands of real users (de Dombal, Horrocks et al. 1971; 
Warner 1989; Wellwood, Johannessen et al. 1992; Murphy, Friedman et al. 1996). This 
was true even if the research was conducted in a simulated environment, where 
researchers were able to maximise the chances of finding a true effect by eliminating 
real life barriers to system usage such as access to the tool, time pressure and clinical 
workload. 
V1.1.1 Limitations of system performance testing 
VI. I. I. ] Baseline userperformance 
Since intended users are not involved in system performance evaluation, it is easy to 
overestimate the beneficial effects of a CDSS by failing to take the baseline 
performance of the user into account. If intended users are already performing at an 
optimal level, and little further improvement can be made to their decision making, it is 
usually not possible to demonstrate a significant effect irrespective of how well a 
system performs. It is possible that this 'ceiling effect' may explain why some systems 
fail to change healthcare processes. For example, in a randomised study of a computer 
program which issued physician alerts to prescribe medications for deep venous 
thrombosis prophylaxis, the authors concluded that the already high rate of prophylaxis 
in the control group considerably reduced the effect size of the intervention (Kucher, 
Koo et al. 2005). 
VI. I. I. 2 Focus on the wrong outcome 
Developers have a much better understanding of a system's intended purpose, and use 
relevant outcome measures to test its performance. When clinicians are provided access 
to the same system in an impact evaluation, they may use them in a manner other than 
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that expected by the developers, leading to negative results. For example. if subjects use 
a diagnostic system to simply lookup information about diseases, rather than to access 
diagnostic advice, it is unlikely that the investigators will be able to demonstrate 
meaningful changes in diagnostic performance (Bemer, Brooks et al. 1989). 
VI. 1.1-3 Poor system design 
A poorly designed system prevents clinicians from being able to use it in an effective 
manner. User interaction at the time of data entry may be time consuming and 
laborious; the inference engine may be suboptimal and generate erroneous results; the 
knowledge base may be poorly constructed and lack relevant medical content; and the 
advice provided by the system may be unclear, unconvincing or not available in time. 
For example, while the developers of DXplain indicated that data entry took an average 
of I minute in their initial report on the performance of the system, subjects spent a 
median of 22 minutes during case analysis in a study of two similar diagnostic systems 
(Barnett, Cimino et al. 1987; Friedman, Elstein et al. 1999). 
VI. 1.2 Need for an Isabel impact evaluation 
Despite encouraging results from the Isabel performance evaluation described in chapter 
111, a realistic assessment of its benefits in clinical practice could only be made from an 
evaluation of its impact. This step constituted the logical next phase in the sequential 
evaluation of the system. An experimental design was deliberately chosen as an interim 
step before a full-fledged clinical trial to shield patients from the effects of decisions 
made by study subjects. Written cases were used to test the influence of Isabel advice on 
subjects' clinical decision making. 
It was impossible to simply extrapolate the anticipated impact of the Isabel system on 
clinical decision making from similar studies of previous 'expert' systems. A number of 
significant differences existed between the Isabel system model and the traditional 
4 expert system' model, related to all three key components of the decision support 
system structure (knowledge base, inference engine and user interface) shown in Figure 
VI. '. 
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Figure VIA: Traditional components of a clinical decision-support system 
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Since the Isabel knowledge base was constructed from uncoded and unformatted text 
derived from various medical textbooks, it was obvious that key clinical concepts were 
buried within the text in the form of natural language terms, rather than in coded 
fashion. Since no effort was made to manually extract the relevant findings, or to create 
specific relationships between concepts in the knowledge base, the database structure 
raised the possibility that, since the information was not machine-readable in a 
conventional sense, it would be difficult to extract appropriate medical concepts to 
generate disease profiles from the text within the knowledge base, and match these to 
the user query. Although this aspect was tested during system performance evaluation 
using real and hypothetical case scenarios, data was entered into the DDSS by the 
developers, who were familiar with the manner in which the decision aid worked, rather 
than by system-naYve users. An impact evaluation would provide useful information on 
the strengths and weaknesses of the Isabel knowledge base model. 
VI. 1.2.2 Inference engine 
The ability of NLPS to display relevant diagnoses in response to free text queries was 
tested during system performance evaluation, but users had not directly interacted with 
the system. It is possible that the rich variety of natural language terms expected from a 
large sample of subjects would adversely affect the performance of the software, result 
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in significant inconsistency in the nature of reminders generated for different users, and 
compromise the quality of the diagnostic advice offered. The inference engine was also 
dependent on the custom synonym file created by the system developers, intended to 
translate non-medical terms and medical slang into medical terminology. This function 
had not been tested against a wide variety of words and phrases. Finally, since the 
software was essentially a 'black-box' for users, in the sense that the explanatory 
capacity of the system was limited, there were concerns that users would not trust or 
follow the advice provided. ' 
VI. 1.2.3 User interface 
Since the Isabel system interface aimed to simplify the data entry by accepting natural 
language input without the need for a controlled vocabulary, it was important to test 
whether user interaction time would be greatly diminished, and how this would affect 
decision making. It was also unclear how users would choose between various 
suggestions contained within the list of diagnostic reminders, especially when they were 
not ranked by clinical likelihood. 
This chapter describes the main study design considerations, a review of previous 
evaluations of the effects of expert systems on subjects' diagnostic reasoning, and the 
results of a simulated assessment of Isabel's impact on users' clinical assessment in an 
acute setting. 
VI. 1.3 Aims and study design considerations 
The main aim of this simulated impact evaluation was to study the effects of the Isabel 
system on the diagnostic performance of real clinicians. 
VI. 1.3.1 Case and subject characteristics 
Previous studies that examined the impact of expert systems showed that the level of 
case difficulty had a significant effect on diagnostic performance. In a study of QMR, 
subjects' overall diagnostic performance was higher in less challenging cases, although 
subjects perceived DDSS to be more useful when difficult cases were assessed (Berner 
and Maisiak 1999; Berner, Maisiak et al. 1999). In a large study involving two DDSS, 
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Friedman showed that in the cases where subjects did not include the 'correct' diagnosis 
in the pre-consultation list (i. e. diagnostically challenging cases), the DDSS did not 
display the *correct' diagnosis either, suggesting that cases that were difficult for 
subjects were difficult for computerised aids too (Friedman, Elstein et al. 1999). 
Similarly, it has been demonstrated that experienced subjects derive less benefit from 
DDSS compared to junior grades of subjects such as medical students and residents. 
Significant differences were demonstrated between the diagnostic accuracy rates of 
students and attending physicians before and after DDSS consultation (26% and 35% 
for students versus 49% and 52% for attending physicians) (Friedman, Elstein et al. 
1999). In another preliminary evaluation, it was clear that when faced with difficult 
diagnostic cases, medical students added significantly more diagnoses from ILIAD's 
differential compared to the residents or attending physicians (Murphy, Friedman et al. 
1996). 
Since the main role of the Isabel diagnostic aid was to remind users of key diagnoses, it 
was hypothesised that most subjects would find the system useful in both easy and 
difficult cases. In order to examine how various case and subject combinations affected 
the ability of the DDSS, to provide optimal diagnostic support, simulated cases of 
varying levels of difficulty and subjects of different grades were used in an 
experimental study design. 
VI. 1.3.2 Measuring appropriateness of decision making 
Previous studies used diagnostic accuracy as the main outcome measure to examine the 
effects of DDSS on users. Since the purpose of the Isabel tool was to remind users of 
key diagnoses, the quality scores developed and validated as part of this research 
program were used as the main outcome measure in the simulated field trial. These 
scores focused on the appropriateness of diagnostic workup and clinical management, 
rather than accuracy, and had never been used as an outcome measure before. 
VI. 1.3.3 Variability in data entry 
Many DDSS provided system-specific terminology for users to enter clinical data in an 
attempt to convert the natural language used by the clinician into computer-readable 
codes. Despite this, Bankowitz showed that when a physician and a physician assistant 
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assessed a set of 19 cases with QMR, concordance for positive and negative findings 
was only 0.66 or less, indicating that variability in processing a case was an inevitable 
consequence of inter-subject differences in prior knowledge and clinical experience 
(Bankowitz, Miller et al. 1991). Therefore, during the planned Isabel simulated impact 
assessment involving a number of subjects at different grades, significant variability 
was expected due to the free text manner in which clinical findings were normally 
entered into the system. Assessment of the effect of inconsistency in data entry on the 
nature of diagnostic advice provided by the system was a key consideration during this 
study. 
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VI. 2 Materials and Methods 
The simulated field study of Isabel's impact involved measurement of changes in the 
quality of clinical decisions made by subjects. Clinicians processed a standard set of 
cases; their clinical decisions regarding diagnoses, test-ordering and treatment were 
recorded, both before and immediately after diagnostic assistance from the Isabel 
system. The main focus of the measurement was subjects' decisions; the quality of 
diagnostic suggestions generated by the system itself was examined only to check that 
its advice remained consistent across subjects and cases. The study was conducted 
between February and August 2002 at St Mary's Hospital, Imperial College School of 
Medicine. 
VI. 2-1 Study design 
The simulated impact evaluation was a laboratory-based research project, using a 
within-subject before-after comparison and a prospective balanced experimental study 
design. 
VI. 2.2 Subjects 
Since the Isabel system was a paediatric decision support system, the majority of the 
subjects for this experiment were chosen from a convenience sample of paediatric 
trainees and consultants. At the time of this study, the Isabel system was freely available 
to registered users. Registered users were typically paediatricians, but also comprised 
general practitioners, other specialist physicians and healthcare staff. 
Registered medical users working in UK paediatric posts at the time of the project were 
requested to participate in the simulated study by means of a single email invitation. All 
users who evinced interest were sent details of the proposed study procedure by email. 
All users who subsequently consented to be involved in the study following this 
explanation were recruited. Recruited subjects consisted of a mixture of regular Isabel 
users as well as those who had never used the system after initial registration. Subjects 
belonged to various grades - senior house officers, registrars and consultants - and were 
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from different locations in the UK. Final year medical students from one medical school 
(St Mary's Campus, Imperial College School of Medicine, London), undergoing their 
paediatric rotation at the time of the study, were also invited to participate. All students 
who consented to the proposed study procedure were recruited. 
VI. 2.3 Case material 
The decision to use textual cases to simulate a patient encounter was based on research 
conducted in the educational field, where the validity of using case simulations has 
previously been demonstrated in medical education exercises as well as during the 
assessment of mock clinical decision making (Issenberg, McGaghie et al. 1999; 
Clauser, Margolis et al. 2002; Dillon, Clyman et al. 2002). 
Twenty four simulated cases representing a range of paediatric specialities as well as 
difficulty levels were used. These cases were selected from a larger pool using a 
structured methodology to ensure validity of case material in range and difficulty level. 
VI. 2.3.1 Creation ofsimulated cases: step I 
The candidate constructed 72 cases with a textual description of the presenting clinical 
features of children presenting to an emergency department. Cases were based on real 
clinical encounters and were drawn from data collected during the Isabel system 
performance evaluation from four UK emergency departments (chapter 111). A set of 
general rules was used to guide the creation of the simulated cases: 
Each case was between 150 and 250 words long, and described the initial presenting 
symptoms, clinical signs and basic laboratory test results available at the time of 
clinical assessment. 
All cases included ample negative as well as positive features to avoid the reader 
picking up salient clues from the text. 
All cases were drawn from clinical presentations to an emergency department; hence, 
the amount of clinical information available at assessment was limited but typical 
for 
this setting. 
An example of one simulated case is provided below: 
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A 6-week old infant is admitted with a week's history of poor feeding. Whereas previously the infant had 
been growing along the 25th centile, he has now fallen below the 10th centile. In the past week, his 
parents also think he is breathing quite quickly. He has a cough and is vomiting most feeds. 
On examination, he is tachypnoeic, has moderate respiratory distress, and a cough. A grade 3 murmur is 
heard all over his precordium. He also has a3 cm liver palpable. Initial lab results show Haemoglobin 9 
g/dL, White cell count 12.4 x 106/ ýtl,, Platelets 180 x 106/ [tL. 
VI. 2.3.2 Creation of simulated cases: step 2 
The aim of this step was to generate cases of varying difficulty levels and covering a 
range of topics for the study. To this end, the candidate then assigned each case to one 
of twelve different pre-defined paediatric sub-specialties (e. g. cardiology, respiratory). 
Within each sub-speciality, each case was then assigned to one of three case difficulty 
levels. Case difficulty levels were also pre-defined, and applied to UK district general 
hospital paediatric practice. 
Case difficulty level I- unusual clinical presentation 
Case difficulty level 2- typical clinical presentation 
Case difficulty level 3- common clinical presentation 
VI. 2.3.3 Creation ofsimulated cases: step 3 
The process of allocating cases first to a sub-specialty and then to case difficulty level 
was independently duplicated by a consultant in paediatric medicine with >3 years 
experience at this grade. Identical definitions were used during the process of case 
allocation. 
Both investigators allocated 57 cases to the same sub-specialty; 42 cases were assigned 
to both the same sub-specialty and the same level of case difficulty (raw agreement 0.79 
and 0.58 respectively). From this subset, 24 cases were finally chosen. In order to 
ensure adequate diversity, case selection was performed in such a way that two cases, 
each representing a different level of case difficulty, were chosen per sub-specialty 
(paired combinations being either level I&2,1 &3 or 2& 3). This detailed case 
selection process ensured that a balanced set of cases representing all sub- specialties, 
and comprising easy as well as difficult cases, was chosen for the purpose of this study. 
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VI. 2.4 Study website 
It was important that case assignment and data collection from subjects was 
standardised during the study. In order to minimise the time between making their own 
clinical decisions and being displayed diagnostic advice from the Isabel system, it was 
necessary to allow subjects instant access to diagnostic decision support during the 
study without having to separately log into the Isabel system. For these reasons, a 
custom version of the Isabel website was used to collect data during the study. The chief 
functions of this study website are summarised below: 
a) The system was password protected to allow only legitimate study subjects to log 
in. All details regarding log in such as time and date of access as well as time spent 
on the system were recorded. 
b) The website was configured to display 12 study cases to each subject in sequence. 
Cases were randomly selected, with the proviso that all sub-specialities were 
represented in the set. 
c) Each attempt by a subject at a case was defined as a case episode. At the beginning 
of each case episode, a unique study number was automatically assigned to that 
episode. 
d) The website ensured that subjects proceeded from the each step to the next without 
being able to skip steps or go backwards. 
e) Subjects' clinical decisions (diagnoses, tests and treatment) pre- and post-DDSS 
consultation were recorded in a structured fashion. 
f) Time spent at each stage of the procedure was recorded. 
VI. 2.5 Training 
Training was intended to familiarise enrolled subjects with the study website, not to 
train them to work a simulated case. Subjects practised with one sample case. Since 
most subjects were from geographically disparate locations, only medical students were 
supervised during training; detailed instructions regarding the website were provided by 
email to other subjects. Medical student training was supervised by one investigator in 
group sessions involving two or three subjects. At each step on the website, context- 
specific help was provided for user assistance during the practice session. All subjects 
completed their assigned practice case, and were recruited for the study. 
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VI. 2-6 Study procedure 
Subjects were given three weeks to process their allocated set of twelve cases. They 
were allowed to complete case assessment from any computer connected to the Internet 
at any time (i. e. case episodes were not supervised). Following log in, subjects were 
automatically assigned a set of 12 cases by the study website, and presented with text 
from the first case. 
VI. 2.6.1 Screen I 
Subjects read through the case as presented and keyed in the salient clinical features 
(according to their interpretation of the case) into a designated search box in natural 
language. Following this, subjects recorded their own clinical decisions regarding 
diagnostic workup, test-ordering and treatment into designated textboxes. No specific 
terminology or controlled vocabulary was used to record these clinical decisions. 
Decisions made by subjects at this stage constituted pre-DDSS clinical decisions. See 
Figure VI. 2 for an illustration of this step. 
Figure VI. 2: Screenshot of simulated study procedure - step I 
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VI. 2.6.2 Screen 2 
On submitting information recorded on screen 1, a list of diagnostic suggestions was 
instantly presented to the subject based on the clinical features entered by the subject. 
On the basis of these suggestions, subjects could modify their pre-DDSS clinical 
decisions by modifying, adding or deleting items - these constituted post-DSS clinical 
decisions. On this screen, subjects could not read the case text again, preventing them 
from processing the case a second time, avoiding 'second-look' bias. See Figure VI. 3 
for an illustration of this step. 
Figure VI. 3: Screenshot of simulated study procedure - step 2 
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Diagnostic suggestions displayed varied between subjects since the search query was 
unique for each subject, depending on their understanding of the case and the clinical 
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features they entered in natural language. The text from one case, and the variability 
associated with its interpretation, is depicted in Table VI. I and Table VI. 2. 
Table VI. I: Example of a case used in the simulated study (this case was assigned to Cardiology and 
case level 2 by both investigators) 
A 6-week old infant is admitted with a week's history of poor feeding. Whereas previously the infant had 
been growing along the 25th centile, he has now fallen below the 10th centile. In the past week, his 
parents also think he is breathing quite quickly. He has a cough and is vomiting most feeds. 
On examination, he is tachypnoeic, has moderate respiratory distress, and a cough. A grade 3 murmur is 
heard all over his precordium. He also has a3 cm liver palpable. Initial lab results show Haemoglobin 9 
g/dL, White cell count 12.4 x 106/ [tL, Platelets 180 x 106/ [tL. 
Table VI. 2: Variability in clinical features as abstracted by five different users, expressed verbatim 
failure to thrive, growth below 1 Oth centile, previous growth on 25th centile, 
User A tachypnoeic, moderate respiratory distress, cough, precordial grade 3 murmur, 
palpable liver 3cm, neutrophilia, thrombocytophilia 
User B poor feeding for 1/52, FTT, DIB + COUGH + vomiting, HEART MURMUR, liver 
palpable 
User C Weight loss, cough, vomiting, respiratory distress, heart murmur, hepatomegaly 
User D poor feeding, failure to thrive, tachypnoeic, cough, vomiting, respiratory 
distress, 
heart murmur, large liver, anaernia 
User E poor feeding, wt loss, tafchypneic, cardiac murmur 
Subjects could terminate their session at any time and return to complete the remainder 
of cases. If a session was terminated midway through a case, the case was presented 
again on the subject's return. If the website detected no activity for >120 minutes, the 
subject was automatically logged off. 
VI. 2.7 Intervention 
The main intervention in this study consisted of the diagnostic suggestions displayed by 
Isabel. 
VI. 2.8 Outcome measures 
The primary outcome measure used in this simulated field study was the change in the 
number of diagnostic errors of omission among subjects. 
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Secondary outcome measures examined included: 
a. Mean change in subjects' diagnostic, test-ordering and treatment plan quality 
scores. 
b. Change in the number of irrelevant diagnoses contained within the diagnostic 
workup. 
c. Proportion of case episodes in which at least one additional 'important' diagnosis, 
test or treatment decision was considered by the subject after Isabel consultation. 
d. Presence of all 'must-not-miss' diagnoses within Isabel's list of diagnostic 
suggestions 
e. Additional time taken for system consultation. 
The outcome measures were chosen to reflect the aims of the study as well as the nature 
of the differences between the Isabel system and previous 'expert systems'. The main 
aim of this simulated study was to assess if the provision of key diagnostic reminders 
would improve the quality of the clinical decision making by reducing subjects' errors 
of omission. A subject was defined to have committed a diagnostic error of omission if 
they failed to include all 'must-not-miss diagnoses' in their diagnostic workup, for a case 
episode. 
'Must-not-miss' diagnoses 
'Must-not-miss' diagnoses were generated by an expert panel, comprising two general 
paediatricians with >3 years consultant level experience and >10 years overall 
experience in paediatrics. The description of the panel's work is described in detail in 
chapter V as part of the quality score development process, and is summarised below. 
The expert panel independently assessed each simulated case used in the study and 
generated their own list of key diagnoses, tests and treatments. A master list of 
suggestions (generated from a combination of key items suggested by the panel and 
subjects' clinical decisions) was created by the candidate. Before this master list was 
created, subjects' diagnostic suggestions were mapped to the nearest equivalent term in 
the Isabel database, since subjects' clinical decisions had been entered in free text and 
not through a controlled vocabulary. Panel members then scored each diagnostic 
suggestion on the master list using a pre-assigned scale. Highest scoring diagnostic 
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items on the scale were defined as 'must-not-miss' diagnoses. The failure to include 
'must-not-miss' diagnoses in a subject's workup was pre-defined to represent clinically 
unsafe decision making. 
VI. 2.9 Analysis, including statistical analysis 
VI. 29.1 Diagnostic errors of omission (DEO) 
Subjects were used as the unit of analysis for the primary outcome measure. For each 
subject who had completed all twelve assigned cases, the total number of DEO was 
counted separately for pre- and post-Isabel diagnostic workup plans. Statistically 
significant changes in the number of DEO following system consultation and its 
interaction with subject grade were assessed by two-way mixed-model analysis of 
variance (grade being between- subjects factor and time being within-subjects factor). 
Mean number of DEO was calculated for each subject grade, and DEO were 
additionally analyzed according to level of case difficulty. Statistical significance was 
set at ap value of 0.05. SPSS 10.0 was used for all statistical calculations (SPSS, 
Chicago, IL). Sample size calculations for the study, expecting an average reduction of 
I DEO across all 12 cases assessed by a subject (standard deviation 2, power 80%, level 
of significance 5%), suggested that 65 subjects needed to be enrolled. 
VI. 2.9.2 Quality scores 
Subjects were used as the unit of analysis for the change in mean quality scores for 
diagnostic, test-ordering and treatment plans. For each case episode, subjects' quality 
score (pre- and post-DDSS consultation) was first calculated. A mean quality score 
across all twelve cases was then computed for each subject. Subjects who had not 
completed all assigned cases were excluded. A two-way mixed model analysis of 
variance (grade as between- subjects factor; time as within-subjects factor) was used to 
examine statistically significant differences in quality scores. This analysis was 
performed for diagnostic quality scores as well as test ordering and treatment plan 
scores. Sample size calculations using this variable showed that data from 64 subjects 
were needed to demonstrate a mean diagnostic quality score change of 0.03 (standard 
deviation 0.06, power 80%, level of significance 5%). 
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VI. 2.9.3 Irrelevant diagnoses 
Using subjects as the unit of analysis, the mean count of all diagnoses, and irrelevant 
diagnoses, included in the workup was calculated for each subject as an average across 
all case attempts. Only subjects who attempted all assigned cases were included in this 
analysis. A two-way mixed model analysis of variance was used to assess statistically 
significant differences in this outcome with respect to grade as well as occasion. 
VI. 2.9.4 DDSSperformance 
Using subjects as the unit of analysis, the mean count of case episodes per subject in 
which the Isabel system did not display all the 'must-not-miss' diagnoses was 
calculated. Only subjects who attempted all 12 cases were included in this analysis. 
Analysis of variance was used to determine if there were significant differences between 
the various grades in the performance of the diagnostic aid. 
VI. 2.9.5 Other analyses 
All other outcome variables used case episodes as the unit of analysis. The proportion of 
case episodes in which at least one additional 'must-not-miss' diagnosis, test or 
treatment was prompted by Isabel was determined. Similarly, the proportion of case 
episodes in which at least one such decision was deleted, or at least one inappropriate 
decision was added,, following system consultation, was computed. All data were 
analysed separately by subjects' grades. We also aimed to ascertain whether changes to 
subjects' decisions resulted from system consultation or simply from thinking again 
about their assigned cases (second-look bias). All case episodes in which at least one 
additional 'must-not-miss' diagnosis was added by subjects were examined. If the 
particular additional diagnostic suggestion had been present within the DSS list of 
suggestions displayed to the subject, it strongly suggested that the system, rather than 
re-thinking, prompted these changes. 
V1.2.10 Ethical and Regulatory considerations 
This quasi-experimental study was conducted at Imperial College, London at St Mary's 
Hospital Campus of the School of Medicine. The study was approved by the Local 
Research Ethics Committee Chair. All sub ects gave verbal consent to participate in the j 
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research study. No patient identifiable data were collected in this experiment. Data 
regarding subjects were stored in accordance with the Data Protection Act on the Isabel 
system server with restricted administrator access. Only pseudonymised data were used 
for study analysis. 
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VI. 3 Results 
V1.3.1 Subjects 
97 subjects were invited to participate in the study after they responded to a single email 
sent to all registered paediatric physicians working in the UK. Although all subjects 
consented and completed their training, only 76 subjects attempted at least one case 
during their allocated three week study period (attempters). This group consisted of 
medical students, senior house officers, registrars and consultants. Only six subjects 
(7.9%) reported that they had used the Isabel system regularly (defined as >1 episode of 
use/week) prior to the study period. The others had registered for the service and used 
the system on one occasion, but never used it subsequently. Fifty two subjects 
completed all allocated 12 cases (completers) while 24 only completed some cases 
(non-completers). The majority of non-completers had worked at least two cases (75%); 
slightly less than half (42%) had worked at least 6 cases. A flowchart of participants in 
this study is shown in Figure VI. 4. 
Figure VIA Flowchart of participants in simulated study 
Subjects invited to participate 
97 
Completed all allocated cases 
52 cases 
24 
Case episodes 
624 
Characteristics of subjects is summarised in Table VI. 3. 
Completed only some allocated 
Case episodes 
127 
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Table VI. 3: Study participants, cases and case episodes in the simulated study* 
Grade of subject 
Consultant Registrar SHO Student Total Case Cases 
NNNN episodes 
Subjects invited to participate 27(27.8) 33(34) 20(20.6) 17(17.5) 97 
Subjects who attempted at 
least one case (attempters) 18(23.7) 24(31.6) 19(25) 15(19.7) 76 751 24 
Subjects who attempted at 
least six cases 16(25.8) 18(29) 15(24.2) 13(20.9) 62 715 24 
Subjects who completed all 
12 cases (completers) 15(28.8) 14(26.9) 10(19.2) 13(25) 52 624 24 
Regular DSS users (usage 
>once/week) 21306 
Since each case was assessed more than once, each attempt by a subject at a case was termed as a 'case 
episode'. 
Statistically significant differences were examined between the characteristics of 
attempters and non-attempters as well as completers and non-completers. There was no 
significant difference between attempters and non-attempters with respect to grade (Chi 
square test, p 0.07). Completers and non-completers also did not differ significantly 
with respect to grade (Chi square test, p 0.06). However, more subjects were trained 
remotely in the non-completers group (Chi square test, p 0.003). 
VI. 3.2 Cases 
All 24 cases were used by subjects in the study. Due to the random nature of case 
allocation and the fact that non-completers processed only some of their assigned cases, 
there was variability in the number of times each specific case was assessed by subjects. 
The trial website ensured that completers attempted cases representing each sub- 
speciality. In total, 751 case episodes were available for analysis (624 from completers 
and 127 from non-completers). Characteristics of cases used in the study are shown in 
the table below. 
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Table VI. 4: Characteristics of cases used in simulated study 
Case ID Speciality Case level Number of times used in 
study 
9 Cardiovascular 1 24 
10 Cardiovascular 2 40 
11 Endocrine 1 34 
12 Endocrine 1 27 
13 Gastrointestinal 3 34 
14 Gastrointestinal 1 27 
15 Haernatology/Oncology 3 36 
16 Haematology/Oncology 2 29 
17 Infections 3 27 
18 Infections 1 37 
19 Neonatal 2 37 
20 Neonatal 3 26 
21 Neurology 3 26 
22 Neurology 2 38 
23 Respiratory 1 39 
24 Respiratory 3 25 
25 Musculoskeletal 1 26 
26 Musculoskeletal 3 36 
27 Allergy/Immunology 3 31 
28 Allergy/Immunology 1 28 
29 Social 3 30 
30 Social 2 30 
31 Surgical 3 37 
32 Surgical 2 27 
VI. 3.3 Primary outcome measure 
The expert panel assigned 47 diagnoses to the 'must-not-miss' category (mean: 2 
diagnoses per case). 624 case episodes generated by 52 subjects were used to examine 
diagnostic errors of omission (DEO). In the pre-Isabel consultation phase, all subjects 
performed a DEO in at least one of their cases, and 11/52 (2 1.1 %) in more than half 
their cases. In the pre-Isabel consultation stage, medical students and SHOs committed 
the greatest and least DEO respectively (6.6 vs. 4.4); this gradient was maintained post- 
consultation (5-9 vs. 4.1). 
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Overall, 5.5 DEO were noted per subject pre-Isabel consultation; this reduced to 5.0 
DEO after Isabel advice (p<0.001). No significant interaction was noticed with grade 
(173,48 = 0.71, p=0.55). Reduction in DEO following system advice within each grade 
is shown in Table VI. 5. 
Table VI. 5: Mean count of diagnostic errors of omission (DEO) pre- and post-Isabel consultation 
Grade of subject DEO pre-Isabel (SD) DEO post-Isabel (SD) Reduction 
- 
(SD) 
Consultant 5.13 (1.3) 4.6(1.4) 0.53(0.7) 
Registrar 5.64(l. 5) 5.14(l. 6) 0.5(0.5) 
SHO 4.4(l. 6) 4.1(1.6) 0.3(0.5) 
Medical student 6.61(l. 3) 5.92(l. 4) 0.69(0.7) 
Mean DEO across all subjects* 5.50(1.6) 4.98(1.5) 0.52(0.6) 
*n=52; total number of subjects who completed all 12 assigned cases 
Overall,, more DEOs were noted for easy cases compared to difficult cases pre- and 
post-Isabel advice (2.17 vs. 2.05 and 2.0 vs. 1.8), although this was not true for medical 
students as a subgroup (2.5 vs. 2.9). Improvement following DDSS advice seemed 
greater for difficult cases for all subjects, although this was not statistically significant. 
These findings are summarized in Table VI. 6. 
Table VI. 6: Mean DEO count analyzed by level of case and subject grade 
Grade Difficult cases Easy cases 
Pre-DSS Post-DSS Pre-DSS Post-DSS 
Consultant 1.66 1.47 2.0 1.87 
Registrar 2.21 1.93 2.14 1.92 
SHO 1.3 1.2 2.0 1.8 
Medical student 2.92 2.54 2.54 2.30 
VI. 3.4 Secondary outcome measures 
VI. 3.4.1 Changes in mean quality scores 
Quality scores were assessed for diagnostic, test ordering and treatment plans. 624 case 
episodes from 52 subjects who had completed all assigned cases were used in this 
analysis. There was a significant change in the weighted mean of the diagnostic quality 
score (0.044; 95% confidence interval: 0.032,0.054; p<0.001). No significant 
interaction was demonstrated between grade and occasion. In 9/52 subjects (17.3%), the 
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pre-Isabel score for diagnostic quality was higher than the post-Isabel score, indicating 
that subjects had lengthened their diagnostic workup without substantially improving its 
quality. Table VI. 7 summarizes mean diagnostic quality scores pre- and post-Isabel 
consultation, and the change in mean quality score for diagnoses, for each grade of 
subj ect. 
Table VI. 7: Mean quality scores for diagnoses broken down by grade of subject 
Mean pre-DDSS score Mean post-DDSS score Mean score 
changýý 
Consultant 0.39 0.43 0.044 
Registrar 0.40 0.44 0.038 
SHO 0.45 0.48 0.032 
Medical student 0.31 0.37 0.059 
Weighted average (all subjects)t 0.383 0.426 0.044 
* There was no significant difference between grades in terms of change in diagnosis quality score (one- 
way ANOVA p>0.05) 
Overall, the mean score for test-ordering plans increased significantly from 0.345 to 
0.364 (an increase of 0.019,95% Cl 0.011-0.027, t5l=4.91, p<0.001); this increase was 
smaller for treatment plans (0.01,95% Cl 0.007-0.012, t5 1=7.15, p<0.001). 
VI. 3.4.2 Number of diagnoses and irrelevant diagnoses 
624 case episodes from 52 subjects were used for this analysis. The results are 
illustrated in Table VI. 8. 
Table VI. 8: Increase in the average number of diagnoses and irrelevant diagnoses before and after 
DDSS advice, broken down by grade 
Grade No. of diag noses No. of irrelevant dia gnoses 
Pre-DSS Post- Increase Pre-DSS Post- Increase 
DSS DSS 
Consultant 3.3 4.6 1.3 0.4 0.7 0.3 
Registrar 4.3 5.9 1.6 0.8 1.3 0.5 
SHO 4.4 6.1 1.7 0.6 1.4 0.8 
Medical student 4.0 6.6 2.6 1.1 2.2 1.1 
Overall, the mean count of diagnoses included by subjects in their workup in the pre- 
Isabel stage was 3.9. This increased to 5.7 diagnoses post-Isabel (an increase of 1.8). 
The increase was largest for medical students (a mean increase of 2.6 diagnoses) and 
least for consultants (1.4 diagnoses). The ANOVA showed significant interaction 
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between grade and occasion (F3,58=3.14, p=0.034). The number of irrelevant 
diagnoses in the workup changed from 0.7 diagnoses pre-Isabel to 1.4 post- (an increase 
of 0.7 irrelevant diagnoses, 95% Cl 0.5-0.75). There was a significant difference in this 
increase across grades (most for medical students and least for consultants; 1.1 vs. 0.3 
irrelevant diagnoses, F3,48 =6.33, p<0.01). The increase in irrelevant diagnoses did not 
result in a corresponding increase in the number of irrelevant or deleterious tests and 
treatments (an increase of 0.09 tests and 0.03 treatment decisions). 
VI. 3.4.3 Changes to 'must-not-miss' diagnoses, tests and treatments 
At least one 'must-not-miss' diagnosis was added by the subject to their differential 
diagnosis after Isabel consultation in 94/751 case episodes (12.5%, 95% CI 10.1%- 
14.9%). 47/76 (61.8%) subjects added at least one 'must-not-miss' diagnosis to their 
diagnostic workup, after consultation. Overall, 130 such diagnoses were added after 
system advice during the experiment. In general, students were reminded to consider 
many more important diagnoses than consultants, although this was not statistically 
significant (44 vs. 26, Chi square p >0.05); a similar gradient was seen for difficult 
cases, but Isabel consultation seemed helpful even for easy cases. These results are seen 
in Table VI. 9. 
Table VI. 9: Number of case episodes in which clinically 'important' decisions were prompted by 
Isabel consultation 
Number of 'important' decisions prompted by Isabel Diagnoses Tests Treatment 
steps 
1 69 56 42 
2 19 12 5 
3 2 2 2 
4 3 0 0 
5 1 0 0 
None 657 637 678 
No. of case episodes in which at least ONE 'significant' 94(12.5%) 70(9.3%) 49(6.5%) 
decision was prompted by Isabel 
Total number of individual 'significant' decisions prompted 130 86 58 
by Isabel 
No clinically significant diagnoses were deleted after consultation. Important tests 
included by subjects in their pre-Isabel plan were sometimes deleted from the post- 
Isabel plan (64 individual items from 44 case episodes). A similar effect was seen for 
treatment steps (34 individual items from 24 case episodes). An inappropriate test was 
added to the post-Isabel list in 7/751 cases. Analysis performed to elucidate the source 
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of changes seen in the rate of diagnostic error indicated that all additional diagnoses 
included by subjects in their post-consultation plans were present in the system's list of 
possibilities. 
V13.4.4 Effect of variability in subjects'data entry on DDSSPerformance 
Data from 624 case episodes, across the 52 sub ects who completed all cases were j 
included. The mean number of case episodes in which the Isabel tool did not display all 
the 'must-not-miss' diagnoses was 7.75 (65%). No significant differences were seen 
between the various grades (F3,48 = 0.47, p=0.70). 
VI. 3.4.5 Consultation times 
Reliable data on consultation times were available in 633/751 episodes. The median 
time taken for subjects to abstract clinical features from the cases and record their initial 
clinical decisions on the trial website was 6 min (IQR 4-10 min). Median time taken to 
examine Isabel diagnostic suggestions and modify clinical decisions was I min (IQR 30 
sec-2 min). Time taken for Isabel to load the page containing its suggestions was less 
than 2 sec on all occasions. These data are shown in Table VI. 10. 
Table V1.10: Time taken to process case simulations broken down by grade of subject 
Median time pre-ISABEL Median time post-ISABEL 
Consultant 5 min 5 sec 42 sec 
Registrar 5 min 45 sec 57 sec 
SHO 5 min 54 sec 53 sec 
Medical student 8 min 36 sec 3 min 42 sec 
Overall 6 min 2 sec (IQR: 4: 03 - 9: 47) 1 min (IQR: 30 sec - 2: 04) 
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VI. 4 Discussion 
The quasi-experimental study described in this chapter formed the second stage in the 
step-wise evaluation process involving the Isabel diagnostic tool. Following a clinical 
performance assessment conducted by the system developers (chapter III), it was 
important to assess the utility of the diagnostic aid in the hands of clinicians. In a 
simulated envirom-nent, the impact of Isabel on diagnostic decisions made by subjects 
was examined without affecting patient care; in addition, it was possible to control for 
factors that may affect real life use such as poor access to computers, workload and lack 
of time. 
The salient findings were: 
a) Errors of omission occur frequently during diagnostic workup, including in less 
challenging cases. Errors occurred in all grades of subjects, irrespective of the level 
of their experience. 
b) It was possible to influence clinicians' diagnostic workup and reduce errors of 
omission using a reminder system capable of providing advice following rapid 
interaction. On average, one error of omission was reduced for every 24 cases 
processed by the subjects after Isabel consultation. 
c) Both clear benefits and adverse effects resulted from the use of the diagnostic aid. A 
number of irrelevant diagnoses were prompted, especially if subjects were 
inexperienced and less able to discriminate between suggestions. However, the net 
result was that 'must-not-miss' diagnoses were reminded in 12.5% of all 
consultations. 
d) Despite a number of subjects of different grades using the system, no significant 
inconsistency was seen in the advice offered by the diagnostic aid. 
VI. 4.1.1 Comparison with other DSS evaluations 
The current impact study differed from previous evaluations in two respects: study 
methodology and results. The main methodological difference was the use of the 
ýcorrect' diagnosis as the gold standard in expert system evaluations (Elstein, Friedman 
et al. 1996; Berner and Maisiak 1999). Since the purpose of expert systems was to assist 
users in cases without a clear diagnosis, case material was prepared from complex and 
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challenging cases, with a proven final diagnosis obtained either from diagnostic tests 
such as tissue biopsy or from autopsy. However, studies indicate that diagnostic failure 
may result from three distinct reasons: no fault errors, system-related errors and 
cognitive errors (Kassirer and Kopelman 1989; Graber, Gordon et al. 2002). No-fault 
errors occur either when the disease is rare, disease presentation is atypical, or when 
patients are uncooperative. In these cases, it would normally be impossible for 
clinicians to make the correct diagnosis, even with a faultless chain of reasoning and 
appropriate investigations, until specific diagnostic tests or autopsy results confirm the 
final diagnosis. Friedman showed that when experienced clinicians found diagnoses to 
be challenging, the DDSS also found them challenging, implying that the use of an 
ýexpert' system may not necessarily enhance diagnostic accuracy in these circumstances 
(Friedman, Elstein et al. 1999). On the other hand, cognitive errors occur due to lack of 
adequate medical knowledge, adequate synthesis of available clinical information or 
inadequate data collection; there is evidence that ineffective synthesis of available 
clinical data to reach a coherent diagnostic workup is the main reason for diagnostic 
errors in medical practice (Graber, Franklin et al. 2005). 
Cognitive errors were the main target for intervention in the current study; the 
evaluation centred on the concept of a 'safe' diagnostic workup in the acute setting, 
where the main goal was the inclusion of 'must-not-miss' diagnoses in the workup. In 
acute settings such as in emergency rooms, where an incomplete and evolving clinical 
picture results in considerable diagnostic uncertainty at assessment, the ability to 
generate a focused and 'safe' workup is a more clinically relevant outcome, one which 
accurately reflects the nature of decision making. Consequently, diagnostic errors of 
omission were defined as the 'failure to consider all clinically important diagnoses, 
judged by an expert panel working the same cases as must-not-miss'. This definition 
used a 'minimum' safe list of diagnostic possibilities, rather than a comprehensive list 
of plausible diagnoses, as the measure against which quality of decision making was 
assessed. 
Friedman performed a large-scale evaluation of the effects of two general medical 
DDSS, QMR and ILIAD, on clinicians' diagnostic reasoning (Friedman, Elstein et al. 
1999). Only diagnostically challenging cases were used in a simulated setting. A wide 
range of subjects were chosen to process cases (medical students, residents and 
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attending physicians). The 'correct' diagnosis was prompted by DDSS use in 
approximately 1 in 16 consultations. Although we used a similar experimental design, a 
mix of easy as well as difficult cases was used to test subjects. Our results showed that 
subjects were prone to incomplete workups in diagnostic conundrums as well as in 
routine clinical problems. Other studies did not assess the effect of changes in 
diagnostic reasoning on related test-ordering and treatment decisions. In modem 
healthcare, where cost effectiveness of diagnostic tests and treatment options is an 
important measure of the quality of service delivery, it is important to estimate the 
'downstream' effects of computerised diagnostic advice . We examined these effects in 
our simulated field study as robust markers of the impact of diagnostic decision support 
on the patient care. We were able to demonstrate an improvement in test-ordering in I 
in 10 DDSS consultations, indicating that diagnostic systems strongly influence patient 
management, despite only offering diagnosis-related advice. 
VI. 4.1.2 Key results and implications forfuture work 
The research design employed in this study allowed us to confirm a number of 
observations previously reported in the informatics literature, as well as to generate 
numerous unique ones. These findings mainly relate to the operational mechanisms and 
consequences of providing diagnostic assistance in practice. 
VI. 4.1.2. A System design 
One of the main aims of the Isabel system was to allow unrestricted access to users on a 
familiar and simple technical platform. A web-based model allowed users from different 
parts of the country to participate in this study without the need for additional 
infrastructure or financial resources; such an implementation model would promote 
widespread dissemination and minimise the cost associated with deployment. The 
DXplain system was made available on the World Wide Web for the same reason 
(Barnett, Famiglietti et al. 1998). In recent times, there has also been an emphasis on the 
use of service-oriented architecture for health systems; most systems described in this 
context use web technologies to allow integration and interoperability with other 
systems (Kawamoto and Lobach 2007; Nadkarni and Miller 2007). It is crucial that 
future diagnostic systems are integrated into health information systems to deliver 
diagnostic advice in an active manner, with minimal effort on part of the user. 
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The Isabel system was developed as a computerised system to prompt clinicians of key 
diagnoses. The reminder system model has been successfully used to alter physician 
behaviour by reducing errors of omission in preventive care (Ornstein, Garr et al. 1991; 
Garr, Ornstein et al. 1993; Tooher, Middleton et al. 2005). The Isabel system design 
aimed to utilise the strength of this model to enable clinicians to generate 'safe' 
diagnostic workups in busy environments where there is a high risk of diagnostic error. 
While diagnostic errors occur in emergency settings for a number of reasons, cognitive 
biases, such as premature closure and faulty context generation, remain main 
contributors (Croskerry 2002). The use of a reminder system may minimise the adverse 
effects of these cognitive biases. Future work should focus on using diagnostic tools as 
ýsafety nets' to reduce the incidence of omission errors in practice. In addition, 
reminders to perform important related tests and treatment steps will have a greater 
impact on patient outcome than simply suggesting diagnoses for inclusion in the 
workup. 
The Isabel system was designed for rapid use by busy clinicians. The time taken to 
process cases without system advice in this study compared favourably with the 
evaluation of QMR and ILIAD (6 vs. 8 minutes). Time taken to generate a revised 
workup with Isabel assistance, however, was dramatically shorter (1 min vs. 22 min) 
(Friedman, Elstein et al. 1999). Study and system design may both account for these 
differences. In previous evaluations, subjects processed cases twice, once without using 
the DDSS, and again with DDSS assistance. In the Isabel study, subjects processed the 
case and recorded their own clinical decisions while using the system for clinical data 
entry. As such, comparisons can be made only using the total time involved in 
processing each case (30 min vs. 7 min). This time saving was most likely to have been 
a result of the use of natural language text entry. Formatting the results in terms of body 
systems rather than clinical likelihood may also lead to the clinician focussing on the 
most likely set of diagnoses based on a clinical impression of the body system involved. 
VI. 4.1.2. B Data entry 
The means of entering clinical data into computerised decision support systems has 
been a subject of significant research (Payne 2000). In summary, two main mechanisms 
are used: manual data entry by users or automatic extraction of relevant data from 
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electronic medical record systems. All previously evaluated general DDSS used a 
controlled vocabulary to facilitate manual data entry. Terms included in these 
vocabularies varied between systems, and did not in general correspond to established 
medical terminologies such as SNOMED or Clinical Terms (Read Codes) (Stuart- 
Buttle, Read et al. 1996; Chiang, Hwang et al. 2006). However, despite the use of a 
controlled vocabulary, there was significant variability in the expression of clinical 
findings by different subjects working the same case during an evaluation of QMR 
(Bankowitz, Miller et al. 1991). Due to the facility to enter free text natural language 
queries into Isabel, we found marked variability in the summary of clinical findings 
entered into Isabel by different users for the same case. Despite this, the diagnostic 
suggestions offered by Isabel to different subjects did not vary noticeably. It is likely 
that the enormous diversity associated with natural language disease descriptions drawn 
from multiple sources in the diagnostic tool's database was responsible for this finding; 
the synonym file that automatically converted medical slang into recognized medical 
terms may also have contributed. Examination of the effect of entering whole chunks of 
narrative data into the Isabel system was a future aim following this study. Recently, 
this work has been reported by other investigators who were not involved in Isabel 
system development (Graber and Mathew 2008). 
VI. 4.1.2. C Diagnostic reasoning 
In keeping with other evaluations, different subject grades processed system advice in 
different ways, depending on their prior knowledge and clinical experience, and 
benefited to different extents. Since Isabel merely offered diagnostic suggestions, and 
allowed the clinician to make a final decision regarding which diagnoses to workup, 
subjects ignored even important advice in some cases. In some other cases, they added 
irrelevant decisions or deleted important decisions after system consultation, leading to 
a reduction in the net positive effect of the diagnostic tool. For some subjects whose 
baseline performance was already high, a ceiling effect prevailed, and no further 
improvement could be demonstrated. These findings are particularly useful, since they 
complement the results of our earlier system performance evaluation, which solely 
focused on the system's diagnostic accuracy and not on how the user interacted with the 
system to alter their decision making. 
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One of the main findings from this study was that consultants often generated shorter 
diagnostic workup lists containing the 'most likely' diagnoses, with a tendency to omit 
other important diagnoses that might account for the patient's clinical features. This led 
to a higher incidence of DEO among consultants. Experienced clinicians are more likely 
to resort to established pattern-recognition techniques and the use of heuristics while 
making diagnostic decisions (O'Neill 1995). While these cognitive shortcuts enable 
quick decision making in practice, and work successfully on most occasions, they 
predispose the clinician to a number of biases such as 'premature closure' and 
cconfirmation bias' (Elstein 1999). Medical students generated long diagnostic workup 
lists, but missed many key diagnoses leading to a high rate of DEOs. Inexperienced 
clinicians may not have developed adequate pattern-recognition techniques or acquired 
sufficient knowledge of heuristics to make sound diagnostic decisions. It may well be 
that grades at an intermediate level are able to process cases in an acute setting with a 
greater emphasis on clinical safety. Interestingly, we have shown that all subject grades 
gained from the use of Isabel in terms of a reduction in the number of DEO, although 
subjects benefited to varying degrees. Diagnostic omissions occurred more in cases 
considered to be routine in practice than in rare and difficult cases in the pre-DDSS 
consultation phase. Heuristics and subconscious pattern recognition may be to blame. 
Recognition that a case is unusual may trigger a departure from pattem-recognition and 
clinical shortcuts to a more considered cognitive assessment, leading to fewer DEO in 
these cases. 
System advice mainly improved decision making for difficult cases, with a smaller 
effect on easy cases; subjects may have been more willing to revise their decisions for 
difficult cases on the basis of Isabel suggestions. It is also possible that some subjects 
ignored relevant advice because the system's explanatory capacity was inadequate and 
did not allow subjects to sufficiently discriminate between the suggestions offered. The 
impact of DSS advice also showed a decreasing level of beneficial effect from 
diagnostic to test-ordering to treatment decisions. This may be a result of system design: 
Isabel does not explicitly state which tests and treatments to perform for each of its 
diagnostic suggestions. This advice is usually embedded within the textual description 
of the disease provided to the user, leading to the conclusion that busy clinicians will 
not benefit from information that is not readily available to them during decision 
making. 
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The role of diagnostic DSS in medical education and training needs formal evaluation. 
A number of reports have emphasised the role of expert systems in medical education 
(Bacchus, Quinton et al. 1994). In the current study, medical students gained 
significantly from the advice provided, suggesting that use of computerised diagnostic 
aids during the learning of specific tasks (e. g. problem-based case exercises) might be a 
valuable adjunct to current educational strategies. Familiarity with DDSS at an early 
stage in medical education may also predispose to greater adoption of computerised aids 
during clinical decision making in later practice. 
VI. 4.1.3 Limitations 
The limitations stem mainly from the experimental design. The repeated measures 
design raises the possibility that some of the beneficial effects seen are a result of 
subjects 'rethinking' the case or the consequence of a reflective process. Any such 
effects are likely to be minimal since sub ects did not actually process the cases twice j 
during the study, and spent negligible time between their first assessment of the cases 
and processing the diagnostic suggestions. The study design chosen provided the power 
to detect differences between users with minimal resources; a randomized design using 
study and control groups of subjects would have necessitated the involvement of over 
200 subjects. 
The cases used in our study contained only basic clinical data gained at the time of acute 
assessment, and may have proved too concise or easy to process. This seems unlikely 
since subjects spent an average of 8 minutes to process diagnostic conundrums in the 
pre -consultation stage, and 6 minutes with the cases used in this study. The cases used 
pertained to emergency assessments, making it difficult to generalize the results to other 
ambulatory settings. However, the focus of the current piece of work was on the acute 
paediatric setting. The ability of subjects to extract clinical features from textual cases 
may differ from their ability to assess patients in a real clinical encounter where missing 
data or 'red herrings' are quite common. The inherent complexity involved in patient 
assessment and summarising clinical findings in words may lead to poorer performance 
of the Isabel system in real life, since its diagnostic output depends on the quality of 
user input. As a corollary, some of our encouraging results may be explained by our 
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choice of subjects -a few were already familiar with surnmarising clinical features into 
the DDSS. 
Subjects were not supervised during their case exercises since they may have performed 
differently under scrutiny, raising the prospect of a Hawthorne effect. The use of a 
website to explicitly record clinical findings and decisions may have invoked the check- 
list effect. Since decision making was measured at a single point in time, it was difficult 
to assess the effects of iterative usage of the system on the same patient. Finally, the 
definition of diagnostic error in this study aimed to identify inadequate diagnostic 
workup at initial assessment that might result in a poor patient outcome. In the 
simulated setting, it was not possible to test whether inadequate diagnostic workup 
would directly lead to a diagnostic error and cause patient harm. 
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VIIJ Background 
Even when computerised systems demonstrably change users' decision making in the 
simulated setting, they may fail to influence practice within the clinical environment. 
Over the past few decades, a number of computerised systems have been described that 
failed to change healthcare processes or patient outcomes during field trials or following 
system implementation into the workplace (Hunt, Haynes et al. 1998; Garg, Adhikari et 
al. 2005). 
VILLI Factors that influence the success of CDSS in the clinical 
setting 
In order to avoid the development, evaluation and implementation of expensive 
computerised systems that do not deliver anticipated benefits, it is crucial to understand 
why some systems fail to influence clinical practice. 
a) Inadequate or non-existent need: A technological solution to a non-existent 
problem is likely to be rejected by users; equally, a CDSS may not always be the 
most effective solution to a clinical problem, since it may be more inefficient than 
paper-based approaches or involve the disruption of established clinical processes. 
For example, a large proportion of improvement in diagnostic accuracy seen in the 
Leeds abdominal pain study could be achieved with the use of a paper-based 
checklist alone (Adams, Chan et al. 1986). The description of a needs analysis for 
general medical DDSS has been previously reported (Berner and Shugerman 1991). 
b) Trustworthiness of advice: Even if computerised systems are developed to fulfil a 
specific clinical need, users need to be able to trust their recommendations. 
Appropriate advice may not be followed either if the CDSS is unable to explain its 
logic to the user or if the user does not trust the source of the underlying knowledge. 
For example, in a simulated assessment of the impact of a DDSS, Friedman showed 
that despite displaying the 'correct' diagnosis as part of its suggestions, QMR did 
not change subjects' diagnostic decisions in all cases (Elstein, Friedman et al. 
1996). 
c) Poor integration into workflow: One of the most important reasons 
for the failure 
of CDSS when introduced into a clinical setting is lack of integration 
into existing 
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workflow. Clinical productivity may in fact be reduced when the effort required to 
use a computerised system is much greater than the existing processes. Some of the 
most successful CDSS have been integrated as part of an electronic medical record 
(EMR) (Aronsky and Haug 1999; Dexter, Perkins et al. 2001). 
d) Poor usability: Even an integrated system will be unable to change practice unless 
the user interface enables users to extract the maximum benefit from the DSS in the 
shortest possible time. In the case of a standalone system, rapid use with minimal 
data entry remains a key requirement. For example, small changes to the format of 
advice provided in an integrated CDSS resulted in a significant benefit when none 
was demonstrable previously (Overhage, Tierney et al. 1996). 
e) Poor system use: Despite the availability of a well-integrated, usable CDSS, it is 
possible that clinicians never use the system frequently enough to gain from the 
system. For example, a large randomised study of the effects of decision support for 
asthma and angina showed a negative outcome because the CDSS was used in less 
than 10% of all eligible patients (Eccles, McColl et al. 2002). 
f) Socio-cultural factors: Poor usage may be a function of many factors, the most 
important of which relates to the socio-cultural beliefs that drive clinical practice. 
Clinicians may be concerned about losing autonomy of decision making; they may 
be fearful of computers or unfamiliar with technology, or worried about how 
patients may perceive the use of CDSS during care (Ridderikhoff and van Herk 
1999). 
g) System factors: Unless the health system allows clinicians to use CDSS easily 
within their workplace by providing adequate infrastructure, resources and time, 
with a commitment to reduction in errors and improving patient safety, it is unlikely 
that a computerised system will be adopted for routine use. 
VII. I. 2 Current status of DDSS in clinical practice 
Following the initial promise of computerised tools for diagnosis, interest in their 
development and evaluation waned after reports of their disappointing performance 
(Kassirer 1994). None of the DDSS were ever evaluated at multiple sites, other than the 
Leeds abdominal pain system; at the present time, none of the diagnostic systems, 
including the Leeds system, are in routine use within the NHS. While sporadic use of 
systems such as QMR and DXplain has been reported from the US, the main focus has 
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been on their educational value, rather than their role as computerised diagnostic aids 
for use 'on the frontlines' (Arene, Ahmed et al. 1998; Bauer, Lee et al. 2002). 
Reasons for the lack of widespread adoption of diagnostic aids in clinical practice, 
despite promising reports of their impact on decision making in simulated cases, are not 
completely understood. Recently, Berner suggested that factors related to the design and 
implementation of DDSS, users themselves, and the healthcare system in which 
clinicians work may all contribute to varying degrees (2006). 
Design and implementation 
One of the most important reasons why DDSS have not been used in routine practice 
relates to the fact that they are stand-alone in nature. While it has been easy to integrate 
reminder-based CDSS or CPOE systems into existing electronic medical records, the 
integration of diagnostic aids has remained a significant challenge, mainly due to the 
narrative, unstructured format in which details on acute patient assessment (history and 
physical examination) are collected. Since DDSS is separated from clinicians' routine 
workflow, the user is forced to expend extra effort in actively seeking decision support 
and entering clinical data. The time taken to process a lengthy list of suggestions that 
are too broad for clinical use may also be a significant impediment to usage. 
User-related factors 
Clinicians may themselves be unaware of their need for decision support during 
diagnosis. It was reported recently that physicians may be overconfident in their own 
diagnostic performance even when they are wrong. Lack of feedback regarding the final 
diagnosis, especially in settings such as primary care or emergency departments, may 
further exacerbate this phenomenon. Clinicians may not, therefore, seek decision 
support frequently enough to result in improvements in the diagnostic process 
(Friedman, Gatti et al. 2005). 
System-related factors 
Increasing specialisation and fragmentation in healthcare may lead to a failure in 
recognising the significance and impact of diagnostic errors and the need for Potential 
solutions. Since diagnosis has traditionally remained the exclusive preserve of the 
individual clinician, and diagnostic errors continue to be perceived as the result of 
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individual cognitive failures, healthcare systems may be unwilling to be involved in the 
system-wide adoption of computerised tools to aid the process of diagnosis. 
VII. 1.3 Aims and study design considerations 
The main aim of the current evaluation was to examine the effects of Isabel use on 
decision making by junior doctors during the acute assessment of paediatric patients in a 
clinical environment. The study also aimed to understand how frequently clinicians 
would seek diagnostic advice in practice, the specific circumstances in which they 
would do so, characteristics of the DDSS that would influence practice, and the barriers 
to adoption of computerised diagnostic aids in the clinical setting. 
VII. 1.3.1 Limitations of the simulatedfield study 
It was shown in chapter VI that the Isabel system altered decision making in an 
experimental setting when clinicians processed a set of simulated cases. Although the 
study design provided an efficient mechanism to test the impact of Isabel on different 
case-subject combinations during diagnostic decision making (and a preliminary idea of 
the user-friendliness of the system), it did not provide the environment encountered in 
real life. In day to day practice, the interplay of a multitude of factors, technical, socio- 
cultural and system-related, may nullify the benefits demonstrated in the simulated 
study. For this reason, it was crucial to study Isabel's impact on clinical practice in the 
real life NHS environment. We hypothesised that lessons learnt from a small scale 
implementation of diagnostic decision support could be generalised to the design, 
implementation and evaluation of other stand-alone DDSS in the future; it might also 
clarify the risks associated with the routine use of a diagnostic system. 
VIL 1.3.2 Clinical evaluations of other DDSS 
Only a few DDSS have been studied in clinical trials. The largest study involved eight 
centres and tested the use of the Leeds abdominal pain system in 12 610 patients with 
acute abdominal pain over a two year period. Personal computers pre-loaded with the 
statistical program were available at all centres. Although junior doctors were 
encouraged to use the system in 7757 patients, they used it in less than 
45% (3451 
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patients) due to lack of time. In a further 30% of patients, clinical data was entered by 
an on-site research assistant (Adams, Chan et al. 1986). 
Of the general diagnostic systems, MEDITEL was evaluated in a randomised clinical 
study where suggestions generated by the system were provided to the clinical team 
looking after patients without a clear diagnosis. A computer printout was provided to 
clinicians in the study group. Time to final diagnosis and number of tests ordered were 
studied as outcome measures (Wexler, Swender et al. 1975). In a study of QMR in a 
clinical environment, suggestions from the system were provided to the clinical team 
involved in patient care, following data entry into the DDSS by consultants 
experienced in the use of QMR. The effects of the computerised aid in terms of changes 
made by subjects to diagnostic workup were measured (Bankowitz, McNeil et al. 1989; 
Bankowitz, McNeil et al. 1989). 
In the above evaluations, an indirect consultation model was employed, in which users 
did not use the DDSS themselves, relying instead on system advice being provided to 
them by a researcher in the form of a computer printout. Lack of direct interaction 
between users and the system can lead to misleading estimates of the system's utility 
and benefits on clinical decision making. Research studies may also carry the risk of 
fundamentally altering work processes to accommodate conduct of the study itself - 
presence of a dedicated study investigator to train users, a research assistant to enter 
clinical data and promote system use, or the provision of additional time for system use 
during clinical work may lead to a false estimate of the system's benefits when 
implemented in the natural environment. 
We planned to study the effects of Isabel use in as natural a setting as possible. 
Provision was made for users to interact directly with the DDSS during their routine 
clinical work without any input from study investigators other than brief initial training 
in the use of the system. This chapter describes a multi-centre clinical trial examining 
the impact of the Isabel system on acute decision making. 
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VII. 2 Materials and methods 
We aimed to measure the clinical impact of the Isabel system on diagnostic decision 
making in the users' natural environment. Diagnostic suggestions were provided to 
junior doctors during acute paediatric assessments in which they sought decision 
support. Standardised scores developed during this research program (described in 
chapter V) were used to measure changes in the quality of decision making. A 
qualitative element of the study was planned to understand barriers to system use and 
adoption. The study was co-ordinated from St Mary's Hospital, Imperial College 
London and conducted between December 2002 and April 2003. 
VII. 2.1 Study centres 
It was intended that only district general hospitals (DGH) would be used as study 
centres, rather than large teaching hospitals, the rationale being that the considerably 
higher availability of senior consultant cover at teaching centres would reduce the need 
for diagnostic advice among junior doctors. It was hypothesised that this approach 
would maximise the impact of the assistance provided by the Isabel system. It was also 
important that at least some members of staff had previously used the Isabel system at 
the hospital, so that training requirements could be minimised. Therefore, all non- 
London DGH at which >4 individual users were registered in the Isabel database were 
shortlisted for further consideration. 
Four paediatric departments (two university-affiliated DGHs and two DGHs without 
official academic links) were finally enrolled, based on a combination of logistical and 
clinical reasons. All sites volunteered for the study; consultant contacts at these centres 
were familiar with the study investigators; and all sites were <100 miles driving 
distance from London. Three centres were geographically clustered in the Eastern 
Region. Two sites were separated by large distances from their tertiary referral centres, 
suggesting that the need for diagnostic assistance would be greater at these remote sites. 
None of the study centres were involved in the development of the Isabel system. The 
baseline characteristics of each of the participating centres are detailed in Table VII. 1. 
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Table VILI: Characteristics of participating centres in the clinical trial 
Centre A Centre B Centre C Centre D 
Nature Univ-DGH DGH DGH Univ-DGH 
24 hours dedicated PAU no* yes yes yes 
Annual PAU attendance 4194 4560 4780 4800 
Number of junior doctors 31 21 12 16 
Number of consultants (total) 10 7 7 11 
No. of consultants (acute cover) 6 4 4 7 
Computers in PAU 2 1 1 3 
Metropolitan area yes mixed no no 
Distance to referral centre (miles) <25 26 71 69 
Clinical activity (PAU attendances per 1.1 0.53 0.54 0.67 
hour PAU open) 
Computer accessibility index 1.8 1.9 1.85 4.5 
(available computers per unit clinical 
activity) 
Senior support (number of acute cover 0.2 0.2 0.3 0.4 
consultants Der subiect enrolled) 
PAU = paediatric acute assessment unit, *PAU open from 0800 to 0000 only 
VII. 2.2 Participants 
All junior doctors (Senior House Officers and Registrars) in substantive posts at each of 
the participating paediatric departments during the study period were enrolled after 
informed verbal consent. Consultants and locum doctors were excluded. 
VII. 2.3 Patients 
All children (age 0- 16 years) presenting with an acute medical complaint, and assessed 
by a junior doctor in a designated Paediatric Acute Assessment Area or Ambulatory 
Unit (PAU), were eligible for DDSS consultation. Outpatient attendances, re- 
attendances for follow up following recent discharge from the wards, and day case 
admissions were ineligible. We consulted subjects at each centre regarding their opinion 
on whether the Isabel system could be used universally in all eligible patients. Their 
feedback indicated that this was impossible within the time available for clinical 
consultation. Based on this, we allowed junior doctors to consult the DDSS only for 
patients in whom they experienced diagnostic uncertainty at the time of acute 
assessment. This subset of patients formed the study population. 
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VII. 2.4 Study design 
The evaluation was planned as a within-subject 'before' and 'after' study in which each 
study subject acted as their control (repeated measures design). There was no 
randomisation or the use of a contemporaneous control. During the clinical assessment 
of cases in which they felt the need for diagnostic assistance, participants explicitly 
recorded their diagnostic workup and clinical plans for tests and treatment first in the 
Isabel system. Following real-time DDSS consultation, subjects chose to either act on 
system advice by recording revised diagnostic workup and clinical plans, or not, thus 
ending the consultation episode. 
VII. 2.5 Intervention 
VII. 2.5.1 Decision support system 
The Isabel system available on the public website (http: //www. isabel. org. uk) performed 
two distinct functions - provision of diagnostic reminders and access to reference 
material. It was important that the current study design was not compromised by the 
various informational resources available to the subject, and that only diagnostic 
reasoning was studied. For this reason, a limited version of the system was used with 
only the diagnostic reminder function, and which utilised 128-bit SSL encryption and 
password-protection for secure transmission of patient data (htt-ps: //trial. isabel. org. uk). 
Only the first ten diagnostic suggestions were displayed, and reference material related 
to each diagnosis was not available. 
Subjects at each centre were blocked from using the public version of the system. Two 
methods were used: a) Internet Protocol (IP) address blocking and b) preventing users 
from study centres to newly register on the system. The trial version was accessible at 
each study site only via a designated shortcut icon placed on each computer available in 
the participating PAUs at the time of study commencement. This icon utilised cookies 
and an automatic authorisation script, facilitating the identification of the centre at 
which the request originated, and allowing subjects to access the system without 
individual log-in details. Once logged in, clinical data were captured in two consecutive 
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screens. On screen 1, subjects recorded the patient's clinical details in their own words, 
and entered their own diagnostic workup and clinical plans. 
Figure VIIJ: Screen 1 of the trial website used during the clinical trial 
Step 1: select validator 
I Dr Padmanabhan Ramnarayan 
LUIJ Z. UflLeF pduenv icienVITiers 
dat 
'e 
of birth 01 )101 1'2001 (d d. 1, m m/ 
surname smith 
where patient was seen 
fe. g. Ward, PACU, A&E 
P3LI 
Step 4: my differential 
diaqnosis is 
bacterial meningitis 
encephalitis 
Step 5: 1 have ordered 
these investigations 
blmd CUItUre 
lUmbar puncture 
Step 3: summanse the clinical 
features 
headache 
fe-ver 
neck stiffness 
petechial rash 
j, tc obtain accurate results, follovi 
the-=e simple rulesj 
Step 6: my 
treatment/management plan 
Is 
Based on the clinical details submitted in screen I, diagnostic suggestions were 
displayed on screen 2. Subjects had the choice to revise their original diagnostic workup 
and clinical plans by adding or deleting decisions at this stage. It was not possible to go 
back from screen 2 to screen 1. The consultation ended when data from screen 2 were 
finally submitted, or after >2 hours of inactivity. 
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Figure VII. 2: Screen 2 of the trial website used during the clinical trial 
print this page Step 8: tick the additional diagnoses you feel are relevant to your 
patient: check clinical features 
more diagnoses 
INFECTIOUS DISEASES 
F] Bacterial Meningitis r-R D 
E] Relapsing Fever r-R-Dj 
RV Enterovirus infections FR D1 
Vi ra I Men i ngoen cepha I iti s 
--j rR--D 
Parvoviral infections -1 FP-. D 
Meningoccmr-al Disease 'Ej FR--D 
Ej Herpes Simplex Encephalitis rR-'] D 
R Erythema infeGtiosum rR--D 1 
RESPIRATORY SYSTEM DISORDERS 
[] Pha ryng iti s. rron siII iti s ED- 
RHEUMATIC DISEASES 
Juvenile Rheumatoid Arthritis 
on the basis of the above differential diagnosis list, 
Step 9: what does your 
differential diagnosis include 
now? (there is no need to add any 
that have been ticked above) 
bacterial meningitis 
encephalitis 
Step 10: would you like 
to modify your 
investigations list? 
blood CLIltUre 
lumbar pLin M-Ure 
viral throat s".., vab 
Step 11: would you like 
to modify Your 
anagemenr nste 
3ntibiotics 
lleLiro-obsery, ations 
ily, ý Ci Cl O'd r 
not at all very 
Step 12: Please rate how useful Isabell was for the clinical 
management of this patient , -2 
0G 
012345 
Step 13: Please rate how useful Isabel was as an educational 
tool on this occasion 
Step 14: submit 
OV/ 
VII. 2.5.2 Training 
Training was intended to familiarise users with the features of the trial version rather 
than to train subjects how to use Isabel. Three separate group training sessions were 
organised by the candidate at each centre 30 days before the study start date, such that 
they coincided with mandatory departmental teaching sessions. This ensured maximum 
attendance at the training. Each session lasted 30 minutes. At each session, subjects 
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were asked to use the trial version of the DDSS with practice cases created for the 
study. Training sessions were repeated twice during the 5-month study period to recruit 
and train new starters, rather than to reinforce training for pre-existing users. 
VII. 2.6 Outcome measures 
A number of outcome measures were studied to provide a multi-faceted perspective on 
system utility and implementation. 
a) Primary outcome measure: Change in the proportion of 'unsafe' diagnostic 
workups following Isabel consultation. 'Unsafe' workups were defined as instances 
in which subjects' diagnostic workup deviated from a minimum gold standard of 
'must-not-miss' diagnoses provided by an independent expert panel of paediatric 
consultants. 
b) Secondary outcome measures: 
a. Inclusion of the correct discharge diagnosis in the diagnostic workup 
b. Changes in the quality scores for diagnostic workup and clinical action plans 
C. Time taken by subjects to complete system usage 
d. Number of diagnoses included in the diagnostic assessment pre- and post- 
system consultation 
e. Inappropriate tests and treatments ordered by subjects following system 
advice 
f Significant decisions deleted following consultation. 
c) Qualitative measures: User satisfaction with system use and function; users' 
opinion of barriers to system use; and study investigators' analysis of barriers to 
system use were also studied. 
VII. 2.7 Study procedure 
Study participants consulted the Isabel system during the trial (December 2002-April 
2003). In addition to recording their clinical decisions, subjects were also asked to 
indicate at the end of each consultation episode how useful the diagnostic advice 
provided had been for specific patient management and general educational benefit. 
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This was recorded on a Likert scale ranging from 0-5 (not useful to extremely useful). 
Data were collected during the study by two complementary methods: automatically 
from the trial version system logs and manually by a single research assistant. 
VII. 2.7.1 Automatic data collectionftom system logs 
The entire set of data is surnmarised below: 
Table VII. 2: Data collected automatically by the DDSS 
Patient details 
Surname 
Date of birth 
Age group (neonate, infant, child or adolescent) 
Sex 
User details 
Centre code (based on identity of icon clicked) 
Subject identity (including an option for Anonymous user) 
Subject grade 
Operational details 
Date and time of usage (log in, submission of each page of data) 
Unique study ID assigned at log in 
Clinical details 
Patient clinical features at assessment 
Doctor's differential diagnosis (pre-ISABEL) 
Doctor's investigation plan (pre-ISABEL) 
Doctor's management plan (pre-ISABEL) 
Isabel list of differential diagnoses 
Diagnoses selected from Isabel list by user as being relevant 
Doctor's differential diagnosis (post-ISABEL) 
Doctor's investigation plan (post-ISABEL) 
Doctor's management plan (post-ISABEL) 
Survey details 
Satisfaction score for patient management 
Satisfaction score for educational use 
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VII. 2.7.2 Manual data collection by research assistant 
During the study, the research assistant used the combination of patient identifiers 
recorded by the subject (surname, date of birth and sex) to obtain study patients' 
medical records. It was not possible to use partial or invalid matches to find medical 
records. The available records were photocopied such that all documented clinical notes 
up to the point of DDSS use were available; further information was discarded. 
Photocopies were anonymised by masking patient and centre details. The research 
assistant verified the diagnostic workup and clinical plans recorded by subjects on the 
trial website against the entries made in the medical records and in the hospital 
laboratory systems. Discharge diagnoses were collected from hospital administrative 
data for all study patients, and from discharge summaries where available. Discharge 
diagnoses were validated at the end of the study by one liaison consultant working in 
each study department. Demographic and clinical details of all eligible patients at each 
study centre (irrespective of whether 1sabel was consulted or not) were also collected 
from hospital administrative data. 
The research assistant also conducted open-ended interviews with study participants at 
the end of the study period to seek their opinion on the trial procedure and to elucidate 
any barriers they perceived to participation in the trial or system use. All subjects were 
also sent two rounds of email and postal questionnaires each to collect formal feedback 
at trial completion. 
VII. 2.7.3 Expertpanel 
A panel of four consultant paediatricians independently examined all available study 
medical records. Care was taken to mask subjects' clinical decisions recorded in the 
notes to ensure blinding. In the first instance, each panel member provided a list of 
'must-not-miss' diagnoses, tests and treatments for each case that would ensure a safe 
clinical assessment. The absence of 'must-not-miss' items in a subject's workup was 
explicitly defined during panel review to represent 'unsafe' clinical care. For this 
reason, the panel members did not include all plausible diagnoses for each case as part 
of their assessment, and instead focused on the minimum gold standard. Using this list 
as a template, the appropriateness of each decision suggested by subjects for each case 
was subsequently scored by the panel in blinded fashion using the previously validated 
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scoring system described in chapter V. The scoring system rewarded decision plans for 
being comprehensive (sensitive) as well as focussed (specific). 
Medical records were allocated to the panel members in a randomised block design. 
Study IDs were sorted randomly in sets of twenty. Four medical notes (25%) were 
assigned to all four panel members for review according to the scheme below. A further 
20% was assigned to one of the six possible pairs. In this fashion, slightly more than 
half the records were assessed by a single panel member. 
Figure VII. 3: Allocation scheme for medical notes in the clinical trial 
Panel members ABC and D will 
score 
123456789 101112 1314 15 16 17 18 1920 
12 346789 11 12 13 14 16 17 18 19 
(A and B) B (B and Qc (C and D) D (D and A) 
For each case, the minimum gold standard was collated from the panel members' 
opinion. For cases assessed by multiple panel members, 'must-not-miss' decisions 
provided by a majority of assessors were used to form the gold standard set. 
Concordance between panel members for clinical decisions was assessed by the intra- 
class correlation co-efficient. 
VII-2*8 Analysis, including statistical analysis 
From an operational standpoint, various definitions were used to characterise each stage 
of the consultation process. 
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VII. 2.8.1 Definitions 
a) Access attempt: Each attempt by a subject to log into the DDSS by clicking on the 
icon. Each click on the icon was counted as an access attempt as long as a valid 
Internet connection was available. 
b) Log in success: If screen I was displayed to the user, this was defined as log in 
success. For each successful log in, a unique study identifier was automatically 
generated by the trial website. 
c) Incomplete usage: Only data from screen 1 was saved; screen 2 was displayed. 
This may have resulted either from the user abandoning use once screen I data had 
been submitted or not saving screen 2 data even after viewing DDSS advice. 
Session time out resulting from inactivity on screen 2 may also have led to 
incomplete usage. 
d) Complete usage: Data was available from screens 1 and 2. 
e) System usage time: The difference between the system log in time and session time 
out (or end of consultation). 
f) Advice processing time: The difference between the time screen 2 was displayed 
and the end of the consultation (or session time out). 
VII. 2.8.2 Analyses 
A number of different analyses were conducted to provide a comprehensive view of the 
impact of Isabel system use. 
a) Consultation episodes were used as unit of analysis for the primary outcome 
variable. McNemar's test for paired proportions was used to examine statistically 
significant differences between the number of pre- and post-DDSS 'unsafe' 
diagnoses. 
b) In order to account for the clustering effects resulting from the same subject 
assessing multiple cases, subjects were also used as unit of analysis - the mean 
number of 'unsafe' diagnostic workups for each subject was calculated. Change in 
this variable following Isabel consultation was analysed using two-way mixed- 
model analysis of variance (subject grade being between- subjects factor and 
occasion being within-subjects factor). 
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c) In order to exclude re-thinking effect as an explanation for change in the primary 
outcome variable, all episodes in which there was a difference between the workup 
pre- and post-DDSS consultation were examined. If diagnoses were changed by 
subjects, post-DDSS consultation, and these were present in the Isabel suggestion 
list, it could be inferred that the DDSS was responsible for the change. 
d) A more objective marker of clinical benefit on patient outcome was assessed by 
examining whether the post-DDSS diagnostic workup (but not the pre-Isabel 
workup) included the patient's final discharge diagnosis. 
e) Using subjects as the unit of analysis, changes in pre- and post-DDSS diagnostic 
quality scores, as well as clinical action plan scores were analysed. Statistical 
significance was tested using one-way analysis of variance (grade as between- 
subjects factor) to provide a sensitive measure of changes in diagnostic workup, and 
tests and treatments. 
f) The median test was used to examine differences between grades in system usage 
time and advice processing time. 
Subjects were expected to use the DDSS in only a subset of eligible patients. In order to 
fully understand the characteristics of patients in whom junior doctors experienced 
diagnostic difficulty and consulted the DDSS, this group was analysed in more detail. A 
number of indices were generated to characterise the centre at which the system was 
used. 
PAU activity: number of acute assessments per 60 min period the PAU was 
functional. 
Computer accessibility index: number of available computers per unit PAU 
activity. 
Level of senior support: number of acute cover consultants per subject enrolled 
in the study - 
g) Patient factors (age, discharge diagnosis, outcome of assessment and length of 
inpatient stay if admitted); user factors (grade of subject); and other details were 
studied. These included the time of system usage (daytime: 0800-1800; out-of- 
hours: 1800-0800), centre of use and its nature (DGH vs university-affiliated 
hospital), PAU activity, computer accessibility index and level of senior support. By 
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means of multiple logistic regression analysis, factors that predicted completion of 
DDSS usage were studied. Significant variables were identified by univariate 
analysis and entered in forward step-wise fashion into the regression model. 
h) Characteristics of patients where subjects derived clinical benefit with DDSS usage 
were also analysed using multiple logistic regression. 
A correlation between subjects' own perception of system benefit (based on the 
Likert style response) with actual benefit (improvement in diagnostic quality score) 
was tested using the Pearson test. 
Qualitative analysis of feedback from subjects provided at the end of the study 
period was performed to provide insights into system design and user interface. 
A number of secondary analyses were carried out in order to understand why the Isabel 
system may not have produced the desired beneficial effect on subjects' decision 
making. 
k) The Isabel system was expected to provide advice tailored to the individual patient's 
condition. Lack of such specificity may be a significant reason why users did not 
modify their decisions following system consultation; testing the diversity of 
suggestions offered by Isabel was crucial to explaining its benefits. Across all 
episodes of completed usage, the number of unique diagnoses suggested by the 
system was calculated. An extreme scenario would be that the same diagnostic 
suggestions would be displayed irrespective of the data entered into the system 
(only ten unique diagnoses). 
Statistical significance was set for all tests at p value <0.05. 
VII. 2.9 Sample size estimation 
On the basis of the study in the experimental setting (chapter VI), we calculated that the 
clinical trial required data from 180 cases to detect a 33% reduction in clinically 
6unsafe' diagnostic workups (80% power; type I error 5%). We defined diagnostic 
workups as being 'unsafe' if they deviated from a 'minimum gold standard' provided by 
an independent expert panel. 
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VII. 2.10 Ethical and Regulatory considerations 
The study was co-ordinated from St Mary's Hospital, Imperial College London, and 
was approved by the London multi-centre research ethics committee (MREC/02/2/70) 
and relevant local research ethics committees at each study centre. Individual patient 
consent was waived by the ethics committee as long as a generic patient information 
sheet was given to all eligible patients and made available at each participating PAU. 
Subjects were verbally consented for enrolment into the study. Patient-identifiable data 
collected was limited to surname and date of birth. In combination with information on 
the centre at which they were assessed, the research assistant was able to trace the 
patient medical notes. Originating centre information was integral to the cookie placed 
on the Internet browser, and could not be ascertained in any other way. All patient data 
were collected on the trial version of the website, which utilised secure, 128-bit 
encryption to store and transmit data. Access to the server on which the patient data was 
stored was limited to administrators. All data protection and confidentiality precautions 
were followed according to the Data Protection Act 1998. 
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VII. 3 Results 
The study was conducted between December 2002 and April 2003. During the 5-month 
study period, 8995 children were assessed in the 4 PAUs. Of these patients, 6903 
children (76.7%) presented with medical problems and were eligible for inclusion in the 
study. Based on the number of times the study icon was clicked at the centres, 595 
separate attempts to seek diagnostic advice were computed (8.6% of the eligible patient 
population). 226 study identifiers were generated, implying that subjects successfully 
logged in only in 226 episodes. Some data were available for analysis in 177 cases, 
although complete data was available in 125 cases only (screen I data alone in an 
additional 52 cases). A summary is shown in Figure VIIA. 
Figure VIIA Summary of patients enrolled in study 
8995 patients seen in PAU in 
study period 
Ij 2092 patients excluded 
6903 patients with medical 
problems 
Number of patients in whom 
diagnostic uncertainty 
expressed - unknown 
595 attempts to access DDSS 
226 completed log in 
episodes 
177 episodes in which initial 
decisions submitted 
with surgical problems 
Log in unsuccessful in 369 
episodes 
52 incomplete episodes 
125 episodes in which 
complete data available 
-I Valid medical records 
104 medical records available 
and used for study 
unavailable in 21 cases 
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There was obvious attrition in the number of episodes in which the subjects managed to 
access the Isabel system to consult advice. In addition, medical notes were available in 
only a proportion of patients (Table VII. 3). 
Table VII. 3: Attrition in the number of usage episodes at each study centre 
Centre A Centre B Centre C Centre D Total 
Patients seen in PAU 2679 1905 1974 2437 8995 
Medical patients seen in 2201 1383 1405 1914 6903 
PAU 
Number eligible for unknown unknown unknown unknown unknown 
diagnostic decision support 
DDSS attempts 338 118 52 87 595 
DDSS successful log in unknown unknown unknown unknown 226* 
Step I completedt 47 26 45 59 177 
Steps 1&2 completed 30 25 20 50 125 
Medical records available 24 24 16 40 104 
* Each successful log in was automatically provided a unique study identifier which was not centre- 
specific. The number of successful log-ins was thus calculated as the total number of study identifiers 
issued by the trial website. 
t Step I completed indicates that following successful log-in, the subject entered data on the first screen, 
i. e. patient details and their own clinical decisions. 
V11.3.1 Study patients 
Patient characteristics are summarised in Table VIIA A wide variety of patient 
discharge diagnoses were seen, indicating the diverse nature of patients in whom 
subjects consulted the DDSS for advice (Table VII. 5) 
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Table VIIA Characteristics of study patients in the clinical trial 
Factor Number of DDSS consultation 
episodes (completed episodes) 
PATIENT FACTORS 
Age (n=177) 
Neonate 19 
Infant 33 
Young child (1 -6 yrs) 61 
Older child (6-12 yrs) 38 
Adolescent 26 
Primary diagnostic group (n=77) 
Respiratory 9 
Cardiac 0 
Neurological 6 
Surgical 3 
Rheumatology 5 
Infections 31 
Haematology 3 
Other 20 
Outcome (n=104) 
Hospital admission 58 
Discharge 46 
USER FACTORS 
Grade (n=177) 
SHO 126(79) 
Registrar 51(46) 
OPERATIONAL FACTORS (n=177) 
Time of use 
In hours (0800-1800) 113(84) 
Out of hours (1800-0800) 64(41) 
Centre 
A 47(30) 
B 26(25) 
c 45(20) 
D 59(50) 
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Table VII. 5: Discharge diagnoses from clinical trial 
Diagnosis Number of r)atients 
Viral infection 8 
Acute lymphadenitis 3 
Viral gastroenteritis 3 
Pelvic region and thigh infection 3 
Epilepsy 3 
Acute lower respiratory infection 3 
Allergic purpura 2 
Acute inflammation of orbit 2 
Chickenpox with cellulitis 2 
Gastroenteritis 2 
Rotaviral enteritis 2 
Feeding problem of newborn 2 
Syncope and collapse 2 
Lobar pneumonia 2 
Kawasaki disease 2 
Abdominal pain 2 
Angioneurotic oedema 1 
Erythema multiforme 1 
Constipation 1 
Irritable bladder and bowel syndrome 1 
Coagulation defect 1 
G6PD deficiency 1 
Sickle cell dactylitis 1 
Cellulitis 1 
Clavicle osteomyelitis 1 
Kerion 1 
Labyrinthitis 1 
Meningitis 1 
Myositis 1 
Purpura 1 
Scarlet fever 1 
Staphylococcal scalded skin syndrome 1 
Mitochondrial complex I deficiency 1 
Adverse drug effect 1 
Eye disorder 1 
Musculoskeletal back pain 1 
Trauma to eye 1 
Disorders of bilirubin metabolism 
Foetal alcohol syndrome 
Neonatal erythema toxicum 
Physiological jaundice 
Stroke 
Acute bronchiolitis 
Acute upper respiratory infection 
Asthma 
Hyperventilation 
Juvenile arthritis with systemic onset 
Polyarthritis 
Reactive arthropathy 
Anorectal anomaly 
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The largest subset of patients in whom the DDSS was consulted belonged to the 1-6 
year age group (61/177,34.5%). The mean age of patients was 5.1 years (median 3.3 
years). The DDSS was most frequently used by SHOs (126/177,71.2%). Although 25% 
of all eligible patients were seen on PAUs outside the hours of 08: 00 to 18: 00, more 
than a third of episodes of system usage fell outside the hours of 0800-1800 (64/177, 
36.2%). Subjects at Centre D used the DDSS most frequently (59/177,33.3%). In 
general, usage was greater at university-affiliated hospitals than at DGHs (106/177, 
59.9%). Discharge diagnosis was available in 77 patients. The commonest diagnosis 
was non-specific viral infection; however, a wide spread of diagnoses was seen in the 
patient population. 58 patients on whom the DDSS was consulted were admitted to 
hospital wards, the rest were discharged home following initial assessment. Inpatients 
stayed in hospital for an average of 3.7 days (range: 0.7-26 days). 
VII. 3.2 Subjects 
80 subjects enrolled during the study. 63 (79%) used the system to record patient data 
(mean 2 episodes each, range: 1-12); 56 (70%) provided complete patient information 
and revised clinical decisions post-DDSS consultation (mean 2 episodes each, range: I- 
6). Due to limitations in the trial website design, it was unclear how many of the 
subjects who did not use the system during the study period (17/80) had attempted to 
access the DDSS and failed. It was evident that some subjects used the DDSS on 
multiple (>9) occasions but did not provide revised clinical decisions, leading to 
incomplete system use. 
Figure VII. 5: Number of subjects completing steps I and 2 during clinical trial 
30 - 
25 - 
20 
n Step 1 complete 
15 - 0 [: 1 Steps 1 &2 complete 
10 
E 
:3 z 5 
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123456789 10 11 
Number of episodes of use 
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VII-3-3 'Unsafe' diagnostic workups 
Medical records were only available for 104 cases. Before Isabel consultation, 'unsafe' 
diagnostic workups occurred in 47/104 cases (45.2%), constituting episodes in which all 
4must-not-miss' diagnoses were not considered by subjects during initial decision 
making. Overall, the proportion of 'unsafe' workups reduced to 32.7% (34/104 cases) 
following DDSS consultation, an absolute reduction of 12.5% (McNemar test p value 
<0.001). 
Table VII. 6: Reduction in the proportion of 'unsafe' diagnostic workups 
Pre-DDSS Post-DDSS Relative Reduction 
Unsafe diagnostic workup 
SHO 28 17 39.3 
Registrar 19 17 10.5 
In a further 5 cases, appropriate diagnoses that were missing in subjects' workup did 
form part of Isabel suggestions, but were ignored by subjects during their review of 
DDSS advice. In 11/13 cases in which 'unsafe' diagnostic workups were eliminated, the 
DDSS was used by SHOs. Mean number of 'unsafe' workups per case reduced from 
0.49 to 0.32 post-DDSS consultation among subjects (p<0.001); a significant interaction 
was demonstrated with grade (p<0.01). Examination of the Isabel suggestion list for 
cases in which there was a difference between pre- and post-DDSS workup showed that 
in all cases, the additional diagnoses recorded by subjects formed part of the system's 
advice. Similar results were obtained for clinical plans, but smaller reductions were 
observed. In 3/104 cases, the final diagnosis for the patient was present in the subjects' 
post-DDSS list but not in the pre-DDSS list, indicating that diagnostic errors of 
omission were averted following Isabel advice. 
VII. 3.4 Secondary outcomes 
VII. 3.4.1 Diagnostic quality scores 
104 cases assessed by 51 subjects in whom medical records were available were 
analysed for this variable. Mean diagnostic quality score across all subjects increased by 
0.07 (95% CI 0.04-0.097) after DDSS consultation. The analysis of variance model 
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indicated that there was no significant effect of grade on this improvement (p 0.15). 
Similar changes in clinical plan scores were smaller in magnitude. 
Table VII. 7: Improvement in quality scores following DDSS consultation 
SHO Registrar Overall 
Diagnostic quality score change (SD) 
Clinical action plan score change (SD) 
0.083 (0.12) 
0.014 (0.063) 
0.04 (0.061) 
0.017 (0.074) 
0.069 (0.103) 
0.015 (0.067) 
VII. 3.4.2 Usage times 
Reliable time data were available in 122 episodes. Median time spent on system advice 
was I min 38 sec (IQR 50 sec -3 min 21 sec). There was no significant difference 
between grades with respect to time spent on screen 2 (median test, p=0.9). Total time 
included the time taken to process DDSS diagnostic suggestions, record changes to 
original diagnostic workup and clinical plans, and to complete the user satisfaction 
survey. 
VII. 3.4.3 Other effects of DDSS consultation 
Pre-DDSS, a mean of 2.2 diagnoses were included in subjects' workup; this rose to 3.2 
post-DDSS. Similarly, the number of tests ordered also rose from 2.7 to 2.9; there was 
no change in the number of treatment steps. Despite these increases, no deleterious tests 
or treatment steps were added by subjects to their plans following DDSS consultation. 
In addition, no clinically significant diagnoses were deleted from their original workup 
after Isabel advice. 
VIL 3.4.4 Factors predicting complete usage 
Using forward step-wise regression analysis, grade of the subject (registrar), time of 
system usage (in-hours), study centre, level of senior support and computer accessibility 
index were identified as independent factors predicting the completion of DDSS usage. 
Patients in whom actual benefit was demonstrated on diagnostic decision making were 
more likely to stay longer in hospital. 
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VU. 3.4.5 Diversity in Isabel diagnostic reminders 
469 unique diagnostic suggestions were generated by the DDSS during its use on 125 
cases (mean 3.75 per case). This represented a high degree of diversity of responses 
appropriate for the diverse case mix seen in this study. A static list would have 
consisted of the same ten diagnoses for each case, and a unique set of suggestions for 
each single episode of use would have generated 1250 distinct suggestions. 
VII. 3.4.6 Userperception of benefit 
Data were available in 125 cases in which subjects completed DDSS usage. Mean 
satisfaction score for patient management was 1.6 (95% CI 1.4-1.96). For Isabel use as 
an educational adjunct, this was higher (2.4,95% Cl 1.98-2.82). There was mild 
correlation between subjects' perception of DDSS usefulness in patient management 
and actual increment in their diagnostic quality score (r value 0.28, p value 0.0038). 
Figure VII. 6: Correlation between perceived benefit for clinical use and actual improvement in 
diagnostic quality 
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VII. 3.5 Qualitative analysis 
Feedback from questionnaires indicated that many subjects found the trial website 
cumbersome to use in real time since it forced them to record all their decisions prior to 
advice, taking up time during patient assessment. This was especially problematic since 
many subjects had used Isabel in its original form. A number of subjects were 
dissatisfied with computer access during the trial, mainly related to unavailability of 
passwords to access the Internet, slow computer connections, unavailability of adequate 
workstations at the point of clinical use and lack of infrastructure support. Another 
theme that emerged from user feedback involved the lack of access to reading material 
on diagnoses during the trial period - most users felt this was an important part of the 
system and the advice provided. 
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VII. 4 Discussion 
The final step in the series of planned Isabel evaluations was an impact assessment 
conducted in the clinical environment. The results of the current clinical trial indicate 
that diagnostic uncertainty occurs frequently in practice and that it is feasible for a 
standalone DDSS to improve the process of diagnostic assessment when used by 
clinicians during real life decision making. Improvement in diagnostic workup 
prevented a small but significant number of diagnostic errors of omission. A number of 
barriers to computer and Internet access in the clinical setting prevented system use in a 
significant proportion of eligible patients in whom subjects sought diagnostic assistance. 
VII. 4.1 Study design 
Many previous evaluations of DDSS were confounded by the consultation model they 
adopted. Both QMR and MEDITEL were studied in clinical settings; however, 
clinicians involved in patient care received system advice in indirect fashion. Experts 
familiar with the DDSS, or dedicated research assistants, acted on behalf of clinical staff 
to enter information into the system; users did not interact with the system themselves. 
The diagnostic consultation model maximised usage in a situation where clinicians were 
unfamiliar with the DDSS, and unable to undertake a lengthy process of data entry due 
to the constraints of clinical workload. However, the study design could not clarify how 
clinicians themselves would use and derive benefit from DDSS in a busy clinical 
setting. In the clinical trial described in this chapter, junior doctors were allowed to use 
the Isabel system without extensive training or monitoring, allowing the results to be 
generalised to any acute clinical setting. This naturalistic design allowed us to explore 
the complex interplay between users and the system, how users processed and utilised 
diagnostic advice, and various barriers that prevented system use. 
Some previous field trials of DDSS also utilised a randomised study design. The 
ACORN system for the diagnosis of chest pain was tested in such a trial involving 150 
patients; no difference was shown between the study and control groups. Randomisation 
was not adopted in the current clinical trial due to logistical limitations. By using 
subjects as their controls in a before-after manner, the power of the study was enhanced 
and the sample size was minimised. 
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VII. 4.2 Diagnostic uncertainty and DDSS use 
The main purpose of diagnostic aids is to assist clinicians during the assessment of 
cpuzzling' cases; however, the definition of 'puzzling' may vary from clinician to 
clinician, and perhaps even day to day within the same subject. There is considerable 
lack of information regarding the occurrence of diagnostic uncertainty in routine clinical 
practice. A number of studies have examined information needs of clinicians in various 
settings, mainly in primary care and hospital practice. Most available information 
suggests that clinicians wish for diagnostic assistance in 25-50% of cases. Yet, the rate 
of diagnostically challenging cases at busy referral centres, as described in the literature, 
does not match these figures even remotely. In the QMR study, it was reported that 54 
valid requests for diagnostic consultation were received from among a total of 1700 
patients admitted during a two month period (3%). The MEDITEL study reported that 
8% patients admitted to hospital over a one year period did not have a clear diagnosis at 
admission. It seems evident that diagnostic uncertainty may be an individual clinician- 
specific phenomenon, and is entirely different from a true diagnostic conundrum. 
The current study indicated that subjects sought to access diagnostic advice from a 
standalone reminder-based system in 8.6% of medical cases seen in the paediatric 
assessment units over a five month period. It is unclear whether doctors would have 
sought diagnostic advice in more cases either if the system was more accessible and 
easy to use, or if barriers to system usage such as time pressures, workload and poor 
infrastructure did not exist. In any case, subjects only managed to access diagnostic 
advice in 177 cases (2.5%). This three-fold difference between trying to access the 
DDSS and actually using it was a key finding in this study. It would not have been 
possible to elicit in a consultative model, where users would not directly interact with 
the system. If information needs among clinicians are valid indicators of diagnostic 
uncertainty, subjects should have actively sought DDSS consultation in many more 
cases. Since this was not true, it can be hypothesised that a number of barriers existed 
between subjects perceiving the need for decision support and actually using the DDSS. 
The informal interviews at the end of the study period suggested interesting and varied 
reasons for the poor usage of the system during the trial. Lack of availability of 
computers in the clinical area seriously compromised ease of access to 
decision support. 
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In fact, the computer accessibility index was shown to be a significant factor predicting 
the use of the diagnostic aid. It is possible that the provision of additional dedicated 
computers for the trial may have encouraged system usage; however, this was avoided 
since the trial's aim was to test the DDSS in the usual clinical environment. Poor 
Internet access for junior doctors and slow connections to the Internet were other major 
factors leading to inadequate DDSS use. Paradoxically, the need for subjects to enter 
detailed information into the trial website, such as their own clinical decisions, which 
were not required for the standard website, compromised system usage during the study. 
This observation has been reported in other studies, and limited the extent to which 
usage data from the study can be extrapolated to real life practice. Despite a typical 
consultation time of less than 2 minutes, many of the barriers described above related to 
the fact that the DDSS was standalone in nature, and not integrated into an EMR. Such 
integration would allow finer control on the quality of the clinical input data as well as 
provision of active decision support with minimum extra effort; in addition, it would 
facilitate iterative use of the system during the evolution of a patient's condition, 
leading to increasingly specific diagnostic advice with each consultation. 
VII. 4.3 Diagnostic reasoning 
The Isabel system provided advice in the field of diagnosis, an area in which 
computerised systems have rarely been shown to be effective in modifying users' 
decision making on the frontlines. Following a step-wise evaluation process, the 
candidate has previously shown that the Isabel system demonstrated adequate clinical 
performance when tested in isolation, and significant impact on clinicians' diagnostic 
decision making in a simulated environment. In this multi-centre clinical trial, further 
evidence has been generated that supports the findings of previous evaluation steps. 
Additionally, in a preliminary examination of the system's potential impact on patient 
outcomes, this study showed that three diagnostic errors of omission may have been 
averted by the use of the Isabel diagnostic reminder tool. While the numerical 
significance of these results is small, the findings suggest that widespread use of the 
cornputerised aid may lead to a considerable reduction in diagnostic error. 
The effects of the diagnostic tool on junior doctors' decision making were examined in 
terms of diagnostic decisions as well as clinical management. A number of interesting 
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effects were seen. Despite an increase in the number of diagnoses considered in the 
workup after Isabel advice was provided, no inappropriate tests were triggered. No 
subjects deleted appropriate decisions from their own list after DDSS consultation. 
Significant concerns have been raised regarding the theoretical adverse effects of DDSS 
consultation, such as additional tests or treatments. In practice, it appears that even 
junior doctors are able to discriminate between the suggestions offered by the 
computerised system, and select only appropriate choices to follow up with test ordering 
or treatment steps. This reassuring observation was also shown in the clinical trial 
involving the De Dombal system. Conversely, subjects also rejected a number of useful 
suggestions. In five cases, the final diagnosis was part of the Isabel list of diagnoses; 
yet, subjects did not identify these diagnoses as being important, implying that the 
explanatory capacity of the system may have been inadequate. 
When natural language text is used to drive the diagnostic engine, there is a risk that 
users would enter clinical information in widely variable fashion, leading to different 
results for each subject, compromising the consistency of the advice provided. In 
addition, each user may interpret the results using their own cognitive filter and clinical 
experience; thus, each clinician's experience during DDSS use is unique for each case. 
This interesting observation was demonstrated even when a controlled vocabulary was 
used for data entry during an evaluation of QMR. Despite this variability, it is important 
that the DDSS delivers consistent advice for each user. This function was tested in 
chapter V, where it was shown that the appropriate diagnoses were present in Isabel's 
list in spite of significant heterogeneity in the data entered by users. On the other hand, 
it is also important that the system generates suggestions dynamically, depending on the 
input data. Diversity of advice offered, depending on the case, is an important 
requirement of patient- specific decision support systems. From this clinical trial, it was 
evident that the Isabel system displayed a wide variety of unique diagnoses, consistent 
with the wide range of cases in which the system was used. 
VII. 4.4 Implications of the study results 
Since diagnostic uncertainty only occurs in a subset of acutely ill patients, 
diagnostic decision support interventions will need to be targeted, rather than being 
universally applied across all patient groups. It is likely that users would be the best 
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judges of when to seek diagnostic advice from a DDSS, although there is 
considerable evidence that clinicians' perception of the need for diagnostic decision 
support and their actual diagnostic performance are poorly correlated. Even in the 
current clinical trial, subjects perceived that the system was not useful in many cases 
where the diagnostic aid had prompted them to consider an appropriate diagnosis. 
There was poor correlation between the subjects' own perception of the usefulness 
of the diagnostic tool for specific patient management and the actual improvement 
in diagnostic quality score, further lending support to the fact that users may not 
necessarily be aware of the potential benefit offered by DDSS. Perhaps the best 
model might be an active diagnostic decision support engine running continuously 
within an EMR, which prompts users when they fail to consider key diagnoses. 
b) Although integration of DDSS within an EMR is the most promising option for the 
future, it is likely that the poor adoption of EMR in current practice, especially 
systems in which narrative data is coded, necessitates the use of a standalone system 
that is easy to use. The Isabel system described in this clinical study fulfils a number 
of characteristics of a successful DDSS - rapid, high quality advice from an easy to 
use system that takes up less than two minutes of consultation time. 
C) Since junior doctors, such as SHOs, are more likely to use and benefit from DDSS, 
the educational role of the system is significant. In combination with problem-based 
learning, and the use of meta-cognitive approaches during decision making, DDSS 
may act as 'safety nets' for junior clinicians in practice. 
VII. 4.5 Limitations 
The study design was compromised by the lack of detailed qualitative data that 
prevented investigators from fully exploring issues related to why users sometimes 
ignored DDSS advice, or specific cases in which users found the system useful. Isabel 
was provided variable amount of patient detail depending on the subject who used 
it, 
while the expert panel were provided detailed clinical information from medical notes. 
This discrepancy may have led to an unfair assessment of the effects of system use. 
Changes in decision making were assessed at one fixed point during the clinical 
assessment, preventing the assessment of the impact of 
iterative DDSS use with 
evolving and sometimes rapidly changing clinical 
information. Due to the before-after 
design, it could also be argued that any improvement observed resulted purely from 
182 
Evaluation of impact in a multicentre clinical trial 
subjects rethinking the case; since all appropriate diagnoses included after system 
consultation were present in the DDSS advice, this seems unlikely. In addition, subjects 
spent negligible time between their initial assessment of cases and processing the 
system's diagnostic suggestions. 
Our choice of primary outcome focused on improvements in diagnostic process, 
although we were able to demonstrate a small but significant impact on potential 
diagnostic error using the discharge diagnosis. The link between improvements in 
diagnostic process and patient outcome is difficult to illustrate, as evident from the 
model developed by Schiff (Figure 1.1). However, it seems reasonable to conclude that 
reduction in the number of process errors will lead to reduction in the number of actual 
errors, at least in some instances, as demonstrated in this study. In the current study 
design, it was not possible to test whether an 'unsafe' diagnostic workup would directly 
lead to a diagnostic error in omission and subsequent patient harm, due to the absence 
of a contemporaneous control group. Finally, due to barriers associated with computer 
access and usage, we were not able to reach the target number of cases, leading to 
reduced power of the study. 
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VIII. 1 General discussion 
From the time the World Wide Web was made available in the 1990s, the ready 
availability of information on the Internet has revolutionised human communication and 
access to knowledge. More than 1.5 billion users are believed to access the Web today 
to access medical and non-medical information (www. intemetworldstats. com). The 
Isabel diagnostic system was developed in 2001 as a newer generation decision support 
system that utilised web-based search technologies, a web platform for deployment, and 
sophisticated text-based matching techniques to generate rapid diagnostic reminders in 
response to natural language text entry. The system was made available to registered 
medical practitioners worldwide on the Internet (www. isabel. orR. uk) following an 
initial system performance evaluation. In the first two years of its existence, >15,000 
users registered for its use, 10% of whom used it in more than ten cases, and >60,000 
distinct user-logins were recorded (Ramnarayan, Winrow et al. 2006). These figures 
were comparable to the use of DXplain, a mature system available since the 1990s, 
where 46,000 users logged 122,000 sessions over an 8-year period (Hoffer, Feldman et 
al. 2005). 
The success of Isabel reflects how users have moved away from traditional standalone 
knowledge repositories to Internet-based knowledge bases in their quest for 
information. Powerful search engines such as Google (www. ýzoogle. com) are routinely 
used by clinicians to search for medical information in preference to conventional 
textbooks, due to rapid availability of knowledge during online searching. A recent 
study in which Google was used for medical diagnosis showed that an accuracy rate of 
nearly 60% could be reached for diagnostically challenging cases (Tang and Ng 2006). 
In parallel with Internet-based developments, the availability of greater computing 
power has led to the development of sophisticated software. It is likely that effective 
decision support systems of the future would employ a combination of Internet-based 
techniques for searching, design and implementation, and powerful software for 
processing vast amounts of information; Isabel represents an early prototype on which 
future DDSS may be based. For these reasons, it is important for users to fully 
understand the strengths and weaknesses of the Isabel system, as well as 
its effects on 
clinical decision making. 
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The research undertaken as part of this thesis work involved a series of incremental 
steps in the evaluation of the Isabel system, starting from assessment of its performance 
against standard cases through to assessment of its impact in simulated and real life 
settings. The evaluation focussed on a stable version of Isabel and was summative in 
nature. A new score to measure the quality of acute decision making was developed and 
validated during the investigation. It was demonstrated that the Isabel system performed 
with acceptable accuracy and speed in a wide range of clinical problems; improved the 
quality of diagnostic and related decisions made by all grades of clinicians in easy and 
difficult cases; displayed diagnostic suggestions consistently despite wide variability in 
the nature of data entered as queries; reminded clinicians of a small number of 
diagnoses that were eventually found to be the final diagnosis for the patient; and was 
capable of changing practice in most cases in less than a couple of minutes. While the 
evaluations mainly focused on quantitative outcome measures, some qualitative aspects 
of Isabel usage were also studied. Successful implementation of computerised systems 
into complex, busy and often chaotic clinical environments depends on various human 
cultural, social, organisational as well as technical factors. It is likely that time-motion 
analysis, an ethnographic study design and more robust interviewing techniques would 
have strengthened the work described in this thesis, and provided further information to 
explain why junior doctors failed to use the Isabel diagnostic aid more frequently and 
what aspects of its design they found useful. 
Evaluation of decision support systems can be an arduous and complex task. The work 
described in this thesis showcases some of the difficulties faced by informatics 
researchers working in this field. The candidate had to work through various challenges 
such as uncertainty over the choice of optimal study design, lack of standardised 
outcome measures and performance metrics, and understanding the reasons for failure at 
each stage of the evaluation process. Despite these hurdles, sequential evaluation 
undertaken to explore various interactions between system, user and the environment 
provided useful lessons for the design and implementation of Isabel as well as future 
Intemet-based decision support systems. Successful standalone systems need to provide 
consistent and trustworthy advice to clinicians in their workflow rapidly in response to 
minimal user interaction. The ability of the Isabel system to produce benefits with 
minimal user effort indicates that its widespread use in clinical practice may result in 
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improved diagnostic decision making and lead to a reduction in patient harm from 
missed or delayed diagnoses. Although these aspects were not studied as part of the 
work described in this thesis, they form a crucial part of the argument for clinicians to 
adopt decision aids widely. 
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VIII. 2 Future work 
A number of themes have been identified for future research using the Isabel system. 
Lessons learnt from these studies would provide useful insights not just into Isabel, but 
other decision support systems modelled on Internet search technology. 
V111.2.1 Research into patient outcomes 
Donebedian's work classified the many possible measures of quality of care into three 
main categories (Donabedian 1988). 
a) Structural measures: the resources needed to deliver healthcare (staff, space, etc. ) 
Process measures: the activities occurring in healthcare (diagnostic accuracy, 
number and appropriateness of tests ordered) 
c) Outcome measures: the end result of clinical processes (mortality rate, length of stay 
in hospital, rate of misdiagnoses etc. ) 
The research work described in this thesis focussed specifically on changes in process 
measures rather than outcomes. Examining this with respect to the model of diagnostic 
error described by Schiff et al (Figure 1.1), it is clear that not all diagnostic process 
errors would have resulted in diagnostic errors, and not all diagnostic errors would have 
led to patient harm. Therefore, the available results of Isabel performance do not 
provide any indication of how the system would influence the incidence of 
misdiagnoses, missed diagnoses and delayed diagnoses in practice. Future evaluations 
of Isabel would need to specifically address these research questions, although the rarity 
of such events suggests that a clinical trial to examine reduction in diagnostic error will 
either need to recruit hundreds of patients or examine the impact of Isabel in specific 
high-risk areas such as critical care and emergency departments. 
VIII. 2.2 Integration into an EMR 
One of the main findings from the clinical trial was the relatively low frequency of the 
use of the computerised tool, especially during conditions of high clinical workload and 
time pressure. Despite its ease of use, the standalone Isabel system was not used in a 
number of occasions when doctors experienced diagnostic uncertainty. The main barrier 
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cited in the clinical study was access to computers. An enormous transformation in 
infrastructure has been planned in NHS hospitals as part of the Connecting for Health 
program (www. connectingforhealth. nhs. uk); the increased availability of wireless local 
area networks, handheld devices and mobile tablet PCs would certainly improve access 
to computerised decision support at the bedside. However, it is unclear whether this 
alone will lead to realisation of the benefits of decision support, or whether integration 
into electronic medical records is essential to achieve the promised effects. This 
question needs to be analysed in the context of evidence that clinicians have poor self- 
assessment skills, and may be unaware of the need to seek decision support even when 
their diagnostic reasoning is faulty (Davis, Mazmanian et al. 2006). The success of 
integrated CDSS in other areas such as preventive care and medication administration in 
improving patient outcomes indicates that diagnostic DSS have to be integrated into 
EMRs to achieve similar results. Although reports of QMR and DXplain integration 
into an EMR have been published, widespread integration has been limited by the fact 
that most EMRs do not collect details on clinical assessment in structured form 
(Welford 1994; Elhanan, Socratous et al. 1996). With the Isabel system, it may be 
possible to use narrative free text data from EMRs to drive the search, thus generalising 
its utility further (Graber and Mathew 2008). Future research has to focus on the ease of 
use and impact of an integrated Isabel system on changes in diagnostic process and 
outcomes. 
V111.2.3 Self-learning systems 
Most computerised systems are incapable of automatic self-learning from feedback on 
their performance. While reflective practice and learning from patient follow up can 
improve physicians' future diagnostic reasoning, this aspect has been difficult to 
achieve with diagnostic systems. Dxplain reported a mechanism whereby user 
feedback 
on cases is used to make manual changes to the database; a similar process was 
in place 
for the Isabel system. However, future research will need to examine how and whether 
automatic links to EMRs will allow Isabel to function as a 'closed-loop' system, not 
just 
in terms of accepting clinical information to generate advice, but drawing on follow up 
information. 
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V111.2.4 Research in other care settings 
The primary focus of this thesis was on acute clinical assessment in paediatrics. In other 
areas such as general internal medicine, critical care or general practice, it is possible 
that the benefit of the diagnostic tool will be different, either due to the frequency and 
nature of diagnostic uncertainty or due to differences in clinical practice and clinical 
experience of the users. A comprehensive understanding of the Isabel system's utility 
will only be available when it has been tested in a wide variety of clinical settings. 
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